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Virginia Commonwealth University, 2018
Supervisor: Lukasz Kurgan
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Drugs exert their (therapeutic) effects via molecular-level interactions with proteins and other 
biomolecules. Computational prediction of drug-protein interactions plays a significant role in the 
effort to improve our current and limited knowledge of these interactions. The use of the putative 
drug-protein interactions could facilitate the discovery of novel applications of drugs, assist in 
cataloging their targets, and help to explain the details of medicinal efficacy and side-effects of 
drugs. We investigate current studies related to the computational prediction of drug-protein
interactions and categorize them into protein structure-based and similarity-based methods. We 
evaluate three representative structure-based predictors and develop a Protein-Drug Interaction 
Database (PDID) that includes the putative drug targets generated by these three methods for the 
entire structural human proteome. To address the fact that only a limited set of proteins has known 
structures, we study the similarity-based methods that do not require this information. We review 
a comprehensive set of 35 high-impact similarity-based predictors and develop a novel, high-
quality benchmark database. We group these predictors based on three types of similarities and 
their combinations that they use. We discuss and compare key architectural aspects of these 
methods including their source databases, internal databases and predictive models. Using our 
novel benchmark database, we perform comparative empirical analysis of predictive performance 
of seven types of representative predictors that utilize each type of similarity individually or in all 
possible combinations. We assess predictive quality at the database-wide drug-protein interaction 
level and we are the first to also include evaluation across individual drugs. Our comprehensive 
analysis shows that predictors that use more similarity types outperform methods that employ 
fewer similarities, and that the model combining all three types of similarities secures AUC of 
0.93. We offer a first-of-its-kind analysis of sensitivity of predictive performance to intrinsic and 
extrinsic characteristics of the considered predictors. We find that predictive performance is 
sensitive to low levels of similarities between sequences of the drug targets and several extrinsic 
properties of the input drug structures, drug profiles and drug targets.
1Chapter 1 Introduction
Proteins are fundamental components of all organisms. They are essential to virtually all 
biological processes in cells. At the molecular level, proteins perform their functions by interacting 
with a wide range of molecules including other proteins, DNA, RNAs, and a variety of other
smaller ligands. 
Drug is a chemical substance that is used to prevent, treat, or cure a disease. Drugs work
through molecular interactions with biological macromolecules, such as proteins and nucleic acids,
which are typically referred to as drug targets. Approximately 90% of the existing drugs interact
with human genome-encoded proteins [1], and this is why we focus on the druggable human 
proteome (collection of all the human proteins that are interacting with drugs). The molecular 
interactions between proteins and drugs typically inhibit or stimulate the cellular functions of 
proteins where such changes of functional states lead to the therapeutic effects or side effects [2]. 
Knowledge of the associations between drug compounds and their protein targets is essential for 
a wide range of pharmaceutical and bioinformatics studies. These studies include screening drug 
candidates that targets specific disease-associated genes/proteins [3-6], drug repurposing 
(searching for targets associated with diseases that are not yet known to benefit from the existing 
drugs) [7-11], discovery and characterization of side-effects that stem from the interactions with 
non-therapeutic off-targets [12-16], and elucidation of the druggable human proteome, which is 
2defined as the complement of human proteins that interact with drugs [1, 17-20]. Many databases 
house information on drug-protein interactions (DPIs) and capture knowledge on drugs and targets 
to facilitate these studies [21, 22]. However, these databases are relatively incomplete. They cover
a small portion (~15%) of human proteins that are already known to be drug targets and for which 
the three-dimensional (3D) structures are known [23]. The databases are complemented by 
computational methods that generate putative drug-protein pairs on a large, up to the whole 
proteome scale. These predictions can be used to facilitate discovery of new DPIs by constraining 
the scope of expensive and time consuming in vitro and in vivo experiments that are employed to 
discover and validate the putative DPIs [24-26]. They are also utilized to develop databases of pre-
computed putative DPIs [27-29] and were used to facilitate discovery of the therapeutic 
mechanisms and side-effects of drugs [16, 30, 31].
Computational prediction of DPIs typically incorporates information about drugs and 
structures or sequences of target proteins. Inspired by recent surveys [32-34], we define two 
categories of computational methods for DPI predictions: 1) Protein structure-based methods and 
2) similarity-based methods that do not use 3D structures of the target proteins. The first group 
search for binding sites (the locations on the protein surface where binding occurs) from protein 
3D structures. This group could be divided into two subgroups: molecular docking and structural
alignment. The molecular docking models the physical interactions, including geometric 
complementarity, between a given drug and protein surface to detect potential binding sites. The 
structural alignment finds binding sites that are similar to known binding sites based on protein 
structure alignment. The second group of methods explores similarities between structures and 
profiles of drugs and non-structural information about their target proteins with known DPIs to 
predict novel DPIs. The protein structure-based methods use more information, and therefore the
3predictive quality of their results is typically higher than the predictive quality of the second group 
of methods. However, the protein structure-based methods are limited to the proteins that have 
known 3D structures or for which structures can be accurately predicted. The similarity-based 
methods rely on protein sequences, drug structures and profiles that are more widely accessible 
than protein structures. For instance, in March 2017, 5870 protein structures are available in the 
RCSB Protein Data Bank (PDB [35], a comprehensive repository for three-dimensional structures 
of proteins and nucleic acids) for 19,077 human protein-coding genes [36], while there are 70,946 
gene products (that include isoforms of proteins) in the Universal Protein Resource (UniProt [37]), 
a comprehensive repository for protein sequences and annotations [38]. In contrast to the protein 
structure-based methods, the similarity-based methods can be applied to predict potential protein
targets. Additionally, in general, the protein structure-based methods, in particular the molecular 
docking approaches, are computationally more costly than the similarity-based methods. 
Altogether, the similarity-based methods cover a larger population of target proteins and are less 
computationally intensive compared to the structure-based methods.
1.1 Goals of the dissertation
The objectives of this dissertation are to review and characterize a comprehensive collection 
of methods for the prediction of DPIs, assess their predictive performance, and provide access to 
their predictions. These objectives are addressed with the following three goals:
1) Evaluation of protein structure-based predictions of DPIs and development and 
deployment of DPI database. We empirically assess predictive performance of several
protein structure-based DPI predictors for selected representative drugs over the entire 
4structural human proteome. We develop and deploy a large-scale database of putative and 
native DPIs for the entire structural human proteome.
2) Review of the similarity-based DPI predictors. We provide a comprehensive and in-depth 
review of a comprehensive collection of high-impact similarity-based methods for DPI 
predictions. This review substantially improves and expands over the existing reviews on this 
topic.
3) Empirical assessment and comparative analysis of similarity-based DPI predictors and 
their consensuses. We implement, empirically evaluate, and compare representative 
similarity-based DPI predictors on a novel and high-quality benchmark database. We include 
new ways to assess predictive performance, including analysis of the relation between the 
predictive quality and characteristics of the predictors. We also deploy implementations of 
the representative methods as a webserver.
In this dissertation, we first introduce background knowledge concerning the biological 
foundations of drug-protein interactions and basic information about computational predictions in 
Chapter 2. Then we report empirical findings and provide detailed discussions for each of the three 
goals stated above in Chapters 3, 4, and 5, respectively. Finally, Chapter 6 presents summary, 
conclusions, and possible directions for future works.
5Chapter 2 Background on drug-protein interactions
In this Chapter we introduce the essential knowledge concerning protein sequences and 
structures and their importance to characterize the molecular details of the DPIs. We discuss
significance of computational prediction of DPIs and briefly review the current structure-based 
and similarity-based methods for the prediction of DPIs. 
2.1 Protein sequence and structure
Proteins are involved in virtually all cellular processes and functions. Examples of these 
functions include transcription, translation, gene regulation, cell metabolism, and molecular
transport. Proteins are built from a sequence of 20 different amino acids that are linearly ordered 
in a polypeptide chain and connected by peptide bonds. These peptide bonds and α-carbon atoms 
in the concatenated amino acids constitute of the protein backbone. The sequence of amino acids 
determines the shape of the corresponding protein and is typically referred to as protein primary
structure.
The shape of a protein is formed to a large extent by interactions between amino acids. Protein
structure consists of a collection of the local structures (segments in the primary structure). These 
segments of the local structures are called the protein secondary structures. Typical secondary 
structures include α helices, β sheets, β strands, turns, coils, loops, etc. Formation of these 
6structures is mostly detemined by hydrogen bonds that connect the sequence of amino acids in the 
protein backbone.
The set of secondary structures folds into a specific spatial arrangement, typically forming a 
compact globular molecule. This arrangement defines the protein tertiary structure. The process of 
folding the sequence into this three-dimensional molecule relies on hydrophobic interactions with 
solvent and tertiary interactions between amino acids. An illustration of hierarchical protein 
structures for an example protein (PDB ID: 4NKX [39]) is shown in Figure 1. The sequence 
(Figure 1a) is collected from PDB [35]. The secondary structure (Figure 1b) is annotated by 
Dictionary of Protein Secondary Structure (DSSP) [40, 41]. DSSP is a program that computes
secondary structure assignments for PDB entries, which are graphically illustrated in PDB [35]. 
We use Protein Workshop [42] to visualize the tertiary structure using a ribbon style format (Figure 




Figure 1. Protein sequence and structures of an example protein. This protein is collected from PDB ID: 4NKX [39]. 
(a) Sequence (primary structure) that is represented by single-letter codes for amino acids. (b) Secondary structure
that is generated by DSSP [40, 41] and visualized in PDB [35]. (c) Tertiary structure that is visualized by Protein 
Workshop [42] and represented using ribbons-style format. (d) Molecular surface of the tertiary structure that is
rendered with Protein Workshop [42].
2.2 Drug and drug-protein interaction
8Drugs are chemical substances that are used to prevent, treat, or cure diseases in human and 
other living organisms. Drugs exert their therapeutic effects (desired) or side-effects (undesired) 
through interactions with biological targets including proteins, DNA, RNA, and membrane 
components such as lipid and carbohydrates [43]. There are significant challenges to accurately 
and comprehensively define targets, consistently map these targets to specific proteins and genes,
and comprehensively compile and update repositories of targets [44]. We are very far from having 
all-inclusive and consistent repositories that include all existing drug targets and that specify a 
precise number for different categories of targets, especially for the nucleic acids and other non-
protein partners. However, ongoing attempts have provided a consensus on the overall landscape 
of drug targets. An early and influential study in 2002 conceptualized the druggable genome for 
the first time and showed that the majority of marketed drug targets are proteins, with DNAs and 
other miscellaneous biomolecules accounting for only 3% of targets [18]. Recently, researchers
estimated that 44% of unique human targets associated with approved drugs were G-protein-
coupled receptors, nuclear receptors, protein kinases and ion channels, while 29% were enzymes 
and 15% were transporter proteins [45]; all of these are proteins. Furthermore, as reflected in their
review [45] and a more recent update [1], these protein families make up between 93% and 95% 
of drug-target interactions. Additionally, a recent comprehensive analysis provided a similar
perspective on the characteristics of current drug targets: 96% of 893 mechanistic drug targets 
were mapped to proteins while the remaining 4% of targets are nucleic acids and other 
biomolecules. Moreover, the protein targets are responsible for the clinical efficacy of 89% of 
1578 FDA-approved drugs and involved in 93% of all identified drug-target interactions [44].
Considering that such predominant fraction of targets are proteins, we focus on the DPIs in this 
dissertation.
9Drug discovery and development requires a large amount of money and time to address
identification of the potential targets, to search for drug leads, to analyze massive quantities of data
to select promising leads, to validate leads in a wet-lab, and to perform clinical trials [46]. High-
quality identification and validation of DPIs is a vital prerequisite to investigate new drugs and 
determine their targets. This is important since drugs may interact with undesired targets (off-
targets) that result in adverse events or side-effects, precluding further drug development and use. 
The chemical screening with cell assays is used to measure drug-protein binding affinity (how 
tightly a drug lead compound binds to a selected protein target). However, such experiments are 
limited in scope as they screen against a relatively small panel of protein targets [47, 48]. For 
instance, SafetyScreen44 panel screens against 44 targets recommended by four major 
pharmaceutical companies including AstraZeneca, GlaxoSmithKline, Novartis, and Pfizer [49].
Moreover, Novartis screens against interactions with a panel of 24 targets associated with severe
side-effects and high hit rates [50], Pfizer screens against between 15 and 30 targets [51], and 
Roche uses a panel of 48 targets [52]. Therefore, there is a need to develop high-throughput 
computational methods for the prediction of DPIs. In particular, to develop methods that can screen 
a given drug against a comprehensive set of thousands of protein targets that make up the human 
proteome. The computational methods that identify putative DPIs by exploiting information about 
both drugs and proteins can be used for that purpose. Depending on whether the three-dimensional
structure of a protein is used (known) or not, the prediction methods could be categorized into two 
groups: protein structure-based methods and similarity-based methods that do not rely on protein 
structures. Next, we define and discuss these two groups of methods.
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2.3 Protein structure-based methods
A binding site is a location on the surface of a protein where the intermolecular interaction 
occurs. The structure of binding site typically looks like an open pocket or cavity that provides 
geometrical fit for the structure of the drug. The surface of the pocket not only offers geometric 
complementarity between protein and drug structures but also has to provide favorable physical
characteristics like charge and hydrophobicity. Progesterone is an FDA-approved drug to support 
and regulate embryo implantation, pregnancy maintenance, and the development of mammary 
tissue for milk production [53]. Human cytochrome P450 17A1 and progesterone receptor are two 
representative targets of progesterone that have structures in complex with this molecule. Figure 
2a shows the 3D structure of the cytochrome P450 17A1 (PDB ID: 4NKX [39]) and Figure 2c
shows a binding site where this protein interacts with progesterone compound. The binding site is
a pocket with a specific shape and size that fit the progesterone molecule which is displayed with 
red balls and sticks. Similar protein structures may have similar cavities/pockets that could interact 
with the same drug. Figure 2b is the structure of human progesterone receptor (PDB ID: 1A28
[54]) and Figure 2d is its binding site for progesterone. These two protein structures are globally 
dissimilar with noticeable differences (Root-mean-square deviation of atomic positions = 5.49 Å), 
which can be observed when comparing Figure 2a and Figure 2b. However, the binding sites, i.e., 
the pockets in Figure 2c and Figure 2d, are composed of similar spatial arrangement of secondary 
structures that include three long helices. Significant structural similarity between these two 




Figure 2. Two structurally dissimilar protein structures and their similar binding sites for progesterone. (a) The 
structure of human epidermal growth factor receptor inactive tyrosine kinase domain complexed with progesterone
(PDB ID: 4NKX [39]). (b) The structure of human epidermal growth factor receptor tyrosine kinase domain
complexed with progesterone (PDB ID: 1A28 [54]). (c) Progesterone and its binding site on 4NKX. (d) Progesterone
and its binding site on 1A28. Protein molecules are represented by green surfaces. Progesterone molecule is 
represented by red balls and sticks. We use Protein Workshop [42] to visualize these structures.
The assertion that the same drug may bind to structurally similar proteins with similar binding 
sites provides an opportunity for prediction of DPIs using proteins structures. Thus, the protein 
structure-based prediction of DPIs for a given drug could be done by searching for sites that are
similar to the known binding sites of this drug.
There are three classes of structure-based prediction methods that implement different trade-
offs between accuracy and computational cost. These methods are based on searching for the 
12
similar sites using a reduced representation of protein structure or complete all-atom structure of
protein, and by docking the all-atom structure of ligand into the all-atom structure of the target 
proteins.
The fastest class of methods utilizes the reduced representation, usually in the form of a 
numeric vector that summarizes geometry and physicochemical properties of binding sites. 
Representative examples of such methods that find similar binding sites are PatchSurfer [56, 57]
and method by Tomii’s group [58]. The latter algorithm was recently used to create the PoSSuM 
database [59, 60] that includes 49 million pairs of similar binding sites computed from the known 
binding sites of 194 drug-like molecules over all protein structures from PDB. Given the large 
number of these putative binding sites it is likely that many of them are false positives and would 
have to be further screened via a more advanced method.
The second class of methods that is characterized by a lower throughput performs docking of 
a given compound into protein structures to find which proteins harbor binding sites that are 
complementary to the given ligand. Molecular docking predicts an optimized position and 
orientation of a drug molecule relative to a target protein molecule so that the drug fits the binding 
site and forms a stable interaction. Docking method relies on two steps. The first step is searching 
all possible rotational and translational orientations of the poses of a drug-protein pair. The second
step is scoring and ranking the poses by a particular measurement that indicates the strength of 
binding affinity for each possible pose. An example platform that utilizes such type of docking to 
find targets of a given ligand, specifically focusing on screening a given drug against a large 
collection of targets, is INVDOCK [61]. Given the relatively high computational cost of docking, 
we highlight the availability of the BioDrugScreen database [28]. This database stores results of 
docking with AutoDock and scores these putative interactions based on several scoring functions, 
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such as AutoDock, GoldScore, X-Score, ChemScore, PMF, and DFIRE. This docking-based 
database covers about 1600 drug-like molecules and 2000 cavities on the surfaces of close to 1600 
human proteins. However, these results are limited to interactions that are localized in cavities on 
the protein surface rather than exploring the whole surface. This limitation is motivated by a 
prohibitively high computational costs of searching the entire surface. BioDrugScreen uses 
Relibase+ algorithm [62] to identify pockets of interest, while INVDOCK uses an older algorithm 
by Kuntz and colleagues [63].
The third class of methods is complementary to docking. These methods are not constrained 
to surface pockets and produce accurate predictions of the drug-protein binding at the molecular 
level. They implement inverse ligand binding where structure(s) of the known drug-protein
complex(es), called template(s), is used to predict other protein targets together with the 
corresponding binding sites for the same drug. There are two ways to find potential binding sites 
based on similarity to known binding sites, one based on the similarity of the corresponding protein 
fold and another based on similarity of binding pockets. The first approach is implemented by the 
FINDSITE [64, 65] and eFindSite [66, 67] methods and the other approach by the SMAP [68-70]
and IsoMIF [71, 72] algorithms. The eFindSite predictor is an improved version of the FINDSITE
method that uses meta-threading with the eThread [73, 74] and an advanced clustering algorithm 
[75] to optimize the selection of the ligand-bound templates for a given query structure. The 
eFindSite method was empirically shown to outperform FINDSITE and several geometrical 
methods for detection of pockets [66]. SMAP is designed based on a sequence order-independent
profile-profile alignment (SOIPPA) which finds evolutionary and functional relationships across 
the space of protein structures [68-70]. SMAP utilizes a shape descriptor to characterize the 
structure of the protein template and the SOIPPA algorithm to detect and align similar pockets 
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between the query and template proteins. A recent study shows that eFindSite/FINDSITE and 
SMAP accurately predict targets even when the corresponding structure of the query protein and 
the template(s) are substantially different, i.e., they are from different SCOP folds [76]. IsoMIF 
applies GetCleft [77] algorithm to identify pockets on the surfaces of proteins, uses six chemical 
probes to represent atoms of pockets, and employs subgraph-matching algorithm to compute 
similarities of binding pockets so that putative binding sites could be predicted by comparison with 
known binding pockets [71]. A recent large-scale analysis utilizes IsoMIF to identify opportunities 
to repurpose drugs and to explain side-effects for ~400 drugs and ~8000 proteins and to validate
quality of these putative interactions by comparing them with docking simulations [78]. We 
discuss details of the FINDSITE, eFindSite and SMAP methods in Chapter 3. 
2.4 Similarity-based methods
The protein structure-based methods utilize the 3D structure of the target protein(s). However, 
recent works estimate that only about 20% to 30% of the human proteins have 3D structures [79-
81], which means that the protein structure-based methods are limited to a relatively small fraction 
of the human proteome. Moreover, they cannot be used for proteins with a substantial amount of 
intrinsically disordered regions [20] while recent works show that as many as 44% of human 
proteins contain at least one long (30 or more consecutive residues) disordered region [82-84]. 
Finally, the computational cost of the structure-based predictions for even this small set of proteins 
is typically high, particularly for the docking [32]. At the same time, the entire human proteome
that has a full complement of ~70,000 sequences when including isoforms (source: UniProt 
reference proteome ID UP000005640) that can be covered by the similarity-based predictions of 
DPIs. The similarity-based methods are built based on two assertions: 1) similar drugs likely target
15
the same proteins; and 2) that similar targets tend to interact with the same drugs [32, 85-87]. This 
is motivated in part by a quote from James W. Black, winner of the 1988 Nobel Prize in Medicine:
“the most fruitful basis for the discovery of a new drug is to start with an old drug” [88].
The similarity-based methods for the prediction of DPIs rely on two components: an internal 
database of known DPIs and a predictive model. They work in three steps. First, a user provides 
inputs in the form of drug structure, drug profile and/or its target sequence(s), whatever is available. 
In the second step, similarities between the input drug structure and/or profile and the structures 
and/or profiles of the drugs in the internal database are computed. If the target(s) of the query drug 
are known as input or can be retrieved from the internal database (the query drug is already 
included in the database), then the similarities between the query target and all targets in the 
database are also computed. In the third step, the predictive model combines the similarities to 
produce a propensity score that quantifies a likelihood that the query drug interacts with relevant 
protein targets that are included in the internal database, i.e., the propensity of putative DPI. Novel 
putative interactions generated by these methods could suggest potential ways to repurpose the 
existing drugs and also could explain molecular levels details behind side-effects.
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Table 1. List of surveys concerning similarity-based DPI predictors. These surveys were published in the past five 
years. The bottom row corresponds to our review that is described in Chapter 4.
Survey Year Number of predictors reviewed
Number of recent predictors reviewed 
(published since 2013)
Ding et al. [32] 2013 10 2
Pahikkala et al. [89] 2014 2 1
Mousavian et al. [90] 2014 27 16
Chen et al. [21] 2015 17 10
Cichonska et al. [91] 2015 17 9
Lavecchia et al. [92] 2016 11 9
Hart et al. [93] 2016 8 6
Shahreza et al. [94] 2017 17 8
Fang et al. [95] 2017 10 5
Ezzat et al. [96] 2018 28 17
Hao et al. [97] 2018 12 9
Our review 2018 35 22
The similarity-based methods utilize different approaches to express and quantify the
similarities. The predictive quality of the similarity-based methods is critically dependent on how 
the similarities are quantified and whether and how they are combined. Eleven survey articles that 
were published in the last five years have summarized the development and frontiers of the 
prediction of DPIs for the similarity-based methods [21, 32, 89-97]. Table 1 chronologically lists
these surveys and summarizes the number of prediction methods that are analyzed including the 
number of recent methods which were published in the past five years. In this dissertation, we 
present our own review (bottom row in Table 1) of 35 selected similarity-based methods including 
22 recent studies that appeared in the past five years. Compared to the existing surveys, our 
analysis is broader than most of the existing reviews (35 vs between 2 and 28 approaches in total) 
and more current (22 vs between 1 and 17 recent approaches). Criteria of selection of these 
approaches are described in Chapter 4. Besides the predictive models, some of these reviews also 
summarize the databases of DPIs [21, 22, 32, 91, 92, 94, 95] and the assessment of predictive 
results [32, 89, 96, 97] that are employed in prediction approaches. We present our review and 
compare it at a greater depth with the other surveys in Chapter 4. 
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Chapter 3 Evaluation of protein structure-based predictions 
of drug-protein interactions and development and 
deployment of protein-drug interaction database
In this chapter we assess the predictive quality of three representative protein structure-based 
methods for the predictions of DPIs. Using results produced by these methods, we develop and 
deploy a DPI database that covers interactions between 51 popular, FDA-approved drugs and the 
proteins from the structural human proteome. This repository provides a query interface to search 
a comprehensive set of putative DPIs that are generated by the predictors, as well as annotations 
of native DPIs collected from relevant databases.
3.1 Motivation to develop a novel database
The significant majority of the molecular targets of drugs are proteins and there are several 
databases of the already characterized DPIs. DrugBank [98-102] provides access to biochemical 
and pharmacological information about a large set of 7759 drugs, including 1600 FDA-approved 
compounds, and their known 4104 protein targets. Therapeutic Target Database [43, 103-107]
offers a comprehensive coverage of over 20,000 drugs, including close to 15,000 experimental 
drugs, and their interactions with 2360 protein targets. This database also links targets and drugs 
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to about 900 diseases. Other databases expand beyond the drug molecules to cover small drug-like 
ligands. BindingDB [108-112] gives experimentally measured binding affinities between about 
7000 known protein targets and a large set of almost half a million of small ligands. ChEMBL 
[113-116] contains structures, physicochemical properties and bioactivity (e.g. binding constants, 
pharmacology data) of drug-like small molecules. The current release of ChEMBL incorporates 
1.7 million distinct compounds and 13.5 million bioactivity data points which are mapped to over 
10 thousand protein targets, where the corresponding binding sites are defined at varying levels of 
granularity (protein, protein domain, or residue-level). SuperTarget [117, 118] includes about 6200 
protein targets from several dozens of species and close to 200,000 drug-like compounds. It 
integrates drug-related information from BindingDB, DrugBank, and the SuperCyp database of 
cytochrome-drug interactions [119], adverse drug effects from SIDER [120, 121], drug 
metabolism, and pathways and Gene Ontology (GO) terms for the target proteins. The 
PROMISCUOUS database [122] integrates data from DrugBank, SuperTarget, and SuperCyp and 
covers about 6500 protein targets and over 25 thousands drug-like compounds that are annotated 
with side-effects. This database also provides facilities that can be used to predict novel targets 
based on the structural similarity between drugs and between side-effect profiles of drugs. STITCH 
[123-127] combines information from many sources of experimentally and manually curated 
interactions between small ligands and proteins including ChEMBL, PDB, DrugBank, Therapeutic 
Target Database, text mining of articles from MEDLINE and PubMed, and several other resources. 
It currently houses data on 390,000 chemicals and 3.6 million proteins. The recently released 
IntSide database [128] links about 1000 drugs with their human protein targets collected from 
DrugBank and STITCH, and with close to 1200 side-effects and other annotations of associated 
diseases, pathways, and cellular functions. While most of these resources summarize the 
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interactions at the protein or residue level, scPDB [129, 130] includes molecular-level (all-atom) 
information for native binding sites in proteins structures collected from PDB [35] that are suitable 
for docking of drug-like ligands. It includes molecular-level details of about 9200 binding sites 
(all-atom annotation of binding sites and list of ligand-binding residues grouped by various types 
of bonds) and binding modes (all-atom position of ligand inside the site) for 3600 proteins, and a 
summary of physicochemical properties of approximately 5600 drug-like ligands.
However, many of the established drugs interact not only with the intended therapeutic target 
protein(s) but also with other protein targets (off-targets). Individual compounds were shown to 
on average target 6.3 proteins [10, 131]. Given a high degree of incompleteness of this information 
[131, 132], the number of off-targets is likely substantially higher. To compare, DrugBank includes 
15199 DPIs for 7759 drugs with the average number of targets per drug at 1.96, which further 
substantiates the claim of the incompleteness of the currently available data. This 
polypharmacology can be both beneficial, when a given drug can be repurposed for a different 
disease, and harmful, leading to the side-effects [132]. A couple of high-profile examples include 
imatinib that was repurposed for treatment of gastrointestinal stromal tumors [133] and sorafenib 
for the kidney and liver cancers [134]. The incompleteness of the data combined with the 
importance of polypharmacology motivates research towards the elucidation of novel and more 
comprehensive set of DPIs.
Conventional (non-computational) methods for the identification of novel off-targets rely on 
an in vitro counter-screen of a given drug against a small set of a few dozens of enzymes and 
receptors [49-52, 135]. Compared to the experimental screens, computational methods that find 
novel drug targets are more cost- and time-effective, allow screening of a larger number of targets 
and provide insights into the molecular-level mechanisms of DPIs [136]. These in-silico methods 
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are successful in the context of drug repositioning and identification of off-targets [137]. A couple 
of databases that focus on the putative protein-drug and druggable protein-protein interactions 
were recently released. BioDrugScreen [28] stores results of docking of about 1600 small drug-
like molecules against 1589 known proteins targets in human, which were annotated based on 
DrugBank and HCPIN [138] databases. Docking was run for close to 2000 cavities on the surfaces 
of these proteins, for the total of about 3 million receptor-ligand complexes. Druggable Protein-
protein Interaction Assessment System (Dr. PIAS) [139, 140] is a database of druggable protein-
protein interactions (PPIs) predicted by a machine learning method. This database lists druggable 
interactions predicted from over 83 thousand PPIs in human, mouse, and rat, but they are not 
associated with specific compounds.
We developed Protein-Drug Interaction Database (PDID) that complements existing 
repositories and addresses the lack of access to a comprehensive set of putative DPIs [29]. This 
database relies on predictions generated by three representative protein structure-based methods, 
eFindSite [66, 67], SMAP [68-70], and ILbind [76]. These methods are complementary and 
independent of docking that was used in the BioDrugScreen database. They were also shown 
empirically to provide high-quality predictions of drug targets [76], and their results were already 
successfully used to predict novel off-targets. Examples include applications to find new off-
targets of estrogen receptor modulators [141], cholesteryl ester transfer protein inhibitors [30], 
comtan [142], inhibitors of Trypanosoma brucei RNA editing ligase 1 [143], nelfinavir [31], 
raloxifene [144], and cyclosporine A [16]. We describe in detail and re-assess the selected three 
representative methods to provide a more recent estimate and comparative analysis of their 
predictive performance before we describe the PDID database.
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3.2 Considered protein structure-based predictors
The fundamental principle of protein structure-based predictors is to transfer the binding sites
from known drug-protein complexes to a protein that is structurally similar to these known drug-
complexed proteins. There are two ways to measure the similarity between the input protein 
structure and the known drug-protein complexes: one applies the similarity of the corresponding 
protein fold, such as FINDSITE [64, 65] and eFindSite [66, 67] algorithms, and the other that 
exploits the similarity of binding sites, such as SMAP [68-70] and IsoMIF [71, 72] methods.
3.2.1 FINDSITE and eFindSite
FINDSITE predicts binding sites for an input protein using template protein(s) which have
the structure(s) in complex with a given input drug [64, 65]. These template proteins come from a 
database of templates (a set of non-redundant high-quality structures of drug-protein complexes
curated from the PDB database) that is part of the FINDSITE algorithm. FINDSITE accepts either 
an experimentally determined structure annotated in PDB or a putative structure modelled 
computationally with TASSER [145-147], MODELLER [148, 149] or PROSPECTOR_3 [150], 
three accurate protein structure modelling algorithms. We use experimentally determined 
structures for the input proteins in our experiments. The protocol of FINDSITE is briefly described 
as the following four steps:
1) A threading algorithm, PROSPECTOR_3 [150] is utilized to find template proteins for the 
input protein from the template database. PROSPECTOR_3 threading recognizes template 
proteins which likely have similar structural folds when compared to the input protein based 
on sequence alignment and predicted secondary structure, given the sequence of the input 
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protein. The identified template proteins are supposed to be structurally similar to the input 
protein, no matter whether or not they have high sequence similarity to the input protein.
2) The template proteins that are known to be in complex with the input drug are selected from 
the template set which is obtained by the threading alignment. Then the template set is 
expanded by including homologous proteins of the current templates. Consequently, we get 
a set of template proteins that interact with the input drug, have known three-dimensional 
structures of drug-protein complex, are likely structurally similar to the input protein, and are 
possibly remotely homologous to the input protein.
3) A structural alignment algorithm, TM-align [151], is utilized to superimpose the structures of 
template proteins (including their drug-complexes) into the structure of the input protein. A 
set of superimposed atomic coordinates for each template protein is generated in this step.
4) The superimposed coordinates of the center of the input drug in each template structure are 
clustered based on spatial distance with a threshold distance equal to 8Å. The geometric
center of each cluster is a predicted position of the input drug into the input protein structure, 
which represents a putative binding site for this input drug-protein pair. These predicted 
binding sites could be ranked by the number of templates from the corresponding cluster 
where each binding site (cluster center) comes from.
Besides a putative position of the center of the given drug, FINDSITE also outputs other 
information that allows ranking predictions across different input proteins: (i) TM-score, a 
structural alignment score generated by TM-align; (ii) root mean square deviation (RMSD) of the 
Cα atoms in the aligned region between input protein and templates by TM-align; (iii) alignment 
length which is number of residues aligned with the template protein structure by TM-align; (iv)
fraction of templates that share the predicted binding site (cluster center); (v) sequence identity 
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calculated over the residues aligned by the TM-align; (vi) number of predicted binding sites; and 
(vii) number of predicted binding residues.
As an improved version of FINDSITE, eFindSite combines multiple threading approaches by
machine learning models to select template proteins and employs an advanced clustering algorithm 
to predict the putative binding sites [66, 67]. More specifically, eThread [73, 74], a meta-threading
approach that applies Naïve Bayes classifier to build a consensus threading alignment from ten 
individual threading algorithms, is utilized to identify template proteins; this concerns the steps 1) 
and 2) of FINDSITE. Moreover, eFindSite also improves steps 3) and 4) of FINDSITE. This 
concerns an approach to superimpose template structures to the input protein and to cluster binding 
sites in the template structures. First, Affinity Propagation [75] is utilized to cluster the structures 
of template drug-protein complexes based on structural similarities between templates computed 
with fr-TM-align [152]. Second, the clustered template structures are superimposed into the 
structure of input protein. Finally, the resulting superimposed locations of drug from each clustered 
template constitute the predicted position of the input drug, which in turn can be used to annotate 
putative binding sites in the structures of the input proteins.
3.2.2 SMAP
SMAP works by generating potential binding pockets in the input protein structure and next 
finding whether these pockets are similar to the known binding pockets in the drug-binding 
proteins [68-70]. It relies on a geometric representation of protein structure to characterize binding 
sites [68] and a sequence profile alignment to compare binding sites [69]. The protocol of SMAP 
algorithm is summarized in the following five steps:
1) SMAP reduces the representation of an input protein structure by using only the coordinates 
of alpha carbon (Cα) atoms which are the first carbon atoms attached to the carboxyl group 
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of an amino acid. These Cα atoms are represented as vertices in a graph. A convex hull 
algorithm, Delaunay tessellation, is applied to partition the Cα atoms into tetrahedra 
(triangular pyramids) that are defined by the graph edges [68].
2) The Delaunay tessellation is constrained by removing tetrahedra that include edges (atomic 
distances) longer than 30Å because such distance implies a open binding pocket on the 
molecular surface, not an enclosed sphere. The outside layer of the remained convex hull 
defines a environmental boundary which surrounds the input protein and its binding pockets. 
Next, the tetrahedra larger than 7.5Å are removed. This cut-off length is related to the average 
radius between two amino acids that are in contact with each other. The remaining tetrahedra 
on the outside of the structure form a protein boundary. The removed tetrahedra which are 
the tetrahedra located between the protein boundary and the environmental boundary, make 
up the possible positions where drugs could be located.
3) The distance and orientation of each Cα atom to the protein boundary and environmental 
boundary is computed. Based on these values, a geometric potential is computed using 
specific formulas listed in Ref. [68] for each Cα atom. The geometric potential quantifies the 
positions of a Cα atom and its neighbor atoms relative to the environmental boundary, and 
the relative positions between this Cα atom and its neighbor Cα atoms.
4) The possible positions of drugs obtained in step 2) are clustered based on their overlap in
circumscribed spheres of the corresponding tetrahedron. The cluster centers represent the 
predicted potential positions of the drugs that could bind to the given protein. If a Cα atom is 
located within 10Å from the predicted potential positions and the edge between these two 
atoms are not cut by other circumscribed spheres, this Cα atom (that represents a drug-binding 
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amino acid) is predicted as a part of a binding site. This way the amino acids that make up 
specific binding pockets are defined.
5) The predicted potential positions of drugs generated in step 4) represent a candidate drug-
binding position but without specifying for which specific drug. SMAP uses a sequence order 
independent profile-profile alignment (SOIPPA) method to align the candidate drug-binding 
sites (the corresponding amino acids) in the input protein to the known binding sites in the 
template proteins which are found in complex with the input drug in PDB [69]. Next, a
candidate binding site is mapped to a known binding site of the specific input drug if the 
SOIPPA alignment shows that these two sites are similar enough. SOIPPA algorithm is 
designed to compare and align two subgraphs that are extracted from the geometric 
representations of the input protein and the template protein. The computation of the 
alignment uses the geometric potential scores computed in step 3). The binding sites from the 
template protein are aligned and superimposed as the candidate sites in the input protein. A 
alignment score is computed based on the position specific score matrix [153] to measure the 
similarity of these binding sites.
SMAP outputs seven measurements that can be used to rank binding site similarity between 
the input protein and the template protein: (i) local alignment (pairs of aligned residues) between 
drug-binding sites in the input and template proteins; (ii) alignment score generated by SOIPPA; 
(iii) p-value that estimates the statistical significance of the alignment score by considering a 
random set of PDB chains; (iv) volume of overlapping binding pockets between the input protein
and the template protein computed in the structure of input protein; (v) the same volume computed 
in the structure of template protein; (vi) Tanimoto coefficient between the two proteins; (vii) root 
mean square deviation (RMSD) between the binding sites in the input and template proteins.
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3.2.3 ILbind
The inverse ligand binding (ILbind) predictor is an ensemble machine learning predictor of 
drug-binding sites for a specific input drug. ILbind uses selected outputs (the outputs were chosen 
based on an empirical feature selection process) generated by FINDSITE and SMAP [76] as its 
inputs. This meta-approach exploits the fact that FINDSITE and SMAP use complementary 
approaches for the prediction. FINDSITE’s prediction is based on similarity of protein structures 
while SMAP’s prediction is based on similarity of binding pockets. ILbind was designed to provide 
predictions for a wide range of drugs and nutraceuticals. First, a dataset of ~150 drugs was 
clustered into three structurally similar clusters. These clusters were represented by three drugs
that correspondingly have diverse structures: N-Acetyl-D-glucosamine (NAG), Adenosine-5'-
Diphosphate (ADP), and Palmitic Acid (PLM) [76]. Structures of five randomly chosen complexes 
of proteins with each of these three drugs were used to design ILbind, resulting in total of 15 
configurations. Correspondingly, 15 Support Vector Machine (SVM) models were designed using 
a training dataset. A total of 14 outputs (features) from FINDSITE and SMAP were ranked by 
their average AUC values on the training set. Next, a wrapper-based best-first search to select 
features was applied using cross-validation on the training dataset. The search started from 
including only the top ranked feature, and added next feature from the ranked set of features to the 
feature set if the inclusion of this feature increased AUC value when compared with the feature 
set before including this feature. Between the 15 SVM models, the selected feature sets typically 
contain two or more features which correspond to the outputs from both FINDSITE and SMAP.
Given an input drug and the structure of an input protein, ILbind works in two steps:
1) Compute predictions with the 15 SVM models using the selected outputs of FINDSITE and 
SMAP as the inputs.
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2) Use the consensus (average) of the 15 SVM predictions as the predicted propensity for
binding to the input drug.
Since ILbind does not predict the putative position of the center of the input drug, these 
positions are borrowed from the outputs of FINDSITE and SMAP.
3.3 Assessment of predictive quality
We assessed predictive performance of eFindSite, SMAP, and ILbind to demonstrate that 
predictions from these methods have practical value. This assessment was performed on a set of 
25 representative drugs that are currently included in PDID. These compounds were selected from 
25 clusters of chemically similar drug structures (one compound from each cluster) that were 
generated from the 355 drugs that could be found in complex with proteins in PDB at the time of 
the experiment. The evaluation follows the protocol from [16]. Briefly, native targets of the 25 
drugs were collected from PDB, BindingDB, and DrugBank and we compare predictions from the 
three methods on the structural human proteome against these native drug targets. We clustered 
proteins in the structural human proteome at 90% sequence identity using BLASTCLUST [153, 
154] and evaluated the results on the corresponding clusters, i.e., a given cluster is considered to 
be a native target of given drug (predicted to bind the drug) if at least one protein in this cluster
shares at least 90% identity with a native target of that drug (at least one protein in this cluster is 
predicted to bind that drug). The clustering assures that the evaluation is not biased towards targets 
that are overrepresented with many structures of similar folds.
Empirical results demonstrate that the three methods are characterized by practical levels of
predictive quality. The average AUCs over the 25 drugs of eFindSite, SMAP and ILbind equal 
0.63, 0.74 and 0.76, respectively (Figure 3a). Although ILbind outperforms the other two methods, 
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which is expected given that it combines results of these methods and which is consistent with the 
results in [76], different methods perform better for different drugs. More specifically, eFindSite 
provides the highest AUC for 5 drugs, SMAP for 6 drugs, and ILbind for the remaining 14 drugs. 
Figure 3b gives average true positive rates (fractions of correctly predicted native targets) in the 
function of the fraction of predicted protein targets sorted in the descending order by the 
propensities for the interaction generated by each of the three predictors. This figure shows that 
40% of the native targets (true positive rate = 0.4) are found among the top 4% of predictions from 
ILbind and SMAP and among the top 14% of predictions from eFindSite.
Figure 3. Predictive quality of eFindSite, SMAP, and ILbind for the 25 representative drugs. Panel a shows the average 
AUC computed over the 25 drugs; error bars give the corresponding standard deviations. Panel b shows average true 
positive rate (fraction of correctly predicted native targets) computed over the 25 drugs in the function of the ranking 
of predictions; the x-axis shows fraction of predicted protein targets sorted in the descending order by the predicted 
propensities for the interaction.
We observe that predictive performance of these three methods varies between compounds 
and depends on their size. Higher AUCs are characteristic for medium sized drugs (with a
molecular weight between 200 and 400 g/mol) and lower AUCs for either small (below 200 g/mol) 
or large (over 400 g/mol) drugs. To compare, the average AUCs for the small/medium/large drugs
for eFindSite, SMAP and ILbind are 0.56/0.68/0.58, 0.7/0.83/0.58, and 0.7/0.86/0.59, respectively. 
Example small and large compounds for which predictive quality is relatively low are salicylic 


























































suramin (1297.3 g/mol; 0.55), and cyanocobalamin (1355.4 g/mol; 0.57). Example drugs for which 
prediction are more accurate are naproxen (230.3 g/mol; 0.88), furosemide (330.7 g/mol; 0.94), 
and prednisone (358.4 g/mol; 0.87).
3.4 Protein-drug interaction database
3.4.1 Contents and availability
We collected the structural human proteome from PDB by removing low-resolution structures 
(> 3Å) and following [16, 141] we kept proteins for which sequences were mapped to human 
proteins in Ensembl [155]. More specifically, structures of chains with at least 90% sequence 
identity quantified using BLAST [154, 156] with default parameters to any human protein from 
68th release of Ensembl were selected. As a result, we include a total of 9652 human and human-
like high-resolution structures that correspond to 3746 unique human proteins. Protein chains that 
correspond to these PDB structures were mapped to UniProt [157] to facilitate mapping of proteins 
between PDID, PDB, DrugBank and BindingDB.
The PDID database includes drugs which were solved structurally in complex with at least 
one protein; this is necessary to predict targets. There are 355 such drugs in PDB which we 
extracted with PDBsum [158]. The current release 1.1 of PDID includes 51 drugs compared to the 
release 1.0 that had 26 drugs, all of which were selected from the 355 drugs. We clustered 
structures of the 355 drugs using their structural fingerprint expressed with Tanimoto coefficient 
and sampled at least one drug from each of the resulting 25 clusters to select the 51 drugs. Thus, 
the selected drugs comprehensively sample the structural drug space. These drugs are listed in 
Table 2 and include popular antibiotics, anti-inflammatory, anti-viral and anti-cancers agents, 
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immunosuppressants, and drugs for the treatment of osteoporosis, diabetes, heart attack, 
hypertension, edema, angina, glaucoma and other diseases.
Table 2. Drugs included in the current release 1.1 of PDID.
Drug name Formula PDB ID # complexes Primary use
acetazolamide C4H6N4O3S2 AZM 22 treatment of glaucoma, edema and epilepsy
acyclovir C8H11N5O3 AC2 5 anti-viral for herpes, chickenpox, and shingles
adenosine C10H13N5O4 ADN 107 treatment of cardiac arrhythmia
alendronate C4H9NO7P2 AHD 3 treatment of osteoporosis
ampicillin C16H19N3O4S AIC 8 antibiotic
bepridil C24H34N2O BEP 2 treatment of angina
caffeine C8H10N4O2 CFF 10 stimulant
captopril C9H15NO3S MCO 5 treatment of hypertension
cerulenin C12H19NO3 CER 8 antibiotic 
chloramphenicol C11H12CL2N2O5 CLM 16 antibiotic
chloroquine C18H26CLN3 0TX 1 treatment of malaria
clavulanate C8H9NO5 J01 4 antibiotic
cyanocobalamin C63H88CON14O14P1 CNC 10 vitamin B12 activity
cyclosporin A C62H111N11O12 CSA 30 Immunosuppressant
didanosine C10H12N4O3 2DI 1 anti-viral for HIV
dopamine C8H11NO2 LDP 9 treatment of hypotension and cardiac arrest
efavirenz C14H9CLF3NO2 EFZ 6 anti-viral for HIV
erlotinib C22H23N3O4 AQ4 3 anti-cancer
ertapenem C22H27N3O7S 1RG 3 antibiotic
erythromycin C37H67NO13 ERY 9 antibiotic
estradiol C18H24O2 EST 28 hormonal contraception
exemestane C20H24O2 EXM 1 anti-cancer
furosemide C12H11CLN2O5S FUN 3 treatment of hypertension and edema
gemcitabine C9H11F2N3O4 GEO 3 anti-cancer
ibuprofen C13H18O2 IBP 9 anti-inflammatory
imipenem C12H19N3O4S IM2 12 antibiotic 
indomethacin C19H16CLNO4 IMN 24 anti-inflammatory
isoflurane C3H2CLF5O ICF 2 anesthetic
kanamycin C18H36N4O11 KAN 21 antibiotic
l-carnitine C7H16NO31 152 8 treatment of heart attack and heart failure
mercaptopurine C5H4N4S PM6 2 immunosuppressant
naproxen C14H14O3 NPS 4 anti-inflammatory
niflumic acid C13H9F3N2O2 NFL 2 anti-inflammatory
nitroxoline C9H6N2O3 HNQ 1 antibiotic
pentamidine C19H24N4O2 PNT 7 anti-microbial 
pioglitazone C19H20N2O3S P1B 2 treatment of diabetes
ponatinib C29H27F3N6O 0LI 3 anti-cancer
prednisone C21H26O5 PDN 8 immunosuppressant
progesterone C21H30O2 STR 15 hormone replacement therapy
rifampin C43H58N4O12 RFP 7 antibiotic
ritonavir C37H48N6O5S2 RIT 12 anti-viral for HIV
salicyclic acid C7H6O3 SAL 36 treatment of acne
saxagliptin C18H25N3O2 BJM 1 treatment of diabetes
streptomycin C21H39N7O12 SRY 14 antibiotic 
sulindac C20H17FO3S SUZ 7 anti-inflammatory
suramin C51H40N6O23S6 SVR 12 anti-microbial 
tobramycin C18H37N5O9 TOY 6 antibiotic
tretinoin C20H28O2 REA 30 treatment of acne
vidarabine C10H13N5O4 RAB 2 antibiotic
zidovudine C10H13N5O4 AZZ 4 anti-viral for HIV
zoledronate C5H10N2O7P2 ZOL 12 treatment of osteoporosis
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The PDID database provides access to pre-computed results of computationally expensive 
all-atom predictions by eFindSite and SMAP. Their average runtime for a single protein structure 
and a given drug is about 30 minutes on a single CPU; the runtime of ILbind is negligible since it 
is based a consensus of results generated by the two predictors. This high computational cost makes 
ad hoc predictions for a given user query (a given drug or a given protein) computationally 
impractical.
The current version of PDID includes results of about 1.1 million predictions of targets over 
the 10 thousand structures and 51 drugs, with the corresponding 5172, 7184, and 4444 putative 
targets of these drugs generated by ILbind, SMAP, and eFindSite. It also includes 730 known
targets of the 51 drugs mapped from and linked to the corresponding records in DrugBank, 
BindingDB, and PDB. Figure 4 shows the number of native and putative targets for each drug. The 
median number of putative DPIs equals 23, 30, and 31 for SMAP, eFindSite, and ILbind, 
respectively, compared to the median of 8 based on the known interactions collected from 
DrugBank, BindingDB and PDB.
PDID is freely available at http://biomine.cs.vcu.edu/servers/PDID/. The backend of this 
database is implemented with the MySQL relational database and query pages using PHP script. 
Protein targets are linked to PDB, UniProt, BindingDB and DrugBank. Drugs are linked to the 
corresponding records in PDB, BindingDB, and DrugBank. Protein and drugs are linked with each 
other through their known and putative interactions. The interactions are defined at the molecular
level, i.e., coordinates of the location of the drug in the protein structure file are included. Besides 
displaying this information in the browser window, PDID provides access to the source files with 
the sequence and structure of the target proteins. We also offer download of the parsable raw 
source datasets in text format under the “Datasets” section on the main page. They include the 
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current version of the structural human proteome (IDs of all considered protein structures), a list
of drugs, and predicted targets for each drug together with scores from each of the three prediction 
methods and the corresponding coordinates of the putative positions of the center of the drug.
Figure 4. Number of native and putative targets for the considered 51 drugs. The native targets are based on the 
combined annotations from PDB, DrugBank, and BindingDB. The predictions were generated by ILbind, SMAP and 
eFindSite. The drugs, which are shown on the x-axis, are sorted by their corresponding number of targets in the 
descending order and separately for each of the four annotations.
3.4.2 User interface
The main page of PDID includes an overview of the contents of the database, provides access 
to three available search types (by drug name, by ID of the protein target, and by a sequence of the 
protein target), lists links to the source datasets and related resources, and gives the release date. It 
also includes link to the “About” page that explains contents of the database and introduces related 
methods, and to the “Help & Tutorial” page that explains the interface of the main page and the 
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Figure 5. Main page of the PDID database. The main page includes statistics of drugs, proteins and interactions, three 
types of queries in the database, download links of partial or entire database, and pointers to help and tutorial pages
that can be accessed by clicking on the “?” icon.
The search by drug name returns a table with details of known and putative targets including 
links to the corresponding records in PDB, DrugBank and BindingDB, links to files with structure 
and sequence of each target, and propensities for binding output by ILbind, SMAP, and eFindSite 
(Figure 6a). Targets are sorted by the number of methods that predict them as binding (propensities 
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shown in green font indicate that binding is predicted) and by the scores generated by the most 
accurate ILbind when the number is the same. A more detailed description of the formatting and 
contents of this output page can be found at 
http://biomine.cs.vcu.edu/servers/PDID/help.html#drug_page. Each target protein is available as 
a link that leads to a web page with the summary of results for this protein.
The search by protein ID returns a web page that maps this ID into corresponding UniProt 
protein (quality of mapping is annotated using sequence similarity), gives links to the sequence 
and structure files, and provides customizable visualization of the structure together with the 
localization of the putative (red dots) and known (blue sticks) ligands. The page also includes a 
table that summarizes information about drugs that are known and predicted to bind this protein 
(Figure 6b). This information includes color-coded scores generated by each method that produced
the predictions and the corresponding predicted location of the drug in the protein structure. We 
use JSmol [159] to visualize structures and BLAST to compute sequence similarity. A more 
detailed description of this web page is available at 
http://biomine.cs.vcu.edu/servers/PDID/help.html#prot_page.
The search based on protein sequence invokes BLAST that compares the input chain with the 
target sequences included in the databases. The most similar target is selected given that its 
similarity quantified with the e-value is better than a user-defined cutoff; default e-value cutoff 
equals 0.001. The resulting web page displays the alignment of the query and target proteins and 
the summary of results for the aligned target protein; the format of the summary is the same as for 




Figure 6. Results of queries against the PDID database. Panel a shows results for a query for mercaptopurine. Detailed 
description of this webpage is given at http://biomine.cs.vcu.edu/servers/PDID/help.html#drug_page. Panel b gives 
results form a query for mineralocorticoid receptor protein. Detailed explanations of this page are available at 
http://biomine.cs.vcu.edu/servers/PDID/help.html#prot_page. The “?” icon opens the corresponding help page.
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3.5 Conclusions
PDID provides access to all putative targets (between 4444 and 7184, depending on the 
prediction method used) of several dozens of popular drugs. These data are based on close to 1.1 
million of all-atom predictions over the entire structural human proteome (10 thousand structures 
for over 3700 proteins). Our database offers four unique features:
1) It incorporates accurate predictions generated by three representative protein structure-based 
methods.
2) It provides predictions for a comprehensively defined structural human proteome. We borrow 
structures of similar proteins from other organisms and cluster similar proteins to reduce 
redundancy.
3) It includes molecular level information on localization of the putative position of the center 
of drugs in the structures of the corresponding protein targets.
4) It includes comprehensive annotations of known drug targets that are linked to their sources: 
DrugBank, BindingDB, and PDB.
Numerous drugs are highly promiscuous and we do not know many of their targets. PDID 
addresses this issue by providing access to a complete set of putative DPIs and a set of known 
DPIs in the structural human proteome. Our database includes data that otherwise would be 
accessible only to individuals and research groups with significant computational expertise and 
resources. The putative interactions were generated by three accurate predictors that were shown 
to produce results that have previously led to finding new drug targets [16, 30, 31, 141-144]. PDID 
complements the existing BioDrugScreen database that relies on docking. The database integrates 
annotations of known protein targets collected across DrugBank, BindingDB, and PDB. It also
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links proteins to the corresponding records in UniProt and provides coordinates of the location of 
binding sites in the structures of the putative drug targets.
PDID can be used to systematically catalog DPIs and to facilitate various studies related to 
polypharmacology of drugs [160], such as explaining side-effects caused by interactions with off-
targets and for the drug repurposing. Relevant recent examples include the use of predictions with 
ILbind to find three novel off-targets of cyclosporine A that explain nephrotoxicity associated with
the use of this immunosuppressant [16]. Another example involves repurposing of raloxifene, 
which is used for prevention and treatment of osteoporosis, as a potential compound to treat 
Pseudomonas aeruginosa infections based on predictions with the SMAP method [144].
However, as discussed in section 2.4, the protein structure-based approaches cover only a 
relatively small part the entire human proteome. This is due to the fact that most proteins do not 
have structures. A perhaps extreme example of that are GPCRs, a big family of drug targets
composed of mostly membrane proteins, which almost entirely lack structures [161, 162]. This 
motivates us to investigate the other category of methods for the prediction of DPIs – the similarity-
based predictions which do not rely on the knowledge of protein structures.
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Chapter 4 Review of the similarity-based predictions of 
drug-protein interactions
In this chapter, we investigate the current similarity-based methods for the prediction of DPIs. 
Starting from several recent reviews and a series of selected predictors, we distill the main types 
of similarities that are used to predict DPIs and categorize the available predictors according to the
type(s) of similarities they use and whether they combine these similarities together. We 
qualitatively compare these approaches in the context of their methodological underpinnings, data 
that they cover, and how they were assessed. We also analyze their advantages and drawbacks and 
make a note of missing aspects related to how they were evaluated in the past.
4.1 Overview of recent surveys
A total of 11 surveys that were written in the last five years have focused on the similarity-
based methods [21, 32, 89-97]. We also note two other articles that focus on related topics 
including biological profiles [163] and machine learning tools [164] that are employed in DPI 
predictions. The 11 surveys summarize relevant databases, review representative methods, and 
discuss common criteria that are used to evaluate predictive performance. Table 3 assesses scope 
of these articles with the number of methods they reviewed, coverage of recent predictors, 
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inclusion of summary of databases used by the considered predictors, and presence of empirical 
assessment and analysis of sensitivity of predictive quality. The two most comprehensive surveys 
cover 28 [96] and 27 predictors [90] while the remaining nine articles discuss fewer than 20 
methods. In most cases, over half of the methods that were reviewed was published in the past five 
years. This reflects growing interest in the similarity-based predictors. However, at least eight 
methods that were published in 2016 and 2017 [165-172] were not included in any of these articles. 
While most of the surveys provide a brief discussion of the available DPI databases, these are not 
necessarily the databases that are used by specific predictors to compute the similarity values. In 
fact, only one article provides a more complete discussion that introduces specific databases which 
are utilized by a small set of ten predictors that this survey covers [32]. A complete summary of 
the DPI databases that covers modern methods is still missing, which is why we discuss this topic. 
We survey 35 predictors and investigate two types of relevant databases: internal databases which 
are intrinsic to the predictors and source databases that are used to derive the internal databases. 
Moreover, only four surveys provide empirical assessment of predictive performance of similarity-
based DPI predictors [32, 89, 96, 97]. While they provide quantitative and comparative analysis, 
they focus on a limited set of approaches. In particular, they only consider certain types and 
combinations of similarities. They also do not perform sensitivity analysis, i.e., they do not analyze 
whether and how predictive performance changes with intrinsic and extrinsic characteristics of the 
considered predictors. To summarize, while the previous surveys offer useful insights they also 
have several drawbacks. In particular, they miss several recent similarity-based DPI predictors, 
provide shallow treatment of databases used by these predictors, offer incomplete empirical 
analysis, and do not include sensitivity analysis.
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Table 3. Overview of surveys of the similarity-based methods for the DPI prediction. The surveys are sorted 
chronologically according to their publication year. The check symbol indicates that a given measure (column) is 
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Ding et al. [32] 2013 10 2 √ √
Pahikkala et al. [89] 2014 2 1 √
Mousavian et al. [90] 2014 27 16
Chen et al. [21] 2015 17 10
Cichonska et al. [91] 2015 17 9
Lavecchia et al. [92] 2016 11 9
Hart et al. [93] 2016 8 6
Shahreza et al. [94] 2017 17 8
Fang et al. [95] 2017 10 5
Ezzat et al. [96] 2018 28 17 √
Hao et al. [97] 2018 12 9 √
This dissertation 2018 35 22 √ √ √ √
In this dissertation, we focus on a comprehensive set of 35 similarity-based DPI predictors 
that were published in the last decade, including the largest set of recent predictors when compared 
to previous surveys. The considered predictors comprise of 22 recent tools that were published in 
the last five years and eight latest methods that were published since 2016. This way our review 
includes the latest advances in the DPI predictions. We define the three main types of similarities 
that these 35 methods use to predict compound-protein interactions, describe key architectural 
details of these tools and comment on their impact. We also offer in-depth summary of the internal 
and source databases that these predictors use and discuss how these databases are linked. 
Moreover, under the third goal we also combine multiple sources databases to build a novel 
benchmark dataset that we use to perform comprehensive empirical evaluation. The empirical 
evaluation that we perform as part of the third goal (details are given in Chapter 5) encompasses
representative approaches that rely on each of three main types of drug and protein similarities and 
ensemble predictors that combine two and three types of similarities. Besides providing the overall 
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predictive performance of the considered predictors, we are the first to consider predictive quality 
across individual drugs. Finally, our first-of-its-kind sensitivity analysis investigates whether and 
how the predictive performance depends on several intrinsic and extrinsic factors, e.g., the number 
of targets that are a priori known for a given drug.
The chapter starts with the selection of representative similarity-based predictors. We provide
discussion of their source databases to build up the background to survey the selected predictors. 
These databases include native DPIs that are used to implement predictions by the similarity-based 
predictors. We summarize their timeline, impact, data contents, and overlap. Next, we investigate 
the timeline, impact, and availability of the 35 selected predictors. Moreover, we compare the 
contents of their internal databases and review the types of similarities that they utilize. After that, 
we provide a timeline that links the chronological record of source databases with the emergence 
of the 35 predictors. We also analyze how different types of similarities were used and combined 
over time to develop these methods.
4.2 Selection and overview of similarity-based DPI predictors
To cover a complete landscape of top-tier similarity-based predictors of DPIs, we collected 
corresponding articles that were published in high-impact venues. We searched the PubMed 
repository [173] in April 2018 for relevant articles using the following query: (predict* 
[Title/Abstract] AND (“drug target interaction” [Title/Abstract] OR “drug protein interaction” 
[Title/Abstract])). The query generated 170 possibly germane articles. We manually processed 
these results to select articles that describe similarity-based predictors that were published in 
reputable journals, i.e., journals with impact factor > 3.5. We collected the impact factors from the 
latest Journal Citation Reports that was released by Clarivate Analytics (formerly Thomson 
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Reuters) on June 14, 2017 [174]. This version of JCR is based on the citation data in 2016 and 
reveals the scientific impact of a JCR-indexed journal by quantifying the ratio between the number 
of 2016 citations to the articles published in this journal in 2014-2015 and the number of articles 
published in this journal in 2014-2015. The resulting 35 similarity-based DPI predictors are 
included in this review [165-172, 175-201]. This list is longer than the lists covered in the prior 
surveys which also include methods published in conference proceedings, lower impact factor 
journals as well as methods that target ligand/chemical-protein interactions besides DPIs.
The similarity-based predictors of DPIs are implemented based on the assertions that similar 
drugs may share the same protein targets and that similar proteins may interact with the same drugs.
To identify putative interaction between a given drug and protein, a predictive model typically 
searches its internal database for drugs that are similar to the given drug and their known targets 
that are similar to the given target protein. Therefore, the core aspect that defines these predictions 
is how to measure the drug-drug and protein-protein similarities. Analysis of the 35 similarity-
based DPI predictors reveals that the similarities are typically quantified using information about 
the chemical structures of drugs, side-effect profiles of drugs, and sequences of their protein targets. 
In other words, the predictors rely on three main types of similarities: chemical similarity of drugs 
(DCS), drug profile similarity (DPS), and protein sequence similarity (PSS). Some predictors 
employ one type of similarity to infer putative DPIs. Other methods combine multiple types of 
similarities motivated by an assumption that this may improve predictive quality when compared 
to using just a single type of similarity.
The similarity-based predictive methods are composed of two components: an internal 
database of known DPIs and a predictive model. Prediction of DPIs is performed in three steps. 
First, a user provides inputs in the form of drug structure, drug profile, and/or protein sequence(s) 
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of known target(s) for an input drug, whatever is necessary for the selected similarity-based 
approach. In the second step, similarities between the input drug structure (profile) and the 
structures (profiles) of the drugs in the internal database are computed. If target(s) of the query 
drug are known or can be collected from the internal database (the query drug is already included 
in the database), then similarity between the known target of the query drug and all proteins targets 
in the database is also quantified. In the third step, the predictive model combines the similarities 
to produce a propensity which quantifies likelihood that the query drug interacts with relevant 
protein targets which are included in the internal database.
The architectures of these predictive models are designed and tuned for their corresponding 
internal databases. Thus, data quality of the internal database largely determines the predictive 
performance of similarity-based DPI predictors.  The internal databases typically consist of a set 
of native DPIs that are aggregated and collated from multiple source databases which store curated
annotations of DPIs. Next, we review the source databases that are used to derive the internal 
databases of the 35 selected methods.
4.3 Source databases
We investigate the 35 predictors to come up with a list of all source databases that they use 
to derive the corresponding internal databases. In total, we found 12 publicly accessible source 
databases that these methods utilize. They include, in chronological order of publication: PDSP Ki 
[202], BRENDA [203-211], BindingDB [108-112], TTD [43, 103-107], KEGG BRITE [212-218], 
DrugBank [98-102], GLIDA [219, 220], KEGG DRUG [212-218], SuperTarget [117, 118], 
Matador [117], STITCH [123-127], and ChEMBL [113-116]. One of the selected predictors, SEA 
(Similarity Ensemble Approach) [175, 221], utilizes a collection of drugs and associated targets 
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from a commercial MDL Drug Data Report (MDDR) [222, 223]. This database is not available 
publicly and thus it is excluded from our analysis. Next, we summarize the contents, timeline, 
impact, and relationships between these 12 publicly available source databases.
4.3.1 Timeline and impact
Besides storing the data and providing facilities to conveniently query and access the data, 
databases must be maintained and regularly updated. They also should be periodically 
disseminated to inform the users about their contents and the available features. One way to 
measure the impact of these databases is to tally the citation counts for the scientific articles that 
introduce these databases and their updated versions.
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Table 4. Timeline and impact of the source databases of drug-protein interactions. The source databases were used to 
derive the internal databases of the 35 selected similarity-based predictors. The timeline is a chronological summary 
of publications and releases for these source databases. The impact measures citation counts for the publications of 
databases. This table is sorted chronologically according to the date of the first publication. The data of this table was 





















PDSP Ki [202] 8/1/2000 11/1/1999 N/A 4/1/2018 7/11/2008 231 13
BRENDA [203-211] 10/1/2000 10/1/2000 10/19/2016 1/1/2018 7/1/2008 2557 146
BindingDB [108-112] 12/1/2001 11/1/2000 10/19/2015 4/1/2018 3/4/2016 1398 86
TTD [43, 103-107] 1/1/2002 1/1/2002 11/13/2017 10/4/2017 3/25/2013 961 59
KEGG BRITE [212-218] 1/1/2006 4/1/2005 11/29/2016 4/1/2018 7/1/2008 *13974 *1140
DrugBank [98-102] 1/1/2006 1/1/2006 11/8/2017 4/2/2018 7/1/2008 5822 475
GLIDA [219, 220] 1/1/2006 1/1/2006 11/5/2007 10/10/2010 3/1/2011 194 16
KEGG DRUG [212-218] 1/1/2006 7/1/2005 11/29/2016 3/29/2018 9/3/2012 *13974 *1140
SuperTarget [117, 118] 10/16/2007 10/16/2007 11/8/2011 11/8/2011 7/1/2008 410 39
Matador [117] 10/16/2007 10/16/2007 N/A 10/16/2007 7/11/2008 316 30
STITCH [123-127] 12/15/2007 8/9/2007 11/20/2015 6/30/2016 6/10/2015 1068 104
ChEMBL [113-116] 9/23/2011 10/27/2009 11/28/2016 5/1/2017 7/8/2013 2434 373
1 The date when a given source database was originally published in a scientific article. It corresponds to the publication date of 
early access, if available. Otherwise, the date of the journal issue where the first publication appeared is used.
2 The date when a given database was first made available, which typically is before the database was originally published. We 
collect these dates from the release notes or time stamps recorded on the database websites, if available, and we use the date of the 
first publication, otherwise.
3 The date of the most recent republished article that introduced an updated version of a given database after the database was 
originally published.
4 The date of the most recent release of a given database, which typically is after the latest republishing.
5 The date when a given source database was first to be utilized to derive the internal database of a predictor.
6 The “All citations” column is the total number of citations that include citations to the first publication and all republished articles 
for a given source database. The citation counts were collected from Google Scholar.
7 The “Annual citations” column is the average citation counts per one calendar year (365 days) over the period from the first 
publication date until April 1, 2018, rounded to the nearest integer.
* KEGG BRITE and KEGG DRUG are a part of the Kyoto Encyclopedia of Genes and Genomes (KEGG) project. They were 
published together with the KEGG database and all of its affiliated databases. The citation data for these two databases include the 
citations to the entire KEGG database, and they cannot be distributed to each affiliated database of KEGG. These counts are 
relatively high because they reflect the citations to all 23 databases affiliated with KEGG by now.
Table 4 provides a summary of the 12 source databases. It includes information about 
publications that introduce the original and the updated versions of these databases as well as the 
corresponding citation data. The source databases are sorted chronologically according to the date 
of their first publication. Specifically, we use the date of the early access online publication when 
it was available. Otherwise, we use the date of the journal issue in which the first publication has 
appeared. Apart from the date of the first publication, we also list the date when the database was 
first made available, which typically is before the database was published. We collect these first 
release dates from the release notes or time stamps recorded on the database websites, if available, 
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and we use the first publication date otherwise. In this chronological order, the four earliest source 
databases debuted between August 2000 and January 2002. The next seven databases were 
published several years later, between 2006 and 2007. The last source database was published in 
2011. Eleven out of the twelve sources were published within about one year after their first public 
release. The one exception, the ChEMBL database was first published two years after its initial 
release. ChEMBL was originally a commercial database called StARlite that was launched before 
2005, acquired by EMBL-EBI in 2008, released to the public in 2009, and finally published in 
2011 [224-226]. Given that all these databases were originally released by 2007 or built based on 
an earlier database, the data stored in these 12 source databases are being accumulated for at least 
ten years.
Most of the source databases have been regularly updated and republished. Besides just the 
addition of new data, these updates typically include new features and improved user interface. 
We list the publication date of the latest republished article and the most recent release date for 
each source database as of April 1, 2018. These two dates together with the first release and the 
first publication dates provide interesting insights into the progress of the database development. 
Considering the latest republishing and release dates, GLIDA, SuperTarget, and Matador have not 
been republished or updated in the last six years. This suggests that they are no longer actively 
maintained. The PDSP Ki database is actively and frequently updated, but it has never been 
republished since it was originally published 17 years ago. Meanwhile, the other eight source 
databases are being updated and republished regularly. Frequent dissemination informs the users 
about new contents and features and also may help to attract additional users. In general, these 
frequently updated sources are relatively more mature since they gradually accumulate DPIs, 
include more recent data, and typically offer a more refined interface and a longer list of features.
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Another relevant aspect is to mark when the source databases were de facto used to build the 
similarity-based predictors of DPIs. Thus, Table 4 shows the date when the earliest predictor has 
utilized a given source database to derive its internal database of known DPIs. The list of the source 
databases that were first used to develop the predictors includes PDSP Ki, BRENDA, KEGG 
BRITE, DrugBank, SuperTarget, and Matador. The earlier adoption of these source databases 
reflects to a certain degree their popularity and impact. Moreover, these source databases were also 
used for other purposes including protein structure-based prediction of DPIs [78, 227, 228] and 
development of various cheminformatics and bioinformatics methods and datasets [229-233].
Table 4 summarizes citations for the 12 source databases. The citations are one way to 
quantify the impact of these resources. The citation counts were collected from Google Scholar 
(http://scholar.google.com/) on April 1, 2018. We list the total number of citations that include 
citations to the first publication and all subsequent publications of a given database. Every source 
database has received at least about two hundred citations. BRENDA, BindingDB, DrugBank, 
ChEMBL, KEGG BRITE, KEGG DRUG, and STITCH have accumulated over one thousand 
citations. A notable exception is the KEGG BRITE and KEGG DRUG databases, which are part 
of the Kyoto Encyclopedia of Genes and Genomes (KEGG) project since 2005. They were 
published together with the KEGG database and all of its other affiliated databases in 2006 [212]. 
Currently, KEGG includes 23 individual databases including, for example, KEGG PATHWAY 
that provides pathway maps of molecular interaction, reaction and relation networks. The citation 
data for KEGG BRITE and KEGG DRUG includes the citations to the entire KEGG database; 
these citations cannot be attributed to individual KEGG resources. The citation counts to KEGG 
BRITE and KEGG DRUG are so high because they reflect the citations to all 23 databases 
affiliated with KEGG. 
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An arguably more robust measure to quantify impact are the annual citation counts. The 
annual counts are defined as the average citation frequency per one calendar year (365 days) 
computed over the period from the date of the first publication until the date when we acquired the 
citation data (April 1, 2018). These counts accommodate for the differences in the age of the source 
databases. PDSP Ki, GLIDA, SuperTarget, and Matador received moderate (<50) numbers of 
annual citations. These relatively low citation counts could be a result of a lack of effort to update 
GLIDA, SuperTarget, and Matador which were last updated in 2011 or earlier. PDSP Ki is 
frequently updated but it was last published in 2000. On the other hand, BRENDA, BindingDB, 
TTD, and STITCH have received relatively high (50-150) annual citations. This is likely because 
these are mature resources that have ten years of history of regular republishing and updates. 
Noticeably, DrugBank and ChEMBL attract over 300 citations per year. They were also regularly 
updated and republished. Their success can be attributed to the high-quality of their data contents, 
a broad range of functional features, and a user-friendly web interface. Next, we review the data 
contents for the 12 source databases.
4.3.2 Data contents
Typically, multiple source databases are used to derive an internal database of a given 
predictor. They are used as a source for information about drugs, their protein targets, and native 
DPIs. Table 5 summarizes information about the number of relevant drugs or drug-like compounds 
that are known to interact with protein targets, the number of these targets, and the number of 
annotated drug- and compound-protein interactions for the 12 source databases. These data were 
collected from the latest release of each database on April 1, 2018. We captured the numbers from 
the release notes or statistics page if they were available. Otherwise, we tallied the numbers from 
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the data dumps. BRENDA, a database dedicated to enzyme functions, does not provide specific 
statistics and data downloads. Thus, we could not calculate the quantities for this database.
Table 5. Data contents of the source databases of drug-protein interactions. These source databases were used to derive 
the internal databases of the 35 selected similarity-based predictors. The data of this table correspond to the latest 
release of each database as of April 2018. The numerical data were captured from the release notes or statistics page 
if they were available. Otherwise, we counted the numbers from the data dumps of each database.
Type Database Abbr.1 Drugs2 Proteins3 DPIs4 DPIs/drug5 URL
Drug
Matador MA 801 2,901 15,843 19.8 http://matador.embl.de
KEGG BRITE KB 5,045 1,061 14,222 2.8 http://www.genome.jp/kegg/brite.html
KEGG DRUG KD 5,045 1,061 14,222 2.8 http://www.genome.jp/kegg/drug/
DrugBank DR 10,562 5,020 23,380 2.2 http://www.drugbank.ca
PDSP Ki PK 11,569 1,673 63,619 5.5 http://kidbdev.med.unc.edu/databases/kidb.php
TTD TT 23,486 3,036 33,467 1.4 http://bidd.nus.edu.sg/BIDD-Databases/TTD/TTD.asp
Bioactive 
compound
GLIDA GL 23,214 410 30,410 1.3 http://pharminfo.pharm.kyoto-u.ac.jp/services/glida/
STITCH ST *156,686 *3,908,233 *148,826,348 *949.8 http://stitch.embl.de
SuperTarget SU 195,770 6,219 332,828 1.7 http://bioinformatics.charite.de/supertarget/
BindingDB BI 644,978 7,042 1,439,799 2.2 http://www.bindingdb.org/bind/index.jsp
ChEMBL CH 2,101,843 11,538 14,675,320 7.0 http://www.ebi.ac.uk/chembl/
BRENDA BR Unavailable Unavailable Unavailable Unavailable http://www.brenda-enzymes.org/index.php
1 Abbreviated name of a given source database. The abbreviations are used to denote the source databases of predictors in Table 8.
2 The number of drugs and drug-like compounds that are known to interact with protein targets in a given source database.
3 The number of proteins that are targeted by drugs and drug-like compounds in a given source database.
4 The “DPIs” column is the number of known DPIs that are stored in a given database.
5 The “DPIs/drug” column is the average number of DPIs per drug, which is calculated by dividing the “DPIs” column to the 
“Drugs” column for a given database. Unavailable means that these numbers are missing because BRENDA does not provide 
specific statistics and downloads for the entire collection of DPIs that it store.
* The numerical data for the STITCH database includes both direct and indirect DPIs, while data for other databases include only 
the direct interactions. The indirect interactions are based on effects of signaling pathways where effects of drugs are propagated 
onto proteins that interact with other proteins that directly interact with these drugs. The indirect interactions in this database cannot 
be separated from the direct interactions, and thus the corresponding numbers are higher than expected.
Table 5 categorizes the source databases into two types depending on if they are dedicated to 
drugs or a more generic set of bioactive compounds. The first type of six databases including PDSP 
Ki, TTD, DrugBank, Matador, KEGG BRITE, and KEGG DRUG focus on approved, under a 
clinical trial, and experimental drugs. The other six source databases include both drugs and other 
bioactive compounds that typically are small molecules with drug-like properties. Consequently, 
the first type of databases has fewer compounds, between 8 hundred and 23 thousand, compared 
to the second group that includes between 23 thousand and over 2 million compounds. Table 5 is 
sorted by the number of compounds within each of the two categories. Except for BRENDA for 
which data are not available and GLIDA that is dedicated solely to the G protein-coupled receptors 
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(GPCR), the bioactive compound-centric databases have more DPIs and protein targets than the 
drug-centric databases. Specifically, the six smaller databases include between 15 and 60 thousand 
interactions, compared to the group of larger sources that features up to 148 million interactions. 
The largest compound repository, ChEMBL, stores a comprehensive set of two million bioactive 
compounds. This number is 90 times higher than the total number of the drugs in the largest 
repository that focuses exclusively on drugs, TTD. Unsurprisingly, the number of compound-
protein interactions in ChEMBL is 440 times larger than the number of DPIs in TTD.
The main focus of these databases is typically on the human protein targets. The druggable 
human proteome, which is defined as all human proteins that interact with current drugs, is 
estimated to comprise of between 1000 and 3000 proteins [1, 18-20]. The numbers of protein 
targets in the source databases typically vary between about 1000 and 12,000, with a median value 
of 3036. Half of these databases are larger than the druggable proteome because they cover proteins 
from other organisms. For example, BindingDB contains targets from over 400 organisms. There 
are two exceptions that include GLIDA and STITCH. The GLIDA database focuses on the GPCRs, 
and thus, it is limited to the corresponding 410 GPCR proteins. STITCH covers over nine million 
proteins from 2031 organisms, which include a substantial number of putative and low-quality
annotations of targets. We excluded these predicted and low-confidence interactions (using their 
confidence score < 0.7) when calculating the numbers for Table 5. This resulted in a set of about 
4 million targets and 149 million interactions. The reason why this database is so large is that 
STITCH includes both direct and indirect DPIs, while data in the other databases include only the 
direct interactions. The indirect interactions are derived based on signaling pathways where effects 
of drugs are propagated onto downstream proteins.
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In each of the 12 source databases, the number of DPIs is greater than the number of drugs. 
This is a result of promiscuity of drugs that typically interact with multiple targets. The field of 
polypharmacology [234-236] and efforts in drug repurposing [7, 8, 10] depend on this promiscuity. 
However, drug promiscuity may also lead to undesired side-effects and unintended toxicities [12, 
15, 16]. We measure the drug promiscuity in these source databases by calculating the average 
number of DPIs per drug (see DPIs/drug in Table 5). The median degrees of drug promiscuity for 
the 12 source databases is 2.8, which is close to the promiscuity  measured using assays that ranges 
between 2.6 and 3.4 [237]. Ten databases have between 1.3 and 19.8 DPIs per drug. The STITCH 
database is again an exception. It includes a relatively dense mapping between proteins and drugs 
due to the inclusion of a considerable number of indirect interactions. The drug promiscuity has 
inspired the development of the similarity-based predictive models, where the similarity between 
targets is used to predict DPIs. It also provides an opportunity to use the currently known targets 
of a given drug to build models that predict other targets of the same drug.
Besides the interactions, these source databases also encompass rich annotations of the 
structures, functions, and properties of the drugs and targets, together with the corresponding 
references. For example, DrugBank provides over 200 such annotations. The native DPIs and the 
additional knowledge are accessible through the web interfaces of these sources. The 
corresponding URLs for the 12 source databases are listed in Table 5.
4.3.3 Relationships between source databases
Each of the 12 source databases includes a different collection of DPIs. However, these source 
databases also overlap with each other. This is because different source databases collect the 
interactions from some of the same sources, and because some of them also directly import 
annotations from the other source database. Table 6 summarizes inputs that are used to derive data 
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stored in a given source database. The inputs include data coming from the 12 source databases, 
directly from literature, and from other resources. The first 12 inputs in the table indicate whether 
a given source database directly imports DPIs from another source databases. Seven source 
databases draw DPIs from between one and nine (for STITCH) other source databases. Moreover, 
some of the inputs are more popular than the others. Six of the nine input databases provide data 
for at least three source databases. For example, TTD is used as an input to four source databases 
including DrugBank, SuperTarget, Matador, and STITCH, compared to BRENDA, SuperTarget, 
and STITCH that are never used as inputs. The direct inclusion of source databases as inputs results 
in a substantial overlap between databases. For example, Matador shares a substantial overlap with 
SuperTarget since they both draw data from the same four source databases while SuperTarget 
also imports data from one more source. Interestingly, ChEMBL and BindingDB exchange data 
reciprocally. BindingDB obtains data on compound-protein binding affinities from ChEMBL and 
exports binding data that were extracted from patents to ChEMBL. Noticeably, STITCH includes 
the interactions taken from nine other source databases, which explains why Table 5 shows that it 
hosts the largest collection of interactions. Only the BRENDA database neither imports 
interactions directly from other source databases nor is used as an input.
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Table 6. Relationships between source databases. Each row lists a source database, and each column specifies an input 
where the data of a given source database come from. The inputs include data coming from other source databases, 
literature, and other types of inputs. The “Literature” column denotes that the data are manually curated from scientific 
articles, patents, and annual reports of pharmaceutical companies. The “Other inputs” column includes predictions, 
experimental data, and other databases that are not named in the table. “x” indicates that a given source database draws 



























































































PDSP Ki x x
BRENDA x x
BindingDB x x x x
TTD x x
KEGG BRITE x x
DrugBank x x x
GLIDA x x x x
KEGG DRUG x x
SuperTarget x x x x x x x
Matador x x x x x x
STITCH x x x x x x x x x x x
ChEMBL x x x
Moreover, we list two additional types of inputs: literature and other inputs. The literature 
includes scientific articles, patents, and annual reports of pharmaceutical companies. The other 
inputs incorporate predictions, experimental data, and other input databases that exclude the 12 
source databases. Table 6 shows that all 12 source databases include data coming directly from the 
literature. This is yet another factor that contributes to the overlap in the contents of the 12 source 
databases. The data coming from the literature typically includes information about experiments 
and assays that were used to validate bioactivity and measure affinities of interactions. This 
information provides context for the interactions. Every source database also acquires data from 
other inputs that include predictions, other databases such as the Comparative Toxicogenomics 
Database [238] and PubChem BioAssay [239], and experimental data that were not stored in a 
dedicated database, such as the data from Refs. [240, 241].
54
Our analysis reveals that each of the 12 source databases overlaps with at least one other 
source database. Table 6 qualitatively summarizes this overlap. A quantitative estimate would be 
extremely challenging. This is because these databases lack a uniform definition of drugs and 
targets and a consistent way to name and identify compounds and biomolecules. Even if the same 
literature is used to extract DPIs the resulting data could be different. For example, when the 
interaction is annotated at the gene level, the same gene could be mapped to different proteins and 
different types of protein identifiers, depending on which software and databases were used to 
perform the mapping. The assignments of information from literature to a precisely and uniquely 
defined set of drugs and protein targets is still an open challenge [44]. The bottom line that that 
different databases adopt different nomenclatures and identifiers to represent the drugs and 
proteins, which makes it virtually impossible to quantify the degree of overlap between the 12 
databases. A few works have analyzed the overlap of drugs and targets for a small subset of these 
source databases [23, 177]. A study over a set of 502 approved drugs shows that 49% and 20% of 
the DPIs in DrugBank were included in Matador and PDSP Ki, respectively [177]. The data that 
are unique to DrugBank account for only 46% of its DPIs. Moreover, PDSP Ki shares 42% of its 
known interactions with Matador. As concluded by another investigation, DrugBank had 52% and 
21% of drugs in common with ChEMBL and TTD, respectively [23]. The 74% and 55% of the 
protein targets stored in DrugBank were also included in ChEMBL and TTD, respectively. 
Moreover, ChEMBL covered 91% and 55% of the drugs and targets that were housed in TTD, 
respectively. These numeric analyses support our observation about the relatively large extend of 
overlap and also reflect the fact that source databases have their unique data.
We show that the 12 source databases were developed using some of the same data sources 
and some of them even swap the data with each other. These relationships lead to a certain amount 
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of overlap of information that they store. However, each source database also houses its own 
unique data, and therefore, they should be combined together to collect the most complete set of 
known DPIs. This is in fact the case for 22 out of the 35 methods that we survey. They use at least 
two source databases to develop their internal databases. Moreover, 17 methods, including KRM 
[176], BLM [179], Yamanishi et al. [180], GIP [182], NBI [183], KBMF2K [184], Cao et al. [186], 
BLM-NII [187], DT-Hybrid [189], DINIES [191], Shi et al. [192], RLS-KF [196], NRLMF [197], 
DASPfind [199], PUDTI [168], DVM [169], and iDTI-ESBoost [172] have utilized at least four 
source databases to create their internal DPI databases.
4.3.4 Other drug-target interaction databases
Besides the 12 source databases, we discuss another 19 databases that have not been adopted 
to develop the selected similarity-based predictors. These databases house the drug-target 
interactions accompanied by other information, such as details of mechanisms of DPIs [242], 
unstudied/dark targets [243], interactions at the gene level [244-250], structures of protein targets 
[29, 35, 251, 252], information about protein-protein and drug-drug interactions [253-261], side-
effects of drugs [128], and information focused on specific diseases, such as cancer [262-266]. 
Some databases are constrained to a particular group of drugs [267] or a specific family of proteins 
[268]. Next, we discuss these 19 databases in greater depth.
DrugCentral (http://drugcentral.org) is a comprehensive knowledgebase that integrates 
information about drug actions and pharmacological indications, which can be used to elucidate 
therapeutic mechanisms mediated through DPIs [242]. The Pharos database (http://pharos.nih.gov) 
incorporates drug action data taken from DrugCentral to define druggable levels of protein targets 
and define unstudied/dark protein targets. These dark targets are not yet known to be involved in 
small molecule activities, but they are potentially druggable [243].
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Some resources aggregate biological annotations and disease-related knowledge for the 
druggable genome, which is defined as a collection of genes that encode druggable proteins. These 
resources include the PharmGKB database (http://www.pharmgkb.org) [244], DGIdb 
(http://dgidb.genome.wustl.edu) [245, 246], the Drug2Gene database (http://www.drug2gene.com) 
[247], IUPHAR/BPS GtPdb (http://www.guidetopharmacology.org) [248, 249], and Open Targets 
(http://www.targetvalidation.org) [250].
The next three databases rely on the 3D structures of protein targets. The PDB database 
(http://www.rcsb.org) provides access to an extensive collection of 3D structures of drug-protein
complexes [35, 251]. The BioLip database (http://zhanglab.ccmb.med.umich.edu/BioLiP) 
provides access to residue-level annotations of ligand-binding sites, binding affinity data, and 
biological functions for a comprehensive collection of proteins that have 3D structures [252]. The 
PDID (http://biomine.cs.vcu.edu/servers/PDID) is a structural human genome-wide repository of 
putative and native DPIs that are mapped into the 3D structures of protein targets [29]. It currently 
stores data about over one million interactions for 51 drugs.
A typical database focuses on DPIs. However, some drugs target protein-protein interactions 
and targets that are relevant to the same disease or condition can be modulated by multiple drugs. 
Several databases address these aspects. For example, three databases that focus on the 
druggability of protein-protein interactions include TIMBAL 
(http://mordred.bioc.cam.ac.uk/timbal) [253, 254], 2P2Idb (http://2p2idb.cnrs-mrs.fr) [255-257], 
and iPPI-DB (http://www.ippidb.cdithem.fr) [258, 259]. On the other hand, DCDB 
(http://www.cls.zju.edu.cn/dcdb) is a resource that centers on the therapeutic effects of multi drug 
combinations [260, 261].
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The IntSide database (http://intside.irbbarcelona.org) focuses on drug side-effects. This 
database includes data about both therapeutic and off-targets, relevant pathways, biological 
functions, and chemical traits of drugs [128]. This information is particularly useful to explain and 
understand undesired responses to drug treatments.
The CancerResource (http://data-analysis.charite.de/care) [262, 263] and canSAR
(http://cansar.icr.ac.uk) [264-266] databases aim to bridge cancer research with drug discovery.
These two resources provide underlying information about drug-target interactions that are 
relevant to cancer treatment, such as data of gene expression, mutations in cancer-related genes, 
drug sensitivity in cancer cell lines, and pathways of drug targets.
Finally, some resources are dedicated to a particular collection of drugs or a specific family 
of protein targets. For example, the WITHDRAWN database 
(http://cheminfo.charite.de/withdrawn) includes data on targets and pathways of drugs that were 
recalled from the market due to toxicity or inefficacy [267]. The GLASS database 
(http://zhanglab.ccmb.med.umich.edu/GLASS) is exclusively focused on the ligand-protein
interactions for the G protein-coupled receptors [268]. About 33% of currently used drugs target 
this family of proteins [44].
The additional information that can be extracted from these databases complements the 
information about drug-target interactions that can be obtained from the 12 source databases. We 
suppose that it would be beneficial for the future similarity-based predictors of DPIs to include 
these databases as sources.
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4.4 Similarity-based predictors
We review several key aspects of the 35 selected high-impact similarity-based DPI predictors. 
We classify these methods into different categories according to the types and numbers of 
similarities that they use. We summarize the timeline, impact, and availability of these predictors. 
We link their internal databases to the specific source databases that we discussed in section 4.3. 
We also discuss architectural details of these methods. Finally, we comment on the assessment of 
predictive performance that was adopted by the previous approaches.
4.4.1 Categorization of predictors
The three types of similarities can be combined to formulate an ensemble predictor with the 
underlining goal to improve predictive quality when compared to using single similarity. Many of 
the predictors proposed in recent years rely on the ensembles that include two or three similarity 
types. Consequently, we categorize the 35 considered predictors into three groups: the methods 
that apply one type of similarity (1S), ensemble models that combine two types of similarities (2S), 
and ensembles of all three similarities (3S); see “Type of predictor” column in Table 8 and Table 
9.
4.4.2 Timeline, impact, and availability
The 35 similarity-based predictors were developed in the past decade. Table 7 lists these 
predictors in chronological order by their first publication dates. The first five predictors were 
published between 2007 and 2009. We note a steady pace of the development of methods between 
2010 and 2015. Specifically, eight methods were released between 2010 and 2012, and another 
eight between 2013 and 2015. The pace has picked up recently and already 14 methods were 
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published between 2016 and the first quarter of 2018. These data reveal an increasing interest in 
the development of the similarity-based approaches.
Table 7. Timeline, impact, and availability of the 35 selected similarity-based DPI predictors. This table is sorted 
chronologically according to the date of publication. The data of this table was collected on April 1, 2018.




SEA [175, 221] 2/7/2007 41.7 922 83 WS http://sea.bkslab.org
KRM [176] 7/1/2008 7.3 446 46 None N/A
Campillos et al. [177] 7/11/2008 37.2 892 92 None N/A
COPICAT [178, 269] 6/5/2009 4.5 41 5 WS http://copicat.dna.bio.keio.ac.jp
BLM [179] 7/15/2009 7.3 265 30 SS http://members.cbio.mines-paristech.fr/~yyamanishi/bipartitelocal/
Yamanishi et al. [180] 6/1/2010 7.3 249 32 None N/A
Yabuuchi et al. [181] 3/1/2011 9.8 102 14 None N/A
GIP [182] 9/4/2011 7.3 195 30 SS http://cs.ru.nl/~tvanlaarhoven/drugtarget2011/
NBI [183] 5/10/2012 4.5 339 57 None N/A
KBMF2K [184] 6/23/2012 7.3 125 22 SS http://github.com/mehmetgonen/kbmf/
PKR [185] 9/3/2012 7.3 71 13 None N/A
Cao et al. [186] 9/24/2012 5.0 33 6 None N/A
BLM-NII [187] 11/17/2012 7.3 109 20 None N/A
Cheng et al. [188] 3/25/2013 3.8 49 10 None N/A
DT-Hybrid [189] 5/29/2013 7.3 73 15 WS & SS http://alpha.dmi.unict.it/dtweb/index.php
PRW & NB [190] 7/8/2013 3.8 69 15 SS http://pubs.acs.org/doi/suppl/10.1021/ci300435j
DINIES [191] 5/16/2014 10.2 44 11 WS http://genome.jp/tools/dinies/
Shi et al. [192] 5/6/2015 3.8 24 8 SS http://web.hku.hk/~liym1018/projects/drug/drug.html
Liu et al. [193] 6/10/2015 7.3 24 9 None N/A
RWR [194] 8/19/2015 4.2 11 4 None N/A
SLP & RLS [195] 9/9/2015 4.3 6 2 SS http://pan.baidu.com/s/1dDqDLuD
RLS-KF [196] 1/14/2016 5.0 7 3 SS http://github.com/minghao2016/RLS-KF/
DrugMiner [165] 1/25/2016 6.4 14 6 WS http://www.drugminer.org
NRLMF [197] 2/12/2016 4.5 34 16 SS http://github.com/stephenliu0423/PyDTI/
SDTNBI [198] 3/4/2016 5.1 20 10 SS http://lmmd.ecust.edu.cn/methods/sdtnbi/
DASPfind [199] 3/16/2016 4.2 14 7 WS http://cbrc.kaust.edu.sa/daspfind/
DrugE-Rank [200] 6/11/2016 7.3 23 13 WS http://datamining-iip.fudan.edu.cn/service/DrugE-Rank/
DBN [166] 3/6/2017 4.3 10 9 SS http://github.com/Bjoux2/DeepDTIs_DBN/
EnsemDT/KRR [201] 5/24/2017 3.8 4 5 None N/A
Peón et al [167] 6/19/2017 4.3 3 4 None N/A
PUDTI [168] 8/14/2017 4.3 0 0 None N/A
DVM [169] 9/11/2017 4.3 1 2 None N/A
DTINet [170] 9/18/2017 12.1 4 7 SS http://github.com/luoyunan/DTINet/
bSDTNBI [171, 270] 9/28/2017 3.8 2 4 SS http://lmmd.ecust.edu.cn/methods/bsdtnbi/
iDTI-ESBoost [172] 12/18/2017 4.3 1 4 WS & SS http://farshidrayhan.pythonanywhere.com/iDTI-ESBoost/
1 The name of each predictor is either provided in relevant publications or otherwise, named using the last name of its first author.
2 The date of early access online publication or the date of journal issue where a given predictor was originally published.
3 The “JIF” column is the journal impact factor of the journal where a given predictor appeared. The data were collected from the 
2017 Journal Citation Reports that was released by Clarivate Analytics (formerly Thomson Reuters) on June 14, 2017.
4 The “Citations” column is the number of citations to the article(s) of a predictor, which were collected from Google Scholar.
5 The “Annual citations” column is the average citation counts per one calendar year (365 days) over the period from the publication 
date until April 1, 2018, rounded to the nearest integer.
6 The type of publicly availability of implementations, where WS stands for webserver and SS for standalone software including 
either compiled or source code. None means the implementation is not offered and thus the corresponding URL is not applicable 
(N/A).
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One way to measure the impact is to consider the impact factors of venues where these 
methods were published. The 35 predictors were published in high-impact venues with impact 
factors > 3.5. Table 7 lists the impact factors for these reputable journals, which are based on the 
2017 Journal Citation Reports [174]. The impact factor values for a significant majority of these 
methods, 33 out of 35, range between 3.8 and 12.1. Two pioneering predictors were published in 
2007 and 2008 in journals with the impact factors around 40 [175, 177]. Another way to measure 
the scientific impact of these methods is based on the citation counts for the articles that introduce 
these methods. Table 7 lists the corresponding total citation counts, which were collected from the 
Google Scholar on April 1, 2018. The median total of citations over the 35 methods equals 33. 
Noticeably, the three earliest predictors [175-177] have accumulated over 400 citations each over 
the last decade. Their combined number of citations (2260) is greater than the combined count of 
citations of the remaining 32 methods (1966). These three highly cited predictors have defined and 
used for the first time the three types of similarities. The SEA method is based on DCS [175]. The 
chronologically second method, KRM, was the first to use PSS, which was combined with DCS
[176]. The third method by Campillos et al. has introduced DPS and used it together with DCS to 
make predictions [177]. There are also three other method that secured at least 200 citations. They 
include BLM [179], the predictor by Yamanishi et al. [180], and NBI [183]. The low citation 
counts for the recent methods that were published since 2016 should be dismissed because there 
was not enough time yet to accumulate citations. We also analyze a more robust number of annual 
citations. This number is defined as the total number of citations divided by the number of years 
(365-day periods), measured between the date of publication and April 1, 2018. The median annual 
citation number equals ten. The three highest cited predictors attract over 40 citations per year. 
Moreover, most of the 35 considered methods enjoy high levels of annual citations (median = 10), 
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in many cases exceeding the corresponding journal impact factors (median = 5). This result 
suggests that the similarity-based DPI predictors elicit strong interest of the scientific community.
Table 7 also summarizes availability of implementations for these predictors. The authors of 
eight methods [165, 172, 175, 178, 189, 191, 199, 200] have developed webservers that are geared 
towards less computer savvy users. The webservers are convenient to use because calculations are 
done on the server side and consequently the end users only need an internet connection and a web 
browser to process predictions. Fourteen predictors [166, 170-172, 179, 182, 184, 189, 190, 192, 
195-198] are available as standalone software. In this case, the end users must install and use them 
on their own hardware. This requires more skill and effort but it also facilitates inclusion of these 
methods in other computational pipelines. Two methods [172, 189] are available as both 
standalone software and webserver. The URLs of these 20 publicly available approaches are listed 
in Table 7. The other 15 methods are not available publicly.
4.4.3 Internal databases
Every similarity-based predictor is implemented based an internal database that includes 
known DPIs and relevant information about these drugs and proteins. The contents of internal 
databases are derived from the data that were collected from one or more of the 12 source databases 
that we reviewed in section 4.3. Table 8 lists the source databases that are used to generate the
internal database of each predictor. Individual predictors utilize between one and six source 
databases, with a median of three. Specifically, 13 predictors collect data from a single source 
database, five from two or three sources, 16 from four sources, and one from six sources. The 
authors of KRM predictor [176] have released their internal database. This database combines 
DPIs collected from BRENDA (BR), KEGG BRITE (KB), DrugBank (DR), and SuperTarget (SU). 
This internal database was later reused by another 15 predictors that we review [168, 169, 172, 
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179, 180, 182-184, 186, 187, 189, 192, 196, 197, 199]. It was also used by a different set of 18 
methods which we did not include in our analysis because of the relatively low impact factor of 
the venues where they were published [271-288]. The frequent reuse of this database explains to 
some extent why this predictor enjoys high citation counts in Table 7.
We observe that only up to 6 out of 12 source databases are used to develop an internal 
database. This is in spite of the fact that each of the 12 source databases includes data that are 
unique to that source, and that many other source databases are available, including the databases 
listed in section 4.3.4. We recommend that future predictors should rely on more comprehensive 
internal databases that integrate more source databases. However, this would require a significant 
effort to map and curate data across the sources that utilize different ways to define, name, and 
identify the drugs and protein targets.
Except for the 15 methods that reuse the internal database of KRM [176], the other predictors 
employ unique internal databases by combining data coming from different sets of source 
databases. Some predictors, such as NBI [183], SDTNBI [198], and DASPfind [199], use more 
than one internal database. In our analysis, we combine the contents of these internal databases for 
these three methods. Table 8 summarizes the main characteristics of the internal databases 
including the numbers of drugs, protein targets, DPIs, and average number of DPIs per drug. Table 
8 shows that most of the internal databases cover between 276 and 7,739 drugs. Some of the 
internal databases also include other drug-like molecules, and correspondingly their sizes are larger 
and they span between 22,839 and 105,946 bioactive molecules. The number of protein targets in 
the internal databases ranges between 246 and 6,662. These are typically human proteins, except
for nine methods that do not explicitly specify organism information of the proteins that they use 
(see “Focus on human proteins” column in Table 8). These numbers are comparable to an expected 
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scale of druggable human proteome, which is estimated to include between 1,000 and 3,000 
proteins [1, 18-20]. Another important measure that quantifies coverage of the internal databases 
is the number of DPIs. This number varies between 1,731 and 155,208. While some databases 
include a large number of drugs or targets (e.g., databases for SEA, SDTNBI and EnsemDT/KRR 
predictors), they cover a relatively low number of DPIs per drug. The density of DPIs, which is 
calculated as the average number of DPIs per drug, varies widely between 1.1 and 11.5 (see 
“DPIs/drug” column in Table 8). Databases with low densities might be missing a substantial
number of DPIs and consequently the corresponding predictors might provide inaccurate values 
of similarities. Moreover, higher density of interactions is likely associated with a more complete 
coverage of interactions for individual drugs. The corresponding internal databases can be used to 
provide a more reliable estimation of predictive quality at the drug level.
The medians of the main four characteristics of the internal databases over the 35 predictors 
are 932 drugs, 989 proteins, 5127 DPIs, and 5.1 DPIs per drug. The first three medians correspond 
to the frequently reused internal database of KRM predictor [176]. The corresponding medians for 
the latest releases of the 12 source databases in Table 5 are 23124 drugs, 3036 proteins, 33467 
DPIs, and 2.8 DPIs per drug. Interestingly, the first three numbers are much higher while the last 
number is lower when compared to the sizes of the internal databases. This is in spite of the fact 
that individual predictors combine multiple source databases to derive their internal databases. 
One of the reasons why internal databases are relatively small is that they focus on particular 
collections of drugs and proteins. For example, the internal database of COPICAT [178, 269]
includes only the 964 FDA-approved drugs, while its source database, DrugBank, also stores five 
thousand experimental drugs. The method developed by Liu et al. [193] focuses on H. sapiens and 
C. elegans, while its source databases also cover other organisms such as mouse and E. coli. 
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Another reason is that the internal databases are not being updated in contrast to the source 
databases that are frequently updated and grow in size [23]. In other words, some internal databases 
are based on outdated version(s) of the source database(s). For example, 16 predictors [168, 169, 
172, 176, 179, 180, 182-184, 186, 187, 189, 192, 196, 197, 199], including some recent methods 
that were developed in 2017, utilize the same internal database [176] which has not been updated 
since it was published in 2008.
Although the internal databases include fewer drugs, proteins, and DPIs than the source 
databases, their median drug promiscuity at 5.1 DPIs per drug is 80% larger than the median 
promiscuity of the source databases, which equals 2.8. This increase is due to the aggregation of 
different DPIs for the same drugs that are coming from different source databases. The higher 
promiscuity suggests that the information about the interactions in the internal databases is more 
complete when compared to the individual source databases. This may benefit the similarity-based 
predictive models. For example, knowledge of a larger number of native targets would likely result 
in a larger set of candidate protein targets that could be explored to predict novel targets for a given 
drug. Also, a higher promiscuity increases the chances to identify proteins that are targeted by 
different drugs.
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Table 8. Overview of the source and internal databases of the 35 similarity-based DPI predictors that were published 
in high impact venues. We group these methods into three categories: predictors using single type of similarity (1S), 
ensemble predictors employing two types of similarities (2S) and ensembles of three types of similarities (3S). We 
summarize the source databases that these predictors use to derive their internal databases. We provide information 
about the internal databases including number of drugs, proteins and DPIs, number of DPIs per drug, and number of 
data sources contained in the internal databases. We denote whether or not these methods focus on human proteins 
only. We also indicate whether a given predictor includes only interacting drug-protein pairs or both interacting and 
non-interacting pairs to evaluate predictive performance.
Type of 
predictor














SEA [175] 2007 MD 1 65,241 246 71,094 1.1 complete
PRW & NB [190] 2013 CH 1 105,946 894 155,208 1.5 √ interacting
DrugMiner [165] 2016 DR 1 1,396 1,224 4,729 3.4 √ complete
SDTNBI [198] 2016 BI DR CH 3 22,839 1,541 57,726 2.5 √ complete
Peón et al. [167] 2017 CH 1 745 1,427 8,535 11.5 complete
bSDTNBI [171] 2017 BI CH 2 276 453 1,796 6.5 √ complete
2S
KRM [176] 2008 BR KB DR SU 4 932 989 5,127 5.5 √ complete
Campillos et al. [177] 2008 PK DR MA 3 502 N/A 4,857 9.7 √ interacting
COPICAT [178] 2009 DR 1 964 456 1,731 1.8 complete
BLM [179] 2009 BR KB DR SU 4 932 989 5,127 5.5 √ complete
Yabuuchi et al. [181] 2011 GL 1 866 317 5,207 6.0 complete
GIP [182] 2011 BR KB DR SU 4 932 989 5,127 5.5 √ complete
NBI [183] 2012 BR KB DR SU 4 5,330 4,785 17,610 3.3 √ complete
KBMF2K [184] 2012 BR KB DR SU 4 932 989 5,127 5.5 √ complete
Cao et al. [186] 2012 BR KB DR SU 4 932 989 5,127 5.5 √ complete
BLM-NII [187] 2012 BR KB DR SU 4 932 989 5,127 5.5 √ complete
Cheng et al. [188] 2013 TT DR 2 621 893 3,195 5.1 complete
DT-Hybrid [189] 2013 BR KB DR SU 4 5,330 4,773 17,573 3.3 √ complete
RWR [194] 2015 DR 1 684 627 2,557 3.7 complete
SLP & RLS [195] 2015 DR 1 786 809 3,681 4.7 complete
RLS-KF [196] 2016 BR KB DR SU 4 932 989 5,127 5.5 √ complete
NRLMF [197] 2016 BR KB DR SU 4 932 989 5,127 5.5 √ complete
DASPfind [199] 2016 BR KB DR SU 4 3,897 6,662 12,919 3.3 √ complete
DrugE-Rank [200] 2016 DR 1 1,242 1,324 5,701 4.6 √ complete
DBN [166] 2017 DR 1 1,412 1,520 6,262 4.4 complete
EnsemDT/KRR [201] 2017 DR 1 7,739 4,902 17,483 2.3 complete
PUDTI [168] 2017 BR KB DR SU 4 932 989 5,127 5.5 √ complete
DVM [169] 2017 BR KB DR SU 4 932 989 5,127 5.5 √ complete
iDTI-ESBoost [172] 2017 BR KB DR SU 4 932 989 5,127 5.5 √ complete
3S
Yamanishi et al. [180] 2010 BR KB DR SU 4 443 989 2,649 6.0 √ complete
PKR [185] 2012 KD 1 2,423 436 6,769 2.8 √ complete
DINIES [191] 2014 PK TT DR KD MA CH 6 678 277 1,804 2.7 √ complete
Shi et al. [192] 2015 BR KB DR SU 4 932 989 5,127 5.5 √ complete
Liu et al. [193] 2015 DR MA ST 3 2,486 3,356 7,369 3.0 √ complete
DTINet [170] 2017 DR 1 708 1,512 1,923 2.7 √ complete
This article 2018 PK TT DR CH + 15 19 449 1,469 34,456 76.7 √ complete
1The source databases include MDDR (MD), PDSP Ki (PK), BRENDA (BR), BindingDB (BI), TTD (TT), KEGG BRITE (KB), 
DrugBank (DR), GLIDA (GL), KEGG DRUG (KD), SuperTarget (SU), Matador (MA), STITCH (ST), and ChEMBL (CH). This 
review relies primarily on the Drug2Gene resource where the data are derived from 19 source databases: PK TT DR CH + 15 other 
databases: CGDCP, ChEBI, CTD, HGNC, IUPHAR, Ligand Expo, MICAD, NCBI Gene, Pathway Commons DB, PDBsum, 
PharmGKB, PubChem Bioassay, PubChem Compound, PubChem Substance, and UniProt. 
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4.4.4 Predictive models
The considered 35 predictors rely on three main types of similarities: chemical similarity 
(DCS), drug profile similarity (DPS), and protein sequence similarity (PSS). The three types of 
similarities can be combined to formulate an ensemble predictor with the underlining goal to 
improve predictive quality when compared to using a single similarity. Many of the predictors 
proposed in recent years rely on the ensembles that include two or three similarity types. 
Consequently, we categorize the 35 considered predictors into three groups: the methods that apply 
one type of similarity (1S), ensemble models that combine two types of similarities (2S), and 
ensembles of all three similarities (3S).
Table 9 includes six 1S predictors. Four methods [167, 171, 190, 198] measure DCS based 
on Tanimoto coefficient [289] that quantifies similarity between drug structures which are 
represented using molecular fingerprints [290, 291]. One predictor applies a statistical test over a 
set of DCSs based on Tanimoto coefficients between an input drug and a group of drugs in its 
internal database which are known to bind the input protein target [175]. The other method, 
DrugMiner, converts protein sequences into numeric feature vectors that represent 
physicochemical properties and amino acid compositions. Subsequently, it quantifies PSS for these 
feature vectors using machine learning algorithms and estimates druggability of a given protein 
based on its PSS to the known drug targets [165].
There are twenty three 2S models that utilize two types of similarities. Besides listing the 
similarity types we also define how they are combined together to generate predictions. Almost all 
of the 2S methods (21 out of 23) integrate DCS and PSS. Eleven predictors [176, 179, 182-184, 
187, 189, 195-197, 199] quantify DCS using the SIMCOP algorithm [292, 293] while two other 
predictors [194, 200] utilize Tanimoto coefficient; these 13 methods rely on sequence alignment 
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algorithms such as BLAST [153] and Smith-Waterman [294] to measure PSS. A set of eight other 
methods represents drug structures and protein sequences using feature vectors that quantify DCS
and PSS and they apply machine learning algorithms to generate predictions. These algorithms 
include kernel functions [168, 169, 178, 181, 186, 201], neural networks [166], and decision trees 
[172]. DPS is adopted rarely. Only two 2S predictors combine DPS with DCS [177, 188]. They 
define drug side-effect profile as a vector of binary values that indicate the presence or absence of 
specific side-effect terms. They quantify DPS based on weighted Tanimoto coefficients that 
measure similarities between side-effect profiles. The predictive models applied in these methods 
reveal that DPS could be used to infer DPIs in a similar way to DCS. This approach assumes that 
drugs that have similar side-effects are likely to target the same proteins. The drug profiles that 
were used in Ref. [177] have motivated the development of the SIDER database which stores drug 
side-effect information [120, 121]. This resource was later used in other works that we review 
including another 2S model [188] and three 3S methods [170, 185, 193]. However, SIDER focuses 
on marketed drugs and so the information about drug side-effects it provides is narrower when 
compared to drug structures that encompass a wider spectrum of drugs and protein sequences that 
span the entire human proteome. This is likely the reason why DPS is less frequently employed. 
Moreover, none of the 23 2S methods combines DPS with PSS. There are two ways in which the
predictors combine two similarities. Five predictors apply a simple summation and weighted 
summation of two similarities [177, 187-189, 200]. The other predictors employ a more complex
approach that typically involves operations such as maximum, multiplication, and geometric mean 
of multiple similarities.
There are six 3S methods that combine all three similarities. They utilize the same approaches 
to quantify DCS and PSS as the 1S and 2S models. Three of the six methods compute DPS based 
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on the cosine correlation coefficients between side-effect profiles [180, 185, 191] while two other 
models use Tanimoto coefficients [170, 193]. The sixth predictor [295] defines drug profiles using
the ATC codes, which represent hierarchical classification of drugs and measure semantic 
similarity between ATC codes [192]. Like for the 2S methods, the 3S models utilize either a simple 
summation [191, 193] or a more complex approach to combine similarities [170, 180, 185, 192].
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Table 9. Comparison of similarity-based DPI predictors. We review 35 methods that were published in high impact 
venues. We group these predictors into three categories (separated by horizontal line): predictors using one similarity 
(1S), predictors combining two types of similarities (2S), and predictors integrating three type of similarities (3S). 
Methods are sorted chronologically within each group. We summarize approaches that are used to quantify similarities 
and to compute ensembles of similarities for each predictor. We also summarize availability of empirical evaluation. 
This denotes inclusion of assessment of predictive quality, assessment of benefits of use of ensembles, assessment at 
per DPI and per drug levels, and analysis of sensitivity of predictive performance to intrinsic characteristics (similarity 
of inputs to the database) and extrinsic characteristics (information about the inputs) of predictors. The check symbol 
√ means a given assessment is included in a given method (row) while a blank cell means it is not included. DCS:
chemical similarity; DPS: drug profile similarity; PSS: protein sequence similarity; SE: SEA algorithm that measures 
DCS [175]; SI: SIMCOMP tool that quantifies DCS [292, 293]; TC: Tanimoto coefficient or other similarity score 
which measures similarity between binary or numeric vectors [289]; KF: kernel function that measures similarity 
between feature vectors used by machine learning algorithms; NN: neural networks; CO: correlation; SS: semantic 
similarity of drug profiles represented by the ATC codes [192]; AL: sequence alignment using PSI-BLAST [153] or 





















SEA [175] 2007 SE N/A √ N/A N/A
PRW & NB [190] 2013 TC N/A √ N/A N/A
DrugMiner [165] 2016 ML N/A √ N/A N/A
SDTNBI [198] 2016 TC N/A √ N/A N/A
Peón et al. [167] 2017 TC N/A √ N/A N/A
bSDTNBI [171] 2017 TC N/A √ N/A N/A
2S
KRM [176] 2008 SI AL C √
Campillos et al. [177] 2008 TC TC S √ √
COPICAT [178] 2009 KF KF C √
BLM [179] 2009 SI AL C √ √
Yabuuchi et al. [181] 2011 KF KF C √ √
GIP [182] 2011 SI AL C √
NBI [183] 2012 SI AL C √ √
KBMF2K [184] 2012 SI AL C √
Cao et al. [186] 2012 KF KF C √
BLM-NII [187] 2012 SI AL S √
Cheng et al. [188] 2013 TC TC S & C √ √
DT-Hybrid [189] 2013 SI AL S √
RWR [194] 2015 TC AL C √
SLP & RLS [195] 2015 SI AL C √
RLS-KF [196] 2016 SI AL C √
NRLMF [197] 2016 SI AL C √
DASPfind [199] 2016 SI AL C √
DrugE-Rank [200] 2016 TC AL S √ √
DBN [166] 2017 NN NN C √
EnsemDT/KRR [201] 2017 KF KF C √
PUDTI [168] 2017 KF KF C √
DVM [169] 2017 KF KF C √
iDTI-ESBoost [172] 2017 ML ML C √
3S
Yamanishi et al. [180] 2010 SI CO AL C √ √
PKR [185] 2012 KF CO KF C √ √
DINIES [191] 2014 SI CO AL S √ √
Shi et al. [192] 2015 TC SS AL C √
Liu et al. [193] 2015 TC TC AL S √
DTINet [170] 2017 TC TC AL C √
This dissertation N/A TC TC AL S √ √ √ √ √ √
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4.4.5 Timeline of the use of similarities and their ensembles
There are seven potential types of predictive models including three 1S, three 2S, and one 3S 
models. Figure 7 provides a timeline of the use of these seven types of predictive models for the 
35 considered methods. In general, the ensemble-based models are much more widely utilized than 
the single similarity-based methods. The most frequently developed ensemble includes DCS and 
PSS. At least one of these methods was published every year except only for 2007, 2010, and 2014. 
The second most commonly used type of methods combines the three types of similarities. These 
methods were shown to outperform ensembles that are based on specific pairs of similarities, such 
as ensemble of DCS and PSS and ensemble of DPS and PSS [185]. However, a significant majority 
of current predictors combines only two similarities: DCS and PSS, without DPS. This is likely 
because the information on side-effects is not available in most of the source databases and this 
information used to be difficult to collect, especially before databases such as SIDER [120, 121]
and MetaADEDB [296] were developed. Also, the mapping of drugs from the side-effect databases 
into the drugs in the internal databases is non-trivial. Another reason why DPS is not an attractive 
option is the fact that the side-effect information is limited to the marketed drugs. Consequently, 
this limits the internal databases to this group of drugs. Unlike the two broadly adopted types of 
models mentioned above, the other types of models are published less frequently. These models 
rely on DCS, PSS, and the ensemble of DCS and DPS. Some designs, such as methods that use 
DPS and the ensemble of DPS and PSS, have not been employed among the 35 considered methods. 
In summary, the most popular configuration is the ensemble that combines DCS with another 
type(s) of similarity.
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Figure 7. Timeline of similarity-based predictors of drug-protein interactions. The x-axis (width) denotes when the 
similarity-based predictors were published. The y-axis (depth) denotes the type of predictors. The z-axis (height) 
shows the number of a given predictors that were published in a given year. Green, blue, and red cubes represent drug 
chemical similarity (DCS), drug profile similarity (DPS), and protein sequence similarity-based predictors (PSS), 
respectively. The corresponding ensembles are color-coded according to the mixture of these three base colors shown 
in the figure legend.
Figure 8. Use of individual similarities in predictors of drug-protein interactions. The x-axis denotes the year. The y-
axis shows the fractions of cumulated numbers of uses of drug structure (green bars), drug profile (blue), and protein 
sequence (red) similarities up to a given year. Numbers inside the bars indicate the cumulative count of uses of each 
similarity. The similarity is counted when it is used individually by a single similarity-based predictor, and in tandem 
with other similarities by ensemble-based predictors.
Figure 8 shows how often an individual type of similarity was used over the last decade. We 
include their use individually and also as part of ensembles. Each bar in Figure 8 shows a 
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bars reflect relative fraction of use of specific types of similarities. The first bar reveals that the 
first predictor that was published in 2007 was based on DCS [175]. The relative rate of use of DCS
has gradually decreased between 2008 and 2010 when compared to the other two types of 
similarities. After 2010, the relative rate of use of the three types of similarities has stabilized; this 
is reflected by similar proportions of the three colors. The last bar reveals that in total the 
similarities were used 70 times by the considered set of 35 methods, which correspond to two 
similarities per method on average. DCS was used 49% of the time, while PSS and DPS were used 
40% and 11% of the time, respectively. These fractions are consistent with the observation that 
the ensemble of DCS and PSS is the most frequently utilized type of predictive model. The 
relatively infrequent use of DPS is likely due to low drug coverage and difficulty to collect the 
information on drug side-effects. We believe that with the release and improvements to the 
databases that provide access to drug profiles, including SIDER and MetaADEDB, this type of 
similarity will play a more prominent role in the development of future predictors.
4.4.6 Critique of the current assessments of predictive performance
Another important aspect of the considered DPI predictors is the assessment of their 
predictive performance. The predictions are provided at an interaction level, which means that the 
predictive models identify whether a given drug-protein pair interacts. Two early predictors were 
assessed solely using the interacting drug-protein pairs (see “Scope of evaluation” column in Table 
8) [177, 190]. While such assessment evaluates true positive rate (TPR), which is defined as
fraction of interactions that are correctly identified, it lacks the ability to assess specificity, which 
measures the fraction of correctly predicted non-interactions. The other 33 methods provide 
assessment for both interacting and non-interacting drug-protein pairs. This type of assessment is 
more complete as it measures not only TPR but also the capability to correctly identify the non-
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interacting pairs that constitute majority of all possible drug-protein pairs. Moreover, the 
considered 35 predictors report their predictive performance over all drug-protein pairs that span 
multiple drugs. This means that they did not assess and compare predictive quality for individual 
drugs (see “Predictive quality” column in Table 9). However, drugs differ in their structures, 
profiles, and the number and type of protein partners that they bind to, and these factors likely 
impact the predictive performance.
Besides quantifying predictive performance, it is also essential to justify the use of ensembles. 
Since the ensembles require more computations and are more complex to implement than the 1S 
models, they must offer some benefits to balance these drawbacks. In particular, these benefits 
typically boil down to higher predictive performance when compared to the 1S methods. Only six 
out of 23 2S methods compare 2S model with 1S to quantify the corresponding improvement in 
the predictive quality evaluated per interaction (see “Benefit of ensemble” column in Table 9) [177, 
179, 181, 183, 188, 200]. Additionally, three 3S methods provide empirical evidence that the
ensemble of three similarities boosts the predictive quality at interaction level when compared to 
the 2S ensembles [180, 185, 191]. While this suggests that ensemble models may provide more 
accurate results than the 1S models, follow up studies are needed to explore the benefits of 
ensembles using both per interaction and per drug evaluation. Moreover, none of these methods 
has comprehensively compared all three 1S, three 2S, and one 3S models. Such analysis would 
provide important insights on the use of the similarity-based predictors.
Another interesting aspect is sensitivity of predictive performance to certain characteristics 
of predictors. For example, in a scenario where the query drug is dissimilar to the drugs in the 
internal database of a given predictor, DCS and DPS are likely to be ineffective. On the other hand, 
if the query drug has sufficient levels of similarity to some of the drugs in the internal database 
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then we can use these similar drugs to likely accurately predict the protein targets. Similarity 
between the user-provided inputs and the contents of the internal database of a given predictor 
relies on an intrinsic property of this predictor (i.e., its database). On the other hand, predictive 
performance could be also affected by extrinsic to the predictor and known a priori properties of 
the query drug and targets, such as the drug promiscuity. For instance, it might be easier to identify 
DPIs for a drug that target numerous proteins because this increases a chance to find many other 
similar targets in the internal database. Analysis of sensitivity of performance to these 
characteristics would help to calibrate the expectations of predictive quality and optimize the 
design of predictors for specific use cases. However, this type of sensitivity analysis was never 
addressed in the past studies (see “Sensitivity analysis” column in Table 9).
Besides quantifying predictive performance in silico, some of these predictive tools were also 
assessed experimentally. In that case, the correctness of the putative DPIs that they generate was
additionally verified by in vitro binding assays and cell assays. This type of validation was done 
for the earliest predictor [175], the method that first defined DPS [177], and in one recent study
[170].
4.5 Conclusions
We have discussed the timeline, impact, availability, contents, and architectures for the 35 
high-impact similarity-based DPI predictors and the related 12 source databases.
The source databases store curated annotations of DPIs that are used to derive the internal 
databases of the predictors. Their contents were obtained from relevant literature, experiments, 
and other data repositories. Most of the 12 source databases also directly import the annotations 
of DPIs from the other source databases. Consequently, each source database stores its unique data 
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and also a certain amount of data that overlap with the other source databases. Moreover, some 
source databases focus on the interaction data for the approved and experimental drug compounds, 
while the others include the protein targets for a more generic collection of bioactive compounds 
that includes drugs and drug-like molecules. This contributes to the diversity of contents of the 
source databases, in terms of the number and type of compounds, protein targets, and DPIs. Drugs 
that are included in the source databases typically target multiple proteins. This drug promiscuity 
defines the field of polypharmacology and benefits the development of the similarity-based 
predictors. The source databases have accumulated data for over ten years and have been 
frequently used by the scientific community. This is reflected by the fact that they were cited at 
least 190 times each. Most of the databases are continually updated and periodical republished. 
Our analysis shows that the source databases that are more frequently updated and republished are 
also more often cited.
The similarity-based predictors have been developed at a steady pace over the past decade. 
These methods rely on the internal databases that typically include data derived from multiple 
source databases. We found that recent methods have used a larger number of source databases 
than the older methods, although this number is still relatively low compared to the number of 
available source databases. The internal databases generally include lower numbers of drugs, 
proteins, and interactions but higher degrees of drug promiscuity when contrasted with the 
corresponding source databases. A higher drug promiscuity allows the similarity-based predictors 
to screen a more complete set of candidate protein targets and increases likelihood of identifying 
targets shared by multiple drugs. Given these advantages, the future predictive models should 
exploit an even more comprehensive set of DPIs that would be collected from a larger number of 
source databases.
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Most of the predictors have received a relatively high annual citation counts when compared 
to the corresponding impact factors of the journals where they were published. This points to the 
substantial impact of the similarity-based methods. These methods incorporate predictive models 
that quantify similarities between the input drugs and proteins and the drugs and their known 
targets in the internal databases. We show that they rely on a variety of approaches to quantify 
DCS, DPS, and PSS. Most of these predictors utilize ensembles that combine two or three types 
of similarities, were published in high impact venues and are highly cited. The three earliest 
predictors are the most cited. They were the first to use DCS and the ensemble of DCS and 
PSS/DPS. These pioneering works resulted in the DCS-centric trend for the development of the 
similarity-based models. The vast majority of the 35 methods applies DCS or ensemble models 
that combine DCS with DPS and/or PSS. The ensemble of DCS and PSS is the most commonly 
utilized type of predictive model. Our analysis of the frequencies of use of similarities has found 
that DCS and PSS have been utilized about 90% of the time, while DPS is relatively underutilized. 
The infrequent use of DPS likely results from the incompleteness and difficulty to use and collect 
the drug profiles. This motivates the need to further develop the drug side-effect profile databases, 
thereby facilitating a new generation of methods that would more heavily rely on DPS.
These studies assess predictive performance at the interaction level and some of them have 
demonstrated that the use of certain ensembles leads to improved predictive performance when 
compared to the use of a single similarity. However, a comprehensive empirical comparison of all 
types of similarities and their ensembles is missing. Although the current works perform empirical 
assessments over a large number of drug-protein pairs, primarily in the druggable human proteome, 
the density of DPIs in the databases that were utilized in these assessments is rather low. Moreover, 
per drug assessment of the predictive quality was not yet performed. Similarly, sensitivity of 
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predictive performance to characteristics of predictors was not yet studied. To this end, we provide 
comprehensive and in-depth empirical comparative analysis for a representative set of similarity-
based predictors. First, we build a novel database that includes drugs characterized by high density 
of DPIs. Next, we comprehensively evaluate a representative set of predictors that are based on 
each of the three main types of similarities and the corresponding four possible ensembles. Besides 
evaluating predictive performance at the interaction level, we are the first to perform the drug level 
assessment and to analyze sensitivity of predictive quality to the intrinsic and extrinsic 
characteristics of predictors. This work is described in Chapter 5.
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Chapter 5 Empirical assessment and comparative analysis of
similarity-based methods for prediction of drug-protein 
interactions
We empirically evaluate seven representative similarity-based DPI predictors. These seven 
predictors rely on each of the three individually used similarities (DCS, DPS, and PSS) plus four 
ensembles that combine each pair and all three similarities. We delineate the setup for the 
assessment by describing the seven predictors and defining measures and a novel high-quality 
benchmark database of DPIs that we use to assess the predictive performance. Like in the previous 
studies, we analyze predictive performance at the interaction level. Moreover, we are the first to 
compare all seven representative methods, to measure and compare predictive performance at the 
drug level, and to analyze sensitivity of predictive performance to characteristics of input drugs 
and proteins. We also release a webserver that provides access to the server-size implementations 
of the seven predictors.
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5.1 Experimental setup
5.1.1 Computation of similarities
The key underpinning concepts that define similarity-based predictors of DPIs is how they 
quantify and combine the three similarities. We selected one representative approach drawn from 
previous works to measure each type of similarity. The Tanimoto similarity of chemical structures 
has been widely applied to quantify DCS [289]. Recent comparative studies have demonstrated 
that the Tanimoto similarity is one of the best DCS measures [291, 297, 298]. Eleven selected 
predictors have used the Tanimoto coefficient to quantify DCS [167, 170, 171, 177, 188, 190, 192-
194, 198, 200]. The above reasons motivate our choice of this measure to quantify DCS. Tanimoto 
coefficient is computed based on molecular fingerprint that converts a chemical structure of a 
given drug into a bit vector of fixed size. For a given compound, the fingerprint represents presence 
of certain substructures with a bit value of 1 and their absence with a bit value of 0. Similarity of 
two drug fingerprints is represented by the similarity between their corresponding bit vectors A 
and B:
DCS (A, B) = a1b1 / (a1 + b1 – a1b1)
where a1b1 is a count of corresponding positions where both vectors A and B have values 1, and 
a1 and b1 are the counts of positions with value 1 in vectors A and B, respectively. Higher value of 
the Tanimoto similarity means the two molecules are more structurally similar since they have a 
higher fraction of similar substructures in common. We use the Chemistry Development Kit
software [299-302] to generate 1024-bit molecular fingerprints of drug structures and to compute 
the Tanimoto similarity between drugs.
We quantify DPS based on a drug side-effect profile similarity introduced in one of the 
pioneering predictors that utilized this type of similarity for the first time [177]. A given drug is 
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represented by a profile vector that denotes presence/absence of certain side-effect term with a bit 
value of 1/0. The profile similarity is computed using the weighted Tanimoto coefficient between 
the side-effect profiles of a given pair of drugs. Each side-effect term has its own weight. The 
weight is derived based on an abundance of the corresponding term in a large collection of drugs 
(all drugs included in the internal database) and a correlation of this term with the other terms. 
Higher weights are associated with terms that are less frequent (specific to a small number of drugs) 
and that are dissimilar to other terms (they are infrequently used together with other terms for the 
same drugs). Consequently, higher value of DPS means that a given pair of drugs share a high 
fraction of side-effect terms with high values of weights. This approach to quantify DPS is 
arguably more accurate than the approaches taken by some other methods that use a simpler 
definition of weights [193] or unweighted Tanimoto coefficients [188].
We use sequence alignment to estimate PSS. This is the most popular approach that was
adopted by 18 predictors [170, 176, 179, 180, 182-184, 187, 189, 191-197, 199, 200]. First, we 
run BLAST [154, 156] with default parameters to perform sequence alignment between a sequence 
of a protein target of the input drug provided by user and each protein target in the database of 
known DPIs. BLAST finds the closest protein from the database based on a distance defined as 
the fraction of identical and similar residues in the pairwise alignment. Therefore, proteins from 
the database that have high value of sequence similarity are arguably likely to also interact with 
the input drug by the virtue of being similar to the known target of this drug.
We create the four ensemble models using a linear combination of multiple types of 
similarities. This approach is in line with a number of published ensemble methods [177, 187-189, 
200]. We consider the 3S model that combines the three types of similarities and three 2S 
ensembles that combine each pair of the three similarities, which we denote as DCS+DPS, 
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DCS+PSS, and DPS+PSS. Some of the past methods combine similarities using more sophisticates 
approaches, such as machine learning models and drug-protein networks. A typical machine 
learning-based predictor uses an algorithm such as SVM to combine multiple kernel 
functions/matrices derived from two or three similarities [191]. However, SVM requires 
computationally costly parameterization and this is a black-box method, which means that the 
model is so complex that is impossible to understand how predictions are performed. Network-
based predictors rely on a linear combination of similarities to quantify weights associated with 
edges in the network [187]. These predictors require knowledge of drug-drug or drug-target 
connections (network edges) for an input drug. Consequently, they cannot be utilized to predict 
DPIs for drugs that are not already integrated in the network [32]. We opt to use the linear 
combination of similarities which is computationally efficient, white-box (linear function 
explicitly defines how similarities are combined), and works with novel drugs.
5.1.2 Prediction of drug-protein interactions
To perform the prediction, we screen the query drug against all candidate proteins from the 
internal database of known DPIs to evaluate how likely they may interact with this drug. Given 
the three types of similarities, the input information for the query drug may include drug structure, 
drug profile and/or protein sequences of its known targets. The procedure to perform predictions 
depends on which inputs are available. If the drug structure is available then for every candidate 
protein in the database we compute DCS between the query drug and every single drug that is 
known to bind to that candidate protein (excluding the query structure itself if the candidate protein 
is already known as a binding partner of this drug). The maximal value among these DCS values 
is used as the propensity of DPI between the query drug and the candidate protein. A higher 
propensity indicates that the candidate protein is more likely to bind to the query drug because this 
82
protein is known to be a target of a drug which is structurally similar to the query drug. This is 
consistent with an observation that similar drug structures share the same protein target [32, 85-
87]. A similar procedure is used when the drug profile is available. The propensity of DPI for the 
input drug and a given candidate protein is computed as the maximal DPS between this drug and 
all drugs that are known to bind to this candidate protein in the database of known DPIs. Such 
prediction relies on the assertion that drugs with similar side-effect profiles likely target the same 
protein [177]. If the protein targets of the input drug are known and their sequences are available 
then we compute pairwise PSS between each candidate protein and all known targets of this drug 
(excluding the candidate protein itself if this protein is already known to interact with the query 
drug in the database). The maximal PSS among all known targets is used as the propensity of DPI 
for the query drug and the candidate protein. The sequence similarity-based prediction is motivated 
by an observation that similar proteins tend to interact with the same drug [32, 85-87]. If multiple 
inputs are available then they are combined together. We assess whether such ensembles of two or 
three similarities would provide improved quality of predictions when compared to using these 
similarities individually.
5.1.3 Benchmark database of drug-protein interactions
The DPI predictors rely on the internal database that contains native DPIs. We develop a 
novel benchmark database that we use as the internal database to evaluate these predictors. The 
benchmark database integrate three resources: Drug2Gene [247], Therapeutic Target Database 
(TTD) [43, 103-107], and IUPHAR/BPS Guide to Pharmacology database (GtP) [248, 249, 303-
306]. Our database is primarily derived from Drug2Gene that integrates 19 source databases. These 
sources include four databases, PDSP Ki [202], TTD [43, 103-107], DrugBank [98-102], and 
ChEMBL [113-116], which are used by the 35 considered predictors to derive their internal 
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databases. However, we also include 15 other sources: CGDCP [307], ChEBI [308], CTD [238], 
HGNC [309], GtP [248, 249, 303-306], Ligand Expo [310], MICAD [311], NCBI Gene [312], 
Pathway Commons DB [313], PDBsum [314], PharmGKB [315], Pubchem Bioassay [239], 
PubChem Compound [316], PubChem Substance [316], and UniProt [37]. Considering that the 35 
predictors adopt no more than six source databases, Drug2Gene provides us with a more complete 
information about DPIs. Another survey also highlights Drug2Gene as the most comprehensive 
DPI database [22]. In particular, use of Drug2Gene helps us to acquire high density of DPIs in the 
benchmark database. However, Drug2Gene (version 5) incorporates older versions of the TTD 
database (release 2011) and GtP database (release 2012) when compared its other sources. Thus, 
we combined Drug2Gene with newer versions of TTD (release 2015) and GtP (release 2015). 
These three resources altogether cover 10,515 compounds, 16,880 proteins, and 161,736 
interactions. The density of DPIs for this database is 15 DPIs/drug, before removal of duplicates 
across these sources (see first row in Table 10).
The seven predictors that we assess rely on quantification of the three types of similarities. 
Thus, drug structures, drug profiles, and protein sequences are required for every drug/protein 
entry in the benchmark database. Drug fingerprints were collected from PubChem [316] by 
querying their compound identifiers (CIDs) that are available in three sources databases. Drug 
profiles were obtained from SIDER 2 [120, 121], a database of drug side-effects for marketed 
drugs, by matching PubChem CIDs. Protein sequences were retrieved from UniProt [37] using 
their UniProt accession numbers (UniProt IDs) which are available in TTD and GtP, and with the 
Entrez Gene [312] identifiers which are available in Drug2Gene. Consequently, drugs and proteins 
are respectively indexed by PubChem CIDs and UniProt IDs along with drug structures from 
PubChem, drug profiles from SIDER, and protein sequences from UniProt in the benchmark 
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database. We found redundant drug/protein entries because older versions of TTD and GtP have 
already been imported into Drug2Gene. We removed the duplicate drugs and proteins by 
comparing PubChem CID and UniProt ID, respectively. SIDER 2 provides side-effects for 996 
drugs, which limits the number of drugs in our benchmark database. After collecting information 
for computing similarities and cleaning the duplicates, the resulting benchmark database contains 
965 drugs, 7,565 proteins, 93,015 interactions, and 96 DPIs/drug (see second row in Table 10). 
Like most of studies in this area [165, 168-172, 176, 177, 179, 180, 182-187, 189-193, 196-200], 
we focus on the human protein targets. Thus, we eliminated non-human proteins based on their 
taxonomic identifiers from UniProt. Consequently, 563 drugs, 1,537 proteins, 35,352 interactions, 
and 63 DPIs/drug are left in the benchmark database (see third row in Table 10). Next, to ensure 
that sufficient amount of information about drug structure and protein sequence similarities is 
available to perform empirical assessment and sensitivity analysis, we removed small compounds 
that have fewer than 10 atoms and drugs that have fewer than five known protein targets, 
respectively. The final version of the benchmark database is composed of 449 drugs, 1,469 proteins, 
34,456 interactions, and includes 76 DPIs/drug (see the last row in Table 10). When compared to 
the internal databases of the considered 35 predictors, this benchmark database is among the top 
11% with respect to the number of DPIs shown in Table 8. Moreover, an arguably key indicator 
of a high-quality benchmark DPI database is the density of DPIs. High density of interactions 
facilitates reliable estimates for per-drug assessment of predictive performance. The benchmark 
database has the highest value of average per-drug density of DPIs at 76 DPIs/drug (median density 
= 95 DPIs/drug). Moreover, the median per-target density of DPIs is 4 DPIs/protein. This is a 
direct result of merging the largest number of sources of the DPI data and the fact that we only 
consider drugs that have at least five protein targets. Figure 9 shows the per-drug and per-target 
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density of DPIs for the drugs and proteins in the benchmark database, respectively. The top ten 
drugs that have the highest number of known targets include Imatinib (PubChem: 5291, 485 DPIs), 
Sorafenib (PubChem: 216239, 388 DPIs), Erlotinib (PubChem: 176870, 385 DPIs), Nilotinib 
(PubChem: 644241, 385 DPIs), Dasatinib (PubChem: 3062316, 384 DPIs), Gefitinib (PubChem: 
123631, 343 DPIs), Chlorpromazine (PubChem: 2726, 168 DPIs), Mitoxantrone (PubChem: 4212, 
166 DPIs), Nifedipine (PubChem: 4485, 162 DPIs), and Verapamil (PubChem: 2520, 158 DPIs). 
The top ten proteins that interact with the largest number of drugs include Cytochrome P450 3A4 
(UniProt: P08684, 350 DPIs), Cytochrome P450 2D6 (UniProt: C1ID52, 329 DPIs), Cytochrome 
P450 2C9 (UniProt: P11712, 307 DPIs), Potassium voltage-gated channel, subfamily H (UniProt: 
A0A090N7W1, 298 DPIs), Cytochrome P450 1A2 (UniProt: P05177, 296 DPIs), Mitogen-
activated protein kinase 1 (UniProt: P28482, 288 DPIs), Dopamine receptor D2, isoform CRA_c 
(UniProt: A0A024R3C5, 283 DPIs), Muscarinic acetylcholine receptor (UniProt: A0A024R3S2, 
280 DPIs), Muscarinic acetylcholine receptor M1 (UniProt: P11229, 280 DPIs), and Muscarinic 
acetylcholine receptor (UniProt: A4D1Q0, 279 DPIs). The list of drugs, protein targets, and DPIs 
of the benchmark database are shown in the Appendixes 1, 2 and 3, respectively.
Table 10. Summary of the benchmark DPI database. The numbers were counted after each major step of the procedure 
that that lead to the completion of the benchmark database. The density of DPIs (DPIs/drug) is calculated by the 
average number of DPIs per drug.
Procedure of data processing Drugs Proteins DPIs DPIs/drug
Total counts in original sources databases 10,515 16,880 161,736 15
Filtered by availability of necessary information to compute similarities 965 7,565 93,015 96
Filtered by to include human proteins 563 1,537 35,352 63
Filtered by drug size (> 10 atoms) and number of known targets per drug (> 5 DPIs/drug) 449 1,469 34,456 76
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Figure 9. Density of DPIs for the drugs and protein targets in the benchmark database. Panel A shows the numbers of 
DPIs per drug and sorts the drugs in the decending order by these numbers. Panel B shows the numbers of DPIs per 
protein and sorts the proteins in the decending order by these numbers.
The source DPI databases include annotations of native interacting drug-protein pairs but they 
lack the annotations of non-interacting pairs. In the past, these databases were used to assess 
predictors of DPIs in several ways. A few early studies have assessed predictive performance using 
only the native interacting pairs [177, 190]. These assessments are incomplete since they measured
only the rate of correctly predicted native DPIs while they did not evaluate the predictive 
performance for the non-interacting pairs, i.e., they did not evaluate the number of false positives. 
More recent works have assessed predictions using both interacting and non-interacting drug-
protein pairs. Most of these studies assume that the drug-protein pairs that are not annotated as 
interacting are non-interacting. This assumption may result in mislabeling some of the native 
interacting pairs as non-interacting; in particular, those that were not yet discovered. This 
commonly applied approach to annotate the non-interacting pairs relies on an assertion that the 
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interacting pairs. We are the first to study this assumption empirically. We annotate weak binders 
among the native drug-protein binding pairs and we compare similarity between the assumed non-
interacting drug-protein pairs and the similarity among the weakly binding pairs. We hypothesize 
that the assumed non-interacting drug-protein pairs can be used to represent the native non-
interacting pairs if the difference between similarity of the non-interacting drug-protein pairs and 
similarity among the native interacting pairs is significantly higher than the difference between 
similarity of weak interactors and the similarity of the native interacting pairs.
We map the drug-protein pairs from the benchmark database into the PDSP Ki database that 
provides binding affinities [202]. A high binding affinity (affinity constant Ki < 10 µM) is typically 
considered to indicate an interacting drug-protein pair [177, 234]. Consequently, we divide the 
mapped drug-protein pairs into three subsets: the native interacting pairs with Ki < 10 µM, weak 
native interacting pairs with Ki > 10 µM, and the non-interacting pairs that include all pairs that 
are not annotated as DPIs. We compute DCS, DPS, and PSS for the drug-protein pairs in each 
subset. Figure 10 compares distributions of the values of three similarities for the native interacting 
pairs, weak native interacting pairs (borderline pairs), and non-interacting pairs. The distributions 
are represented by the 5th, 20th, 50th (median), 80th, and 95th percentiles. The results are 
consistent across the three similarities. The similarity values for the non-interacting drug-protein 
pairs are significantly lower when compared to the similarities for the weak native interactors (p-
value < 0.01). They are also significantly lower when compared to the similarities for the native 
interacting pairs (p-value < 0.01). In other words, Figure 10 reveals that only a small portion of 
the non-interacting pairs has DCS, DPS and PSS values that are comparable to the DCS values of 
the native DPIs. We also observe that the distributions for DPS and PSS for the weak native 
interactors are similar to the distributions for the native interactors (p-value = 0.11 and 0.65, 
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respectively). While the difference between weak native interactors and native interactors for DCS
is significant, the median DCS are 0.65, 0.41, and 0.28 for the native interacting pairs, weak native 
interacting pairs and non-interacting pairs, respectively. Over 95% / 80% of the native interacting 
pairs have higher DCS values than at least 50% / 80% of the non-interacting pairs. In agreement 
with previous studies, these results suggest that the assumed non-interacting pairs can be used to 
represent non-interacting pairs since their similarity is significantly lower than the similarity of the 
weak native interactors and the native interactors, while the differences between the latter two sets 
of drug-protein pairs are substantially smaller. We also observe that the number of non-interacting 
pairs that have relatively high PSS is greater than those that have relatively high DCS and PSS. 
This implies that predictions using PSS might be less accurate than the predictions with DCS or 
DPS.
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Figure 10. Distributions of values of the three types of similarities for native interacting drug-protein pairs (Ki < 10 
µM; dark green), weak native interactors (Ki > 10 µM; borderline pairs in light green), and non-interacting drug-
protein pairs (in red). Boxes and whiskers represent the 5th, 20th, 50th, 80th, and 95th percentiles of the similarity 
values. Marker × represents average similarity value for a given set of drug-protein pairs. We assess significance of 
differences between the similarity values for each pair of drug-protein pair sets using the Wilcoxon rank sum test 
[317]; we use the non-parametric test since these data are not normal according to the Anderson-Darling test at 0.01 
significance. * indicates that the difference is statistically significant (p-value < 0.01); otherwise the actual p-value is 
shown.
5.1.4 Assessment of predictive performance
Using the benchmark database, we empirically test predictions for each of the 449 drugs by 
comparing the putative targets generated by a given method with the known native interactors for 
this drug. When testing predictions for a given drug, we remove information about its known 
targets from the database. We analyze the results across all drugs and separately for each drug. 
Like virtually all considered in this review methods we use the receiver operating characteristic 
(ROC) curve and the area under the ROC curve (AUC) to assess quality of DPI predictions [165, 
166, 168-172, 175, 176, 178-189, 191-201]. ROC curve is a plot of True Positive Rates (TPRs) 






























TP (True Positive) and the TN (True Negative) are the numbers of native interacting pairs and 
native non-interacting pairs that are predicted correctly, respectively; the FN (False Negative) is 
the number of native interacting pairs predicted as non-interacting; and the FP (False Positive)
corresponds to the number of native non-interacting pairs predicted as interacting. The predicted 
propensities are transformed into binary predictions (positive vs. negative) using threshold values, 
which are next used to compute the TPR and FPR. Drug-protein pairs with propensity above the 
threshold are assumed to bind (positive), otherwise they are assumed to be non-binding (negative). 
The thresholds are set to be equal to all unique values of the predicted propensities of DPIs in order 
to derive the most accurate ROC curve. Higher AUC values denote better predictive performance, 
i.e., they correspond to predictions that offer higher TPRs (more correct predictions of DPIs) for 
lower FPRs (fewer incorrect predictions of non-interactions as DPIs).
The fraction of the native interacting drug-protein pairs among all drug-protein pairs in the
benchmark database is at about 5%. Thus, for example, if FPR = 10% then the number of predicted 
putative DPIs is about twice the number of actual native interacting pairs. This corresponds to a 
substantial over-prediction of putative DPIs. Moreover, the AUC values are determined primarily 
by the part of the curve where FPR is high, focusing on the over-prediction, i.e., area under the 
curve for the low FPR values is much smaller than for high FPR values. Thus, motivated by recent 
works [318-321] we focus the lower part of ROC with FPR less than 5% (ROClow) where the 
number of incorrectly predicted DPIs is not larger than the number of native DPIs. Accordingly, 
we calculate the corresponding area under ROClow curve (AUClow). Moreover, to ease 
interpretation of this index, we report RatioAUClow = AUClow / AUClow-random, where AUClow-random
is AUClow for a random predictor. A random predictor generates TPRs that are equal to FPRs, 
resulting in a diagonal line in the TPR-FPR space. RatioAUClow measures to what degree a given 
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predictor is better than a random predictor. RatioAUClow > 1 means the method is better than random.
An alternative to measuring the ROC for dataset with low numbers of positive samples is to use 
Precision-Recall curves. However, we opt to use ROClow because this is the most frequently used 
measure in this area [165, 166, 168-172, 175, 176, 178-189, 191-201].
5.2 Empirical analysis of predictive performance
We perform evaluation of the predictive quality of the three 1S predictors as well as their 2S 
and 3S ensembles. We assess predictive performance for each drug by removing it from the 
benchmark database, predicting its interactions with each proteins target in that database, and 
evaluating these predictions against the removed native interactions of this drug. We aggregate 
these results over all the drugs and 659,581 drug-protein pairs. A query drug might be dissimilar 
to the drugs in the benchmark database in terms of its structure and side-effect profile. To simulate 
a practical scenario, we limit the similarity between the query drug and the drugs in database. 
Specifically, given a query drug, we not only remove this drug but we also remove the drugs with
above median DCS and DPS from the benchmark database when performing the evaluations. Use 
of the median represents an average case. Note that the protein sequences are easy to collect and 
all of them are available for every prediction. The complete set of sequences for human proteins 
can be obtained from UniProt. Thus, the predictions for a given query drug are generated based on 
the drugs with the below-median DCS and DPS, and the complete set of protein sequences.
5.2.1 Assessment of predictive performance at the drug-protein interaction level
Figure 11 shows the ROCs and ROCslow that measure the predictive quality at the interaction 
level over all drug-protein pairs in the benchmark database for the three 1S, three 2S, and one 3S 
predictors. The 3S model has the highest AUC, AUClow and RatioAUClow values, which are given 
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in the legend for Figure 11. The 1S models register a modest drop in predictive quality when 
compared to the 2S models. Specifically, the relative difference in AUC (in AUClow) between 3S 
and the best 2S model equals [0.926–0.913]/0.913 = 1.4% ([0.0285–0.0274]/0.0274 = 4.0%) 
(Figure 11A). The corresponding relative difference when comparing 3S and 1S models are at 
least [0.926-0.883]/0.883 = 4.9% for AUC and [0.0285-0.0231]/0.0231 = 23.4% for AUClow. 
These results consistently demonstrate that the use of ensembles results in improvement in 
predictive quality. Moreover, our results show that adoption of the 3S, the three 2S, and DCS and 
DPS models provides high-quality predictions. The only relatively low results for PSS could be 
perhaps explained by the larger overlap of similarities between the native DPIs and non-DPIs 
observed in Figure 10. Although DCS provides more accurate predictions in terms of AUC when 
compared to DPS and PSS, the ensemble of DPS+PSS outperforms the two 2S predictors that rely 
on DCS. Combing DPS and PSS provides the largest improvement over these similarities used 
individually. Specifically, the relative difference in AUC (in AUClow) is 4.8% (13.7%) and 20.4% 
(130%) when comparing DPS+PSS with DPS and PSS, respectively. The corresponding 
improvements for the other two 2S models are more modest. DCS+PSS provides a relative increase 
in AUC (in AUClow) when compared to DCS and PSS by 2.6% (9.5%) and 19.5% (143%), 
respectively. Similarly, the value of AUC (AUClow) for DCS+DPS is better by 1.9% (18.6%) and 
3.3% (29.9%) than the values for DCS and DPS, respectively. One possible explanation for these 
differences is that each of the three similarities offers good predictive performance while DPS and 
PSS are lack any correlation (Spearman correlation coefficient [SCC] = 0.05), DCS and PSS are 
weakly correlated (SCC = 0.14), and DCS and DPS are modestly correlated (SCC = 0.30). 
Therefore, PSS and DPS complement each other the most which results in the largest improvement 
in the quality of predictions.
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Figure 11. Comparison of predictive performance for the 1S, 2S, and 3S DPI predictors measured at the interaction 
level. Panel A shows ROC curves and panel B shows ROClow for which FPRs ≤ 0.05. Diagonal dotted line denotes 
the ROC curve for a random predictor for which TPR = FPR. Values of AUC, AUClow and RatioAUClow are shown in 
the legend for panel A.
When FPR is greater than 0.05, the number of native non-DPIs that are incorrectly predicted 
as DPIs is larger than the total number of native DPIs. In other words, we over-predict DPIs. 
Therefore, we utilize AUClow that considers the ROC curve for FPR < 0.05. The advantages of 
using multiple similarities, i.e., 3S vs 2S and 2S vs 1S, are maintained for AUClow (Figure 11B). 
The RatioAUClow reveals that 3S model is about 23 times more accurate than random predictions 
while 2S and 1S models are up to 22 and 19 times more accurate when compared to the random 
predictions. In particular, 3S predictor identifies 70% and the best 2S model finds 67% of native 
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successfully detect over 63% of native DPIs (TPR > 0.6) at 5% level of FPR, except PSS which 
finds 33% of native DPIs. Similar to the evaluations based on the overall AUC, predictor based on 
DCS is the most accurate 1S model in terms of AUClow. Therefore, DCS drives the predictive 
quality of the ensembles. Moreover, PSS has the lowest performance of the three similarities, 
which is still eight times better than the random predictions. Moreover, PSS is helpful for the 
ensemble models given its lack of correlation with the other two similarities. The AUClow for the 
2S ensembles that include PSS register relative improvement by 9.5% and 13.7% when contrasted 
with DCS and DPS, respectively.
We also evaluate statistical significance of the differences in predictive quality between the 
3S model, the three 2S models, and the three 1S models. To do that, we evaluate the differences 
over a diverse collection of 100 datasets drawn from the benchmark database. Each dataset 
includes 10% of randomly selected (without replacement) drugs from the benchmark database. 
Therefore, overlap between these datasets is minimal resulting in a large and diverse sampling of 
subsets of the benchmark datasets. We measure the AUC, AUClow, and RatioAUClow for each dataset. 
The corresponding averages and standard deviations quantified over the 100 datasets are given in
Table 11. These averages are consistent with the results on the entire benchmark database that we 
give in Figure 11A. The p-values that measure significance of differences between all pairs of the 
considered seven methods are below 0.01, which mean that the differences in the predictive quality 
are statistically significant. This reveals that the benefits brought by the use of multiple similarities 
and the higher predictive performance of DCS compared to other 1S models are consistent over a 
diverse sampling of datasets. Overall, we show that 3S is the most accurate and significantly more 
accurate than the 2S predictors, while the 2S predictors are significantly better than the 1S models. 
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DCS is significantly more accurate when compared to DPS and PSS. These observations provide 
useful hints for future users and designers of the DPI predictors.
Table 11. Significance of differences in the predictive performance of DPI predictors measured at interaction level.
The distribution of AUC, AUClow, and RatioAUClow values quantified over 100 different datasets (randomly selected 
10% of drugs from the benchmark database) are represented by average ± standard deviation. The italic and underlined
fonts represent results of tests of significance of difference in AUC and in AUClow, respectively, for each pair of 
predictors. We quentify the corresponding p-values by running t-test (for measurement with normal distribution) or 
Wilcoxon signed-rank test (for non-normal data) between each pair of predictors. We test the normality with the 
Anderson-Darling test at 0.01 significance.
Method
Predictive quality 
(average ± standard deviation)
Statistical significance (p-value) of the differences 
between all pairs of predictors
AUC AUClow RatioAUClow 3S DPS+PSS DCS+PSS DCS+DPS DCS DPS PSS
3S 0.925±0.005 0.0284±0.0005 22.7±0.4 5.4E-26 4.0E-77 2.3E-46 3.7E-59 1.6E-54 8.5E-104
DPS+PSS 0.912±0.004 0.0240±0.0005 19.2±0.4 1.0E-69 3.3E-10 1.9E-12 1.0E-30 5.5E-51 5.8E-105
DCS+PSS 0.905±0.005 0.0252±0.0005 20.2±0.4 4.7E-64 3.9E-14 7.4E-07 4.1E-37 5.8E-34 4.8E-98
DCS+DPS 0.899±0.006 0.0273±0.0007 21.9±0.6 1.3E-08 1.3E-30 1.7E-18 8.2E-45 8.4E-32 5.5E-81
DCS 0.882±0.006 0.0230±0.0006 18.4±0.5 2.0E-56 3.0E-05 3.2E-22 5.2E-58 3.3E-08 5.1E-74
DPS 0.869±0.008 0.0210±0.0007 16.8±0.6 2.9E-69 3.7E-34 7.9E-39 5.7E-78 8.2E-23 1.5E-66
PSS 0.759±0.012 0.0100±0.0029 8.0±2.3 3.2E-92 9.2E-87 2.0E-88 2.1E-72 1.6E-65 1.2E-57
We study relationship between the predictive performance and similarity values by 
comparing predictions between the 3S and 1S models to understand how the predictive 
performance benefits from combining multiple similarities. We divide values of DCS, DPS, and 
PSS into 20 equally sized intervals and utilize these intervals to partition the benchmark database 
into subsets in which the drug-protein pairs have comparable similarity values. Figure 12
deconstructs the 3S model into two dimensional plots of two similarities, each divided into 20 
intervals for the total of 400 data points. This figure compares the predictive quality of the 3S 
model (shown inside of the first quadrant) with the three 1S models (left most vertical set of points 
and bottom most horizontal set of points, which are outside of the quadrant). The predictive quality 
is measured with accuracy defined as a fraction of correctly identified DPIs and non-DPIs to total 
number of drug-protein pairs in a given data point; we denote that by the bubble size in Figure 12. 
We could not use AUC because some of these data points may not have either native DPIs or 
native non-DPIs. We use colors to denote relative enrichment of native DPIs and non-DPIs for 
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each data point where dark red denotes enrichment in non-DPIs and dark green is for enrichment 
in DPIs. The enrichment is defined as the difference between the fractions of DPIs and non-DPIs, 
which are computed by dividing the number of native DPIs (non-DPIs) in a given data point by
the total number of DPIs (non-DPIs) in the benchmark database. For instance, a light red point for 
DCS ∈ [0.25, 0.3] and PSS ∈ [0, 0.05] in Figure 12B. shows that a modest majority of drug-protein 
pairs with these values of the two similarities are non-DPIs (which is denoted by the light red color) 
and accuracy of the 3S model for this data point is 100% (which is denoted by the large size of the
bubble).
Figure 12A shows that the predictive accuracy for 3S model is separated into two distinct 
regions. The first region includes red data points for DCS ∈ [0.05, 0.45] and DPS ∈ [0, 0.15]. This 
region is enriched in native non-DPIs (red color) and has high predictive accuracy (large bubble). 
The second region includes green data points for DCS ∈ [0.45, 1] and DPS ∈ [0.1, 0.3]. This region 
is enriched in native DPIs (green color) and has lower predictive accuracy (smaller bubble) when 
compared to the red region. As expected, the colors reveal that the native non-DPIs are 
concentrated in the drug-protein pairs with low values of DCS and DPS while the native DPIs are 
more enriched in the drug-protein pairs with high similarities. This demonstrates that similarities 
could be used to discriminate DPIs from non-DPIs. The bubble sizes reveal that it is easier to 
provide high predictive performance for non-DPIs because they contain many drug-protein pairs 
and most of them include drugs which are very dissimilar to drugs which are known to bind the 
same protein. Such dissimilar drugs are easy to be correctly predicted as the non-interacting pairs. 
On the other hand, the predictions are less accurate for the green bubbles. This is because they 
cover drug-protein pairs for which drug structures are similar to the drugs that interact with the 
same proteins. Moreover, some of the pairs in these bubbles are still non-DPIs and they are difficult 
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to differentiate from the native DPIs. Most importantly, Figure 12A explains why 3S model is 
better than the corresponding two 1S models that rely on DCS and DPS. DCS values can be used 
to reliably separate non-DPIs (dark red bubbles in the bottom horizontal line where DCS <0.4) 
from DPIs (dark green bubbles where DCS > 0.5). However, drug-protein pairs for DCS between 
0.4 and 0.5 cannot be easily separated. The separation of these drug-protein pairs into DPIs and 
non-DPIs can be improved by adding the values of DPS. Specifically, drug-protein pairs with DCS
∈ [0.4, 0.5] and DPS ∈ [0, 0.1] are mostly non-DPIs (red bubbles) while the drug-protein pairs 
with DCS ∈ [0.4, 0.5] and DPS > 0.1 are mostly DPIs (green bubbles). Moreover, the bubble sizes 
also suggest that the accuracy of the 3S model is better than DCS model. The bubble for DCS ∈
[0.45, 0. 5] has moderate accuracy = 78%. The corresponding column for the 3S model at DCS ∈
[0.45, 0.5] has includes much larger bubbles that correspond to higher accuracies. The accuracy 
for the 3S model is high (between 89% and 98%) when DPS < 0.2 and DCS ∈ [0.45, 0.5]. On 
average, accuracy of the 3S model for DCS ∈ [0.45, 0.5] equals 84% when compared to 78% when 
DCS is employed alone. Similar observations can be made for Figure 12B. Overall, the 3S model 










































































Figure 12. Comparison of predictive performance between 3S and 1S models in the function of values of the three 
similarities. The values of the three similarities are divided into 20 equally sized intervals. The comparison of the 3S 
vs the three 1S models is divided into two panels that compare the 3S model vs. two sets of 1S models each. Panel A 
shows the comparison of 3S vs. DCS and DPS. Panel B shows the comparison of 3S vs. DCS and PSS. Accuracy for 
the 3S model is shown inside the first quadrant while 1S models are given as a horizontal line below x-axis and a 
vertical line to left from the y-axis. Each bubble represents the drug-protein pairs in a given interval. Bubble sizes 
denote accuracy, which is defined as the fraction of correctly identified DPIs and non-DPIs to total number of drug-
protein pairs in that bubble. Color denotes enrichment in native DPIs/non-DPIs, which is defined as the difference 
between the fractions of native DPIs and non-DPIs. These are computed by dividing the number of DPIs (non-DPIs) 
in a given bubble by the total number of DPIs (non-DPIs) in the benchmark database. We discretize the enrichment 
into five levels: dark green (dark red) bubble denotes significant enrichment in DPIs (non-DPIs) if the difference ≥1%;
light green (light red) bubble indicates moderate enrichment in DPIs (non-DPIs) if the difference ≥0.5%; and white 
hollow bubble means no enrichment for which the difference <0.5%. White space in the figure denotes bubbles that 
we removed because they contain fewer than 100 drug-protein pairs; this is to ensure that statistics are robust.
5.2.2 Assessment of predictive performance at drug level
All previous studies evaluate predictive performance at the interaction level, which measures 
accuracy of the DPI predictions over drug-protein pairs that span across multiple drugs. 
Considering the fact that different drugs may share different levels of similarity to the benchmark 
database, it would be useful to evaluate these drugs individually. We provide first-of-its-kind 
assessment of predictive performance for DPI predictions at the drug level. The drug-level 
assessment provides further insight into complementarity and differences between various 1S, 2S, 
and 3S predictors. We measure the AUC over the DPI predictions for each individual drug 
(AUCdrug), which evaluates the quality of associations that are predicted between a given drug and 
all of the 1469 druggable proteins. We ensure that each drug in the benchmark database has at least 
five protein targets, which allows us to provide relatively robust estimates of the AUCdrug values.
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Figure 13. Comparison of predictive performance for the considered DPI predictors at the drug level. Black and gray 
lines at the top of the figure show the AUC measured per drug (AUCdrug) for each of the three 1S models. Drugs are 
sorted by their AUC produced by the most accurate DCS model. The four sets of bar charts at the bottom of the figure 
show the difference in drug-level AUC between each ensemble model and DCS. Green bar (red bar) means 
improvement (decline) in the AUCdrug values.
The upper half of Figure 13 shows the AUCdrug for the three 1S predictors over each of the 
449 drugs. The drugs are sorted by the corresponding AUCdrug values of DCS, which is the most 
accurate 1S model when measured at the interaction level (Figure 11). We divide the drugs into 
three groups. The first group of 150 drugs has AUCdrug for DCS > 0.96. The AUCdrug for DPS and 
PSS is virtually always lower than AUCdrug for DCS for this group. The second group of 195 drugs 
has AUCdrug for DCS between 0.96 and 0.86. The values of AUCdrug for PSS are almost always 
lower than DCS while AUCdrug for DPS and DCS are similar for these 195 drugs. The third group
of the remaining 104 drugs has AUCdrug values for DCS that are on average lower than DPS and 
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for PSS (0.752) for the third group of drugs is on average higher than the AUCdrug for DCS and 
DPS (0.674 and 0.709). This reveals that although overall PSS provides lower predictive 
performance, it outperforms the other two measures of similarity for 60/449 = 13% of drugs. The 
lists of drugs for each of the three groups are shown as three separate columns in the Appendix 1.
The interaction-level AUC of DCS across the 449 drugs is 0.883 (Figure 11). DCS achieves 
AUCdrug > 0.883 for 324/449 = 72% of drugs. Moreover, AUCdrug for either DPS or PSS > AUCdrug
for DCS for 100 out of the 125 drugs for which AUCdrug for DCS < 0.883. These drugs should be 
of particular focus for the designers of future DPI predictors since they should be predicted with 
the help of the DPS and PSS rather than the most accurate at the interaction level DCS. This reflects 
trade-offs between the three measures of similarity and motivates the development of predictors 
that use consensus of multiple similarities.
We also compare the drug-level performance for the three 2S and the one 3S predictor with 
the most accurate 1S predictor, DCS. The lower half of Figure 13 shows the difference in AUCdrug
between DCS and each of the four ensemble predictors. Overall, the ensemble models are more 
accurate than DCS for most of the drugs (green bars in Figure 13). Specifically, DCS is 
outperformed by DCS+DPS, DCS+PSS, DPS+PSS, and 3S model for 370, 222, 244, and 349 drugs, 
respectively. We measure relative difference in AUCdrug, which is defined as the absolute 
difference in AUCdrug divided by the AUCdrug for DCS. The average relative differences in AUCdrug
over the 449 drugs between DCS and the four ensembles are 2% (when compared to DCS+DPS), 
5% (DCS+PSS), 7% (DPS+PSS), and 8% (3S). Thus, as expected based on the interaction-level 
results, the 3S model is also the most accurate predictor at the drug level. The drug-level results 
for the 2S models are also consistent with the evaluations at the interaction level. DPS+PSS is the 
most accurate 2S predictor that secures 7% improvement over the DCS model. In particular, it 
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benefits from PSS for the drugs in the third drug group. AUCdrug for DCS and DPS are correlated 
for the third drug group (SCC = 0.58). On the other hand, AUCdrug for PSS is not correlated with 
either DCS or DPS (SCC = 0.07 and 0.05) and it secures relatively high AUCdrug values. This 
implies that PSS is a strong predictive input that compliments the other two similarities, which 
explains why the ensemble predictors outperform DCS for the third group of drugs.
Our novel drug-level assessment of predictive performance shows that no single similarity 
could provide accurate DPI predictions across all drugs. DCS is the most accurate 1S model and 
the primary driver of the ensemble-based predictors for the first two group of drugs. For 23% of 
drugs (the third drug group) for which DCS does not provide higher predictive quality, the use of 
the other two similarities substantially increases the predictive performance. The 1S models are 
strongly dependent on the assumption that similar drugs share the same targets and similar proteins 
tend to interact with the same drug. The complementarity between PSS and DCS/DPS allows us 
to accurately cover a wider range of drugs for which only some of these similarities work 
individually.
5.3 Sensitivity of predictive performance to characteristics of predictors
The predictive performance can be influenced by two factors: 1) intrinsic characteristics of 
the similarity-based predictors of DPIs, which are defined based on similarity of the query drug or 
its known targets to the benchmark database; and 2) extrinsic characteristics that are defined solely 
based on properties of the query drug and its known targets. For instance, if the query drug is 
similar to many of the drugs from the benchmark database then we anticipate it might be more 
likely to accurately find its protein targets when compared to a drug that is dissimilar to the drugs 
in the database. Also, a query drug that has a large number of known targets might be easier to 
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predict, irrespective of the predictive system used. This is because its targets can be exploited to 
find more potential new targets from the database when compared to a query drug with no or few 
known targets. We are the first to assess the sensitivity of predictive quality to a set of practical 
intrinsic and extrinsic characteristics of predictors.
5.3.1 Sensitivity to intrinsic characteristics
Similarity-based DPI predictors rely on finding drugs that are similar to a query drug and 
proteins that are similar to the known targets of the query drug. The quality of DPI predictions 
depends on the values of the similarities between query drug/protein and the benchmark database, 
which in turn are dependent on the size and coverage of the database. In principle, the benchmark 
database is incomplete as it only covers the currently known drug structures, drug profiles, and 
druggable human sequences. In a typical practical scenario, a query drug might be dissimilar to all 
the drugs in the benchmark database. This reduces the chance that a DCS- or DPS-based predictor 
successfully identifies potential DPIs for the query drug, even if the query drug actually shares 
targets with the drugs in the benchmark database. We simulate such scenarios by excluding drugs 
(proteins) that share certain levels of similarity to the query drug (target) from the benchmark 
database when making predictions for the query drug (target). We partition the drugs and proteins 
from the benchmark databases into clusters using average-linkage hierarchical clustering [322]. 
As a result, the average similarity of drugs or proteins between any two clusters is lower than a 
predefined similarity threshold used for the clustering. In other words, the drugs (proteins) from 
one cluster are dissimilar to drugs (proteins) from another cluster. Subsequently, given a query 
drug (protein), we exclude the drugs (proteins) that belong to its cluster and use the only remaining
drugs (proteins) to compute DCS/DPS/PSS for prediction. Thus, the predictions are based on drugs 
and proteins that are dissimilar to the inputs. Specifically, we use the 80th, 50th (median), and 20th
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percentile of similarity values over all the drug-protein pairs in the benchmark database as the 
clustering thresholds. We also consider a scenario where all drugs and proteins are utilized for the 
predictions except for the query drug or protein itself. This scenario is equivalent to the clustering 
using the 100th (maximal) percentile of similarity values. Additionally, random predictions that 
correspond to the 0th percentile are also considered. We use these five scenarios to study the 
sensitivity of the predictive performance to the similarities between the query drug (protein) and 



















































































































































































































Figure 14. Sensitivity of predictive performance measured with ROC 
curves for the three 1S models (panel A-C), the three 2S models (panel 
D-F), and the 3S model (panel G) to the intrinsic characteristics of 
predictors. % denotes the percentile of similarity values which is used 
to cluster drugs or proteins. Drugs (proteins) that are in the same cluster 
as the query drug (protein) are excluded when predicting DPIs. Such 
setup simulates scenarios where the input drugs and targets are 
dissimilar to drugs and proteins in the benchmark database. We consider 
clustering using the 100th, 80th, 50th, 20th and 0th percentiles of the 
similarities.
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Figure 15. Sensitivity of predictive performance to the intrinsic characteristics of predictors. The box-plots denotes 
the AUC values for the scenarios where drugs (proteins) similar to the query drug (protein) are excluded from 
predictions based on clustering using the 100th, 80th, 50th, and 20th percentile of the similarities. The bottom bar denotes 
random predictions that corresponds to the 0th percentile (AUC = 0.5).
Figure 14 shows the ROC curves for the five scenarios and the three 1S, three 2S, and one 3S 
model. Figure 15 summarizes the corresponding AUC values. In general, all but one model are not 
sensitive to the three intrinsic characteristics. The range of AUC values between 100th and 20th
percentiles of similarities for the 3S, the three 2S, DCS, and DPS models is narrow. This means 
that predictive quality drops by only between 0.04 (DCS+DPS and DCS) and 0.07 (DCS+PSS and 
DPS+PSS) with the decrease in similarities by 80%. Consequently, the six models offer high 
predictive quality even when dealing with the input drugs that have low similarity to the 
benchmark database. The one exception is the PSS model for which the predictive performance is 
sensitive to the degree of similarity to the targets in the database. Its AUC value substantially drops 
from 0.76 (100th percentile; clustering threshold for PSS = 0.4 which corresponds to 40% pairwise 
sequence similarity) to 0.56 (50th percentile; threshold = 19% pairwise sequence similarity). The 
results for the 20th percentile of PSS (threshold = 10% pairwise sequence similarity) are equivalent 
to random predictions. This is consistent with previous studies which unveiled that protein 
sequences with identity < 0.25 are likely to have different functions and structures [323, 324]. This 















between interacting and non-interacting drug-protein pairs, in particular when compared to DCS
and DPS. 
This analysis also confirms that use of a larger set of similarities in general results in an 
improved predictive performance. In particular, for the 100th percentile scenario, the AUC of the 
best 1S model is 0.91, the best 2S model is 0.93, and the 3S model is 0.94. Because the adoption 
of low PSS similarities results in lower predictive performance, combining it with DCS or DPS 
into a 2S model does not enhance predictive performance (compare DCS+PSS vs DCS, and 
DPS+PSS vs DPS plots in Figure 15).
The results of analysis of sensitivity to the intrinsic characteristics of predictors reveal that 
the predictive performance is not sensitive to the values of DCS and DPS, while it is sensitive to 
the values of PSS. Moreover, combining PSS with DCS and/or DPS makes the predictors robust 
to the low values of PSS. We conclude that use of PSS only model is risky when the known targets 
of query drug are dissimilar to the targets in the benchmark database.
5.3.2 Sensitivity to extrinsic characteristics
Predictive performance could also be sensitive to extrinsic characteristics that describe known 
a priori input drug structure, drug profile, and protein target. We are the first to investigate several 
extrinsic characteristics for each of the three types of similarities. They include surface area, charge, 
shape, weight, size, lipophilicity, number of similar drugs, number of similar drugs sharing targets,
and similarity to the most similar drugs which are computed from the drug structure. We also 
considered three markers of drug profiles: number of side-effects, similarity of the profile to the 
most similar profile, and number of similar profiles. Finally, we investigated three markers of the 
input drug targets: number of known targets, number of known targets that interact with similar 
drugs, and known targets that interact with the most similar drug. We discuss one “best” marker 
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for each type of similarity, which we selected based on the fact that it significantly affects the 
predictive performance and is easy to quantify. These markers include the number of similar drug 
structures that share targets with the input drug, the number of side-effects, and the number of 
known targets. 
We study sensitivity of predictive quality to these extrinsic markers by partitioning the 
considered drugs into two groups for which we observe large differences in predictive performance. 
For the best DCS marker, we compare 177 drugs that share targets with < 50 similar drugs (which 
corresponds to the median level of DCS) vs the remaining drugs that share targets with a larger 
number of similar drugs. Similarly, for the best DPS characteristic, we contrast 55 drugs that have 
relatively small side-effects profile (<40) vs the remaining drugs that have a larger profile. Finally, 
for the best PSS marker, we compare 128 drugs with < 20 native targets vs the remaining more 
promiscuous drugs. Figure 16 compares distributions of AUCdrug values between these groups of 
drugs when considering the corresponding 1S models and the 3S model.
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Figure 16. Sensitivity of predictive quality to extrinsic characteristics of predictors. The boxplots denote the 5th, 20th, 
50th, 80th, and 95th percentiles of AUCdrug values for the 1S and 3S model over the corresponding two groups of 
drugs separated with help of a given marker that characterizes the input drug/targets. The asterisk indicates that the 
difference in the AUCdrug is significant (p-value < 0.05) between drug groups. We assess significance of differences
between the corresponding two groups of drugs using the Wilcoxon rank sum test [317]; we use the non-parametric 
test since these data are not normal according to the Anderson-Darling test at 0.01 significance.
Figure 16 shows that the AUCdrug for DCS varies substantially between 0.38 and 0.96 with a 
median = 0.85 for the drugs that share targets with fewer similar drugs. For the remaining drugs 
that share targets with the larger number of similar drugs, the AUCdrug for DCS is always > 0.86 
with a median = 0.96. These drugs have lower variation and significantly higher values for AUCdrug
(p-value < 0.05) when compared to the drug that share targets with fewer similar drugs. Similarly, 
the 3S model also has significantly higher AUCdrug values with narrower spread for the drugs with 
larger number of similar drugs sharing targets. These observations reveal that the predictive quality 
is significantly higher when working with drugs that share targets with a larger number of similar 
drugs in the benchmark database. Based on the assertion that similar drugs tend to target the same 
proteins, that makes it easier to accurately identify targets for such drugs when using DCS. In 
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The AUCdrug for DPS is lower for the drugs that have a smaller profile (median AUCdrug =
0.92) than for the drugs that have larger profile (median AUCdrug = 0.94), but this difference is not 
statistically significant (p-value = 0.17). The corresponding difference for the 3S model is slightly 
higher and statistically significant (p-value < 0.05): median AUCdrug = 0.93 vs 0.96, respectively. 
The sensitivity to the size of the drug profile is expected since a larger profile offers more 
information that in turn result in a more accurate quantification of DPS.
The differences in AUCdrug between the less vs more promiscuous drugs are significant for 
the PSS and 3S models (p-value < 0.05). The median AUCdrug for the 3S model is 0.91 for the less 
promiscuous drugs while it equals 0.96 for the more promiscuous drugs. Similarly, for the 1S 
model that relies on PSS the median AUCdrug = 0.75 vs 0.77. This trend could be explained by an 
observation that the drugs which interact with many targets are more likely to have targets that are 
highly similar to the proteins in the benchmark database. This is supported by the assertion that 
similar proteins tend to interact with the same drugs.
The results of the analysis of sensitivity to the extrinsic characteristics reveal that the 
predictive performance is sensitive to several easy to estimate characteristics of the input drug 
structures, drug profiles, and drug targets. As expected, we find that it is more likely to secure 
higher predictive quality when a more comprehensive information is available for the input drugs, 
such as a larger number of similar drugs sharing targets, a larger drug profile, and a higher number 
of known targets.
5.4 CONNECTOR webserver
CONNECTOR (prediCtOr of compouNd-proteiN intEraCTiOn based on ensemble of 
similaRities) is a webserver that implements the seven predictors that we evaluate in this review. 
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The webserver and the benchmark database are freely available at 
http://biomine.cs.vcu.edu/servers/CONNECTOR/. Figure 17 shows the interface of the webserver.
Figure 17. The interface of the CONNECTOR webserver.
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CONNECTOR facilitates prediction for any combination of the three inputs including any 
individual input (drug structure, drug profile, and protein sequence), any pair of inputs, and all 
three inputs. CONNECTOR uses the benchmark dataset as its internal database. The computations 
are performed on the server side and thus the end user only needs to access the webserver page via 
any major web browser and provide the inputs. The prediction is performed in three steps: 1) 
provide any combination of the three inputs including drug structure in the SMILES format, 
comma separated list of side effects (drug profile), and/or protein sequences in the FASTA format; 
2) provide email address where a unique link to the results will be sent once the predictions are 
ready; and 3) click “Run CONNECTOR” (see Figure 17). Each submitted job is entered into a 
FIFO queue of jobs on the server. User is notified via the browser window about the current 
placement in the queue and when the job reaches the front of the queue. The results are displayed 
in the browser window and the unique link to the page with the results is sent to the user-identified 
email address. We provide four views of the results:
 All DPIs, which shows all putative drug-protein pairs that include query drug and target(s) 
and similar compounds and proteins.
 DPIs that include the query drug structure, which cover interactions between the query drug 
structure and its putative protein targets (if drug structure was provided as one of the inputs)
 DPIs that include the query drug profile, which include interactions between the query drug 
represented by its profile and its putative protein targets (if drug profile was provided as one 
of the inputs)
 DPIs that include the query protein sequence, which gives interactions between the query 
target sequence and the drugs that are predicted to interact with this target (if target sequence 
was provided as one of the inputs)
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Each putative interaction is coupled with the corresponding value of similarity. Drugs are 
linked to their entries in the PubChem databases and target sequences are linked to their UniProt 
entries. For user’s convenience, similarities between query drug/target and the drug/target used to 
make prediction and the propensities of putative drug-protein interactions are color-coded. Dark 
green/green/light green/pale green/red denotes that the corresponding drug-protein pair is very
likely/likely/moderately likely/unlikely/very unlikely to interact. We annotate these five colors 
based on the values of the similarity that belong to the top 20%, 20 to 40%, 40 to 60%, 60 to 80%, 
and the bottom 20% of the distribution of these values. We also provide a text-based version of 
the results for download. We will store the page with the results for at least three months.
5.5 Conclusions
We have developed a novel benchmark database that includes drugs characterized by high 
density of interactions and we use it to evaluate a representative set of 1S, 2S, and 3S predictors. 
This database integrates data coming from three resources (19 source databases) and includes 449 
drugs, 1469 druggable human proteins, and 34456 native DPIs, resulting in high density of native 
DPIs per drug that equals 76. We observe that most of the surveyed methods have evaluated
predictive performance on both DPIs and non-DPIs, which allowed for computation of TPR, FPR, 
and the resulting AUC values. However, these methods accessed predictive performance only at 
the interaction level that spans multiple drugs which may differ in structure, profile, and the 
number and type of protein partners that they bind to. We are the first to perform both interaction-
and drug-level assessments and to comprehensively and side-by-side compare all 1S, 2S, and 3S 
models. 
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At the interaction level, we reveal that the use of ensembles results in improved predictive 
quality. Specifically, the 3S model significantly outperforms the 1S and 2S models, while the 2S 
models are significantly more accurate than the 1S models. We empirically analyze reasons for 
these improvements and we show that they stem from an improved handling of interactions 
characterized by modest levels of similarities. Among the three 1S models, DCS and DPS are more 
accurate than PSS. We also find a modest level of correlation between DCS and DPS while 
correlations between PSS and DCS as well as PSS and DPS are low. The modest or low levels of 
correlations further explain why the ensembles benefit from the integration of multiple similarities 
and why the majority of current predictors are ensembles.
At the drug level, we demonstrate that the predictive quality varies widely between drugs and 
these differences depend on the type of similarity used. We show that no single 1S model could 
provide accurate DPI predictions across all the drugs. Moreover, we demonstrate that ensembles 
improve over the 1S models. The average relative improvements in AUCdrug over the 449 drugs 
between the best 1S model, DCS, and the four ensembles are: 2% (compared to DCS+DPS), 5% 
(DCS+PSS), 7% (DPS+PSS), and 8% (3S). We divide drugs into three groups: group one includes 
150 drugs with high AUCdrug for DCS; group two includes 195 drugs with moderate AUCdrug for 
DCS; and group three with 104 drugs for which AUCdrug for DCS is on average lower than DPS 
and PSS. We found that the use of 3S ensemble provides particularly large improvements by on 
average 29% in AUCdrug over the use of DCS for the 23% of drugs which constitute the third group. 
Our empirical analysis also reveals that although per-interaction PSS provides the lowest 
predictive performance, it outperforms the other two 1S models for 13% of drugs when assessed 
at the drug level. These drugs should be of particular focus for the development of future DPI 
predictors because more accurate predictions could be obtained with the help of the DPS and PSS 
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rather than with the overall most accurate at the interaction-level DCS that dominates the current 
methods.
DPI prediction relies on accurate values of similarities between the query drug (its known 
target) and the drugs (proteins) in the benchmark database. The quality of these values is likely 
affected by the intrinsic characteristics of predictors, such as the similarity between inputs and the 
benchmark database. We provide the first-of-its-kind sensitivity analysis of predictive quality for 
each of the three similarities. We find that the predictive quality is not sensitive to the values of 
DCS and DPS, which means that the predictive performance of the methods that utilize DCS/DPS 
does not substantially change when the input drug structures or profiles are dissimilar to the 
structures and profiles in the internal database. In contrast, the predictive quality for PSS drops 
significantly when the input protein sequences are dissimilar to the sequences in the database. 
However, such sensitivity to low values of PSS is mitigated when using methods that combine 
PSS with other similarities. These observations demonstrate that the ensembles are not only 
accurate at the interaction and drug levels but they are also robust to low values of similarities.
We are also the first to investigate sensitivity of predictive quality to extrinsic characteristics 
of the predictive models. These extrinsic characteristics are intrinsic to the inputs and include 
information extracted directly from drug structures, drug profiles, and drug targets. We find that 
the 3S model and the corresponding three 1S models are more likely to provide accurate 
predictions when the input drugs share targets with a larger number of similar drugs in the 
benchmark database, when the input drugs have larger side-effect profiles, and when the input 
drugs are more promiscuous. This suggest that a larger amount of available data (number of known 
targets and/or side-effects) leads to calculations of higher quality and higher values of similarities, 
which in turn results in higher predictive performance.
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Chapter 6 Summary and conclusions
This dissertation has three goals that focus on the prediction and analysis of the DPIs in the 
druggable human proteome. In Chapter 2 we provide a brief introduction to the related background 
to explain and motivate our goals. This chapter includes information about protein and drug-
protein complex structures that define molecular-level details of the therapeutic and off-target 
effects of drugs, as well as a summary and classification of current publications related to the 
computational predictions of DPIs. This is followed by the subsequent three chapters which detail 
methods and results for each of the three goals. My original contributions in this dissertation that 
are organized under each of the three goals include:
Goal 1: Evaluation of protein structure-based DPI predictors and development of DPI 
database.
 We provide empirical comparative analysis of the protein structure-based DPI predictors: 
eFindSite, SMAP and ILbind.
 We develop and deploy the PDID database that stores 1.1 million predictions and 17 
thousand high-confidence putative DPIs for the entire structure human proteome and 
provides interface for drug-based, protein-based, and target sequence-based data queries.
Goal 2: Review of the similarity-based DPI predictors.
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 We review a comprehensive set of 35 high-impact similarity-based DPI predictors
spanning from the three pioneering methods in this area which were published a decade
ago to eight most recent approaches which have never been covered by other surveys.
 We define the categorization of similarity-based DPI predictors based on the types and 
numbers of similarities that they use.
 We review the 12 source databases that are used to derive the internal databases of 
predictors and we comprehensively explain connections between the internal and source 
databases.
 We investigate impact and describe internal databases of the 35 considered methods 
including the recent approaches.
 We analyze the use of similarities and ensembles in the considered set of 35 predictors.
 We critically analyze drawbacks of current reviews and methods in this area.
Goal 3: Empirical assessment and comparative analysis of similarity-based DPI 
predictors.
 We develop and release a novel benchmark database that covers large-scale drug-protein 
data and high-density DPIs. This database is particularly suitable for comparative 
empirical assessment of DPI predictors.
 We are the first to compare all seven representative predictors including three individual 
predictors that rely on each of the three main types of similarities and four ensemble 
predictors that combine two or three similarities.
 We are the first to assess predictive quality at the drug level. This novel drug-level 
assessment of predictive performance provides additional insights.
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 We provide a first-of-its-kind sensitivity analysis of predictive performance to the 
intrinsic characteristics of DPI predictors which describe the similarities between the 
inputs and the benchmark database. 
 We are also the first to analyze the sensitivity of predictive performance to the extrinsic 
characteristics that are the priori known properties of the input drug structures, drug 
profiles, and protein targets.
 We develop and release at http://biomine.cs.vcu.edu/servers/CONNECTOR/ the 
CONNECTOR webserver that implements seven similarity-based DPI predictors that 
we assessed.
Following, we summarize the work done and list major conclusions for each of the three goals. 
In the context of the first goal, we empirically assess the predictive quality of three representative 
protein structure-based approaches for the prediction of the DPIs. This is done for dozens of 
representative drugs over the structural human proteome. Out tests show that these three methods 
provide relatively accurate predictions. Relying on the putative DPIs that were accurately predicted 
by these approaches and the native DPIs collected from PDB, DrugBank and BindingDB, we 
develop and deploy a large-scale database of putative and native DPIs. This PDID database stores 
1.1 million predictions that cover 51 popular and representative drugs and the entire structural 
human proteome, which includes 9652 protein structures. PDID maps the drugs to their target 
proteins, where these interactions may correspond to therapeutic effects and/or adverse events. 
The database helps to comprehensively catalogs drug targets, facilitates repurposing and 
repositioning of existing drugs, and unveils an opportunity to systematically analyze molecular-
level DPIs at a proteome scale. The research related to this goal was published in Ref. [29].
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For the second goal, we completed a comprehensive review for 35 selected high-impact 
similarity-based DPI predictors. These similarity-based methods offer the opportunity to perform 
prediction when protein structures are unavailable, complementing the protein-structure based 
methods that are studied in our first goal. We systematically summarize the key aspects of these 
similarity-based predictors including their methodological underpinnings, volume and coverage of 
their internal databases, information about source databases, inclusion of empirical analysis, 
timeline of development, and their impact. Majority of them were published in high-impact
journals and are highly cited, suggesting that they are of substantial value to the community. Our 
review shows that combining more source databases would likely further increase the 
completeness of information about drug promiscuity in the internal databases. This would benefit 
predictive quality of the similarity-based predictors and would also enable the development of 
higher-quality benchmark databases. Additionally, we note that regular update and dissemination 
would help to increase the effectiveness, completeness, and impact of the source databases. 
Periodic publications and peer review will also boost quality of underlying data and features. Given 
the fact that three main types of similarities are used by these methods, we categorize the 35 tools
based on the number of similarities that they apply and combine together. We find that most of 
these methods ensemble two or three similarities. Recently, DCS and PSS are frequently employed 
and combined to constitute ensemble predictors while DPS is infrequently utilized due to the 
incompleteness and difficulty in acquiring side-effect profiles of drugs. Moreover, we unveil 
drawbacks of current reviews and methods: lack of a systematic empirical analysis of predictive 
quality for individual drugs; lack of an in-depth analysis of sensitivity of predictive performance 
to intrinsic and extrinsic characteristics of predictors is missing; and lack of a comprehensive
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comparative analysis that includes the three single-similarity-based predictors and the four 
ensembles.
The third goal was motivated by the drawbacks of the current reviews and similarity-based 
methods which we uncovered in our second goal. To overcome these drawbacks, we implement, 
empirically evaluate, and compare all seven representative similarity-based DPI predictors. We 
develop a novel benchmark database that stores a comprehensive collection of high-quality DPIs 
which we harvested from 19 data sources. The benchmark database also encompasses essential 
information for the development of similarity-based methods, including chemical structures and 
side-effect profiles of drugs and protein sequences of drug targets. Like in the previous studies we 
assess the predictive performance of the seven representative predictors at the interaction level. 
We also provide the first-of-its-kind assessment of predictive quality at the drug level. This drug-
level analysis shows that different combination of similarities should be used for different drugs 
to obtain more accurate predictions. Moreover, we reveal that ensembles of multiple similarities 
offer higher predictive quality than models that rely on single or fewer similarities. This result is 
consistent for evaluations at both interaction and drug levels. We are the first to analyze the
sensitivity of predictive quality to the intrinsic and extrinsic characteristics of predictors. Our
analysis reveals sensitivity to lower values of PSS while the predictive quality is not sensitive to 
values of DCS and DPS. This suggests that the approach using PSS only would not provide 
accurate predictions when the input proteins are dissimilar to the proteins in the internal database. 
However, ensemble models are robust to low values of similarities. The sensitivity analysis also 
demonstrates that the predictive quality could benefit from a larger amount of information for the 
inputs, including a larger a larger number of similar drugs sharing targets in the internal database, 
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a larger side-effect profile, and a larger number of known targets. These conclusions arguably offer 
a useful guidance for the selection of similarity-based predictors for specific drugs and protein 
targets.
The studies and conclusions summarized above inspire several possible directions for future 
works. Combining a larger and more diverse set of source databases would likely further improve 
quality of the internal databases, which in turn would further boosts the predictive quality. Authors 
of future predictors should consider to integrate recent and comprehensive resources, such as the 
DGIdb database [245, 246] and Pharos database [243], to expand our benchmark database and/or 
the internal databases of their algorithms. Additionally, since the size of the benchmark database 
is primarily limited by the availability of drug profiles in the SIDER database, we recommend that 
future works should also consider combining related information about drug side-effects from the 
MetaADEDB [296] and IntSide database [128]. Moreover, most of the current development efforts 
focuses on protein targets that are structured [20]. However, about 30% of eukaryotic proteins are 
either fully disordered or have long regions of intrinsic disorder [83, 325]. These disordered 
proteins are implicated in a wide range of diseases [326-333]. Moreover, certain protein families 
are enriched in the intrinsic disorder, such as nuclear receptors, kinases, and various enzymes [20, 
83, 84, 334-336]. These protein families include important therapeutic drug targets and druggable 
proteins [1, 2, 18, 19, 44]. This prompts our recommendation that future works should invest into 
the development of disorder-specific DPI databases and methods, which by definition cannot rely 
on the protein structure-based computations.
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Appendix 1 List of drugs included in the benchmark 
database for Goal 3
The list of PubChem CIDs and names for the 449 drugs that are included in the benchmark 
database from Chapter 5.
Drug group 1 Drug group 2 Drug group 3
CID Drug name CID Drug name CID Drug name
3366 5-fluorocytosine 5419 Tetrahydrozoline 3080 2,3-dimercaptopropanol
3385 5-fluorouracil 3406 4-methylpyrazole 4075 5-aminosalicylic acid
4114 8-methoxypsoralen 667490 6-mercaptopurine 71158 Acamprosate
1978 Acebutolol 2723601 6-thioguanine 60164 Adapalene
71771 Aceclofenac 1983 Acetaminophen 5493444 Aliskiren
2094 Allopurinol 1986 Acetazolamide 3007 Amphetamine
2099 Alosetron 2022 Acyclovir 2179 Amsacrine
3125 Alpha-methyl-p-tyrosine 2082 Albendazole 2182 Anagrelide
2118 Alprazolam 2088 Alendronate 166548 Anidulafungin
2130 Amantadine 51263 Alfentanil 60795 Aripiprazole
2145 Aminoglutethimide 2092 Alfuzosin 2266 Azelaic acid
2170 Amoxapine 123606 Almotriptan 82146 Bexarotene
3698 Amrinone 2141 Amifostine 104865 Bosentan
2187 Anastrozole 2160 Amitriptyline 2441 Bromazepam
2249 Atenolol 2162 Amlodipine 2471 Bumetanide
2284 Baclofen 2216 Apraclonidine 60953 Capecitabine
2337 Benzocaine 2244 Aspirin 2551 Carbachol
2366 Betahistine 148192 Atazanavir 2678 Cetirizine
2375 Bicalutamide 2265 Azathioprine 2713 Chlorhexidine
2391 Bisacodyl 2267 Azelastine 8612 Chloroprocaine
444 Bupropion 2578 BCNU 2719 Chloroquine
2477 Buspirone 7699 Benzonatate 2789 Clobazam
2478 Busulfan 12555 Benzydamine 25419 Clodronate
2484 Butenafine 2369 Betaxolol 119182 Clofarabine
2541 Candesartan 2370 Bethanechol 151171 Conivaptan
2708 Chlorambucil 39042 Bezafibrate 5625 Delavirdine
2725 Chlorpheniramine 2381 Biperiden 137 Delta-aminolevulinic acid
2749 Ciclopirox 2405 Bisoprolol 2973 Desferrioxamine
2764 Ciprofloxacin 2435 Brimonidine 42113 Desflurane
2802 Clonazepam 68844 Brinzolamide 125017 Desvenlafaxine
2907 Cyclophosphamide 60726 Bromfenac 3009 DFMO
2913 Cyproheptadine 6834 Brompheniramine 3117 Disulfiram
2972 Deferiprone 2474 Bupivacaine 71329 Dofetilide
124087 Desloratadine 2519 Caffeine 681 Dopamine
2140 Diatrizoate 2554 Carbamazepine 4510 DWP-401
3042 Dicyclomine 2576 Carisoprodol 60877 Emtricitabine
3059 Diflunisal 2583 Carteolol 3226 Enflurane
3100 Diphenhydramine 2585 Carvedilol 176870 Erlotinib
36811 Dobutamine 2662 Celecoxib 60198 Exemestane
3151 Domperidone 2726 Chlorpromazine 150311 Ezetimibe
3158 Doxepin 2727 Chlorpropamide 3331 Felbamate
3168 Droperidol 2732 Chlorthalidone 3345 Fentanyl
3198 Econazole 2733 Chlorzoxazone 119 Gamma-aminobutyric acid
140
3241 Epinastine 2756 Cimetidine 10413 Gamma-hydroxybutyrate
564 Aminocaproic acid 2762 Cinoxacin 123631 Gefitinib
59768 Esmolol 2771 Citalopram 774 Histamine
3261 Estazolam 2801 Clomipramine 3647 Hydroflumethiazide
3291 Ethosuximide 2803 Clonidine 60852 Ibandronate
3305 Etidronate 2812 Clotrimazole 60753 Ibutilide
3308 Etodolac 2895 Cyclobenzaprine 104741 ICI 182,780
3324 Famciclovir 2955 Dapsone 5311181 Iloprost
3325 Famotidine 3062316 Dasatinib 3763 Isoflurane
3339 Fenofibrate 2995 Desipramine 27661 Isosorbide-5-mononitrate
3342 Fenoprofen 30623 Dexrazoxane 219078 Lacosamide
6918558 Fesoterodine 3016 Diazepam 612 Lactate
3354 Flavoxate 3019 Diazoxide 216326 Lenalidomide
3365 Fluconazole 679 Dimethyl sulphoxide 3915 Levocabastine
3373 Flumazenil 3105 Dipivefrin 4004 Malathion
3372 Fluphenazine 3108 Dipyridamole 4057 Mepenzolate methylbromide
3393 Flurazepam 3114 Disopyramide 4058 Meperidine
3410 Formoterol 3152 Donepezil 4064 Meprobamate
3446 Gabapentin 3156 Doxapram 6476 Methsuximide
3478 Glipizide 3157 Doxazosin 4139 Methylene blue solution
3510 Granisetron 3182 Dyphylline 4189 Miconazole
3516 Guaifenesin 77993 Eletriptan 51634 Miglustat
2123 Hexamethylmelamine 838 Epinephrine 47641 Naftifine
3637 Hydralazine 3278 Ethacrynic acid 4421 Nalidixic acid
3652 Hydroxychloroquine 2761171 Ethionamide 4436 Naphazoline
3690 Ifosfamide 3292 Ethotoin 50294 Nedocromil sodium
5291 Imatinib 6049 Edetic Acid 4493 Nilutamide
57469 Imiquimod 3333 Felodipine 4499 Nisoldipine
3767 Isoniazid 3348 Fexofenadine 41684 Nitazoxanide
3825 Ketoprofen 3386 Fluoxetine 4616 Oxazepam
3826 Ketorolac 3394 Flurbiprofen 60843 Pemetrexed
3869 Labetalol 3397 Flutamide 4768 Phenoxybenzamine
3883 Lansoprazole 3440 Furosemide 750 Polyglycine
3914 Levobunolol 3454 Ganciclovir 4993 Pyrimethamine
3948 Lomefloxacin 5379 Gatifloxacin 104758 Raltitrexed
3950 Lomustine 3463 Gemfibrozil 56959 Ranolazine
3957 Loratadine 3488 Glibenclamide 449193 Roflumilast
3961 Losartan 3475 Gliclazide 446157 Rosuvastatin
453 Mannitol 3494 Glycopyrrolate 129228 Rufinamide
4053 Melphalan 3519 Guanfacine 5206 Sevoflurane
8271 Mephobarbital 3559 Haloperidol 5312125 Silodosin
4062 Mepivacaine 3598 Hexachlorophene 4369359 Sitagliptin
598 Mesna 3639 Hydrochlorothiazide 216239 Sorafenib
1349907 Methimazole 785 Hydroquinone 5314 Succinylcholine
4107 Methocarbamol 3658 Hydroxyzine 41693 Sufentanil
4171 Metoprolol 3672 Ibuprofen 110635 Tadalafil
4173 Metronidazole 3696 Imipramine 5381 Tazarotene
4174 Metyrapone 3702 Indapamide 5391 Temazepam
4197 Milrinone 3715 Indomethacin 6018 Tetrabenazine
5746 Mitomycin C 3739 Iodipamide 1130 Thiamine
4211 Mitotane 3749 Irbesartan 2720 Thiazide
4236 Modafinil 3759 Isocarboxazid 853 Thyroxine
7638 Monobenzone 3779 Isoproterenol 216237 Tolvaptan
4409 Nabumetone 3783 Isoxsuprine 110634 Vardenafil
4456 Neostigmine 3821 Ketamine 170361 Varenicline
644241 Nilotinib 3827 Ketotifen 2520 Verapamil
4539 Norfloxacin 3878 Lamotrigine 5665 Vigabatrin
4543 Nortriptyline 3899 Leflunomide 1054 Vitamin B6
4595 Ondansetron 3902 Letrozole 68740 Zoledronic acid
4601 Orphenadrine 59708 Levetiracetam 5734 Zonisamide
4614 Oxaprozin 3676 Lidocaine 5735 Zopiclone
4634 Oxybutynin 3958 Lorazepam
4678 Panthenol 3964 Loxapine
4723 Pemoline 3998 Mafenide acetate
4725 Penciclovir 4032 Mecamylamine
4748 Perphenazine 4044 Mefenamic acid
4763 Phenobarbital 4046 Mefloquine
4828 Pindolol 4054 Memantine
4891 Praziquantel 4060 Mephenytoin
4906 Prilocaine 4078 Mesoridazine
4909 Primidone 4086 Metaproterenol
4915 Procarbazine 4091 Metformin
4917 Prochlorperazine 4095 Methadone
4927 Promethazine 4158 Methylphenidate
4932 Propafenone 4168 Metoclopramide
4935 Proparacaine 4170 Metolazone
657298 Propylthiouracil 4178 Mexiletine
1046 Pyrazinamide 4192 Midazolam
5002 Quetiapine 4195 Midodrine
5029 Rabeprazole 4205 Mirtazapine
5039 Ranitidine 4212 Mitoxantrone
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5071 Rimantadine 23897 Molindone
5245 Risedronate 4034 Monamine
2083 Salbutamol 4440 Naratriptan
5152 Salmeterol 4449 Nefazodone
5161 Salsalate 4463 Nevirapine
5193 Secobarbital 4485 Nifedipine
5210 Sibutramine 4497 Nimodipine
5253 Sotalol 4506 Nitrazepam
5318 Sulconazole 4033 Nitrogen mustard
5215 Sulfadiazine 4583 Ofloxacin
5344 Sulfisoxazole 130881 Olmesartan medoxomil
5401 Terazosin 4594 Omeprazole
5403 Terbutaline 34312 Oxcarbazepine
5426 Thalidomide 115237 Paliperidone
5430 Thiabendazole 4679 Pantoprazole
5452 Thioridazine 4680 Papaverine
5479 Tinidazole 4649 Para-aminosalicylic acid
41781 Torasemide 4737 Pentobarbital
5523 Tramadol 4740 Pentoxifylline
5533 Trazodone 3675 Phenelzine
5556 Triazolam 4771 Phentermine
5572 Trihexyphenidyl 5775 Phentolamine
5593 Tropicamide 1775 Phenytoin
119607 Valdecoxib 16362 Pimozide
5656 Venlafaxine 4829 Pioglitazone















































Appendix 2 Druggable human proteome included in the 
benchmark database for Goal 3
The list of UniProt accession numbers for the 1469 druggable human proteins that are included in 
the benchmark database from Chapter 5.
A0N0Q1 A0N0X8 A0PJA6 A0PJF5 A0PJF8 A0ZT98 A1A4V4 A1A5A9 A1E5M1 A1L4K2 A2A3U5 A2RUF7 A2RUS0 A2VDG3 
A3QNQ0 A4D0V9 A4D0X1 A4D1D0 A4D1D2 A4D1Q0 A4D2J9 A4D2N2 A4D2P0 A4QPA9 A5X2V1 A6NGA6 A6NMQ1 A6NNF7 
A6PW57 A7E2E0 A7E2E5 A7LFK2 A8K161 A8K177 A8K1F6 A8K1U5 A8K228 A8K249 A8K2J1 A8K2Q2 A8K2S4 A8K341 
A8K379 A8K3B6 A8K3H3 A8K3J4 A8K3M3 A8K496 A8K4G3 A8K4H7 A8K4S9 A8K5M4 A8K5P7 A8K5W4 A8K5Z0 A8K602 
A8K7I0 A8K7N8 A8K7T1 A8K840 A8K858 A8K8D3 A8K987 A8K996 A8K9L2 A8KAE3 A8KAE4 A8KAF4 A8KAG8 A8MPY1 
A8MWW6 A9ZM15 B0AZM9 B0FWH2 B0LPE5 B0YIY3 B0YJ76 B0YJ89 B0YJ93 B0ZBD3 B0ZBE0 B0ZBE2 B0ZBF6 B1ALM3 
B2CQT6 B2KJ49 B2R7Y7 B2R807 B2R812 B2R9N9 B2RA41 B2RAH7 B2RAP9 B2RAZ5 B2RBL3 B2RC52 B2RCU6 B2RCW8 
B2RDS2 B2RUU2 B2RXH2 B2ZGL7 B3KN77 B3KNJ3 B3KP53 B3KP78 B3KPX6 B3KQH9 B3KQV3 B3KRI8 B3KRP1 B3KRT8 
B3KRV2 B3KRZ3 B3KS07 B3KS12 B3KS39 B3KT70 B3KTT5 B3KU60 B3KUB4 B3KVM3 B3KWC4 B3KXJ4 B4DDG2 B4DER4 
B4DER9 B4DEW2 B4DF27 B4DF30 B4DG22 B4DG79 B4DHI4 B4DII1 B4DIW2 B4DK59 B4DK78 B4DKC0 B4DKH4 B4DLF9 
B4DLR2 B4DM55 B4DM56 B4DMJ5 B4DN15 B4DN83 B4DNF7 B4DNQ5 B4DPF4 B4DR80 B4DS37 B4DT73 B4DTF4 B4DTP4 
B4DTW8 B4DUB1 B4DUC2 B4DUH8 B4DV95 B4DVP5 B4DW50 B4DWC1 B4DX41 B4DXF8 B4DXM8 B4DZW8 B4E000 B4E058 
B4E0R1 B4E0R9 B4E0X2 B4E0Y5 B4E1E9 B4E292 B4E295 B4E398 B4E3E9 B5BNW5 B6D4Y2 B6ZGS9 B7Z1F5 B7Z1F9 
B7Z1G6 B7Z1L9 B7Z1W5 B7Z226 B7Z242 B7Z274 B7Z2G8 B7Z2S5 B7Z325 B7Z3P6 B7Z3P7 B7Z3V5 B7Z3W8 B7Z5E9 
B7Z5K4 B7Z7J5 B7Z9H7 B7ZKJ3 B7ZKN7 B7ZLY6 B7ZM24 B7ZM71 B7ZW53 B7ZW66 B8K2Q5 C1ID52 C4IXS7 C8C060 
C9J1J0 C9J5X1 C9JE82 C9JEV6 C9JXA2 D0VY79 D2CGD1 D2KUA6 D3DNN4 D3DPA4 D3DX95 D3YTB5 D4Q8H0 D6RFW5 
D9YZU5 E5KQF5 E5KS60 E7DBM8 E7ERK3 E7ESA6 E7ETZ0 E7EVN3 E9KL36 E9KL48 E9PER6 E9PG18 E9PJX5 F1D8N3 
F1D8N5 F1D8N7 F1D8P4 F1D8P6 F1D8P8 F1D8P9 F1D8Q5 F1D8S4 F1D8S6 F1DAL4 F1T0G6 F2Z2J1 F2Z2Y4 F5CTF3 
F5GWI4 F5H1T4 F5H2B5 F6U4U2 F7VJQ1 F8VBW7 F8VQZ7 F8W6L1 F8WBA3 F8WCM8 G3V5Q5 G5E9C5 H6UYS5 H6VQ59 
H7BYT1 H9NIL8 H9NIM1 I6L9H2 J3KMW1 J3KNB8 J3KNE8 J3KNN3 J3KRN4 J3QSS1 K9J958 K9JA46 L7RSL3 L7RTI5 
L7RXH5 L8B082 M0R0W6 M0R1I2 O00167 O00325 O00408 O00444 O00459 O00519 O00763 O08562 O14521 O14578 
O14649 O14684 O14727 O14746 O14788 O14842 O14920 O14936 O14939 O14965 O15111 O15118 O15244 O15245 
O15296 O15303 O15374 O15375 O15379 O15399 O15438 O15440 O15460 O15554 O43283 O43318 O43353 O43497 
O43526 O43570 O43704 O43741 O43781 O43849 O54898 O60240 O60331 O60341 O60391 O60568 O60656 O60658 
O60674 O60760 O60840 O60885 O60909 O60939 O70507 O75116 O75164 O75311 O75385 O75460 O75469 O75582 
O75604 O75751 O75762 O75795 O75874 O75899 O75936 O76039 O76068 O76074 O76082 O76083 O88703 O88704 
O88871 O94759 O94768 O94782 O94804 O94806 O94925 O94956 O95069 O95255 O95259 O95263 O95264 O95342 
O95382 O95467 O95665 O95835 O95907 O96017 P00156 P00325 P00326 P00352 P00374 P00390 P00403 P00491 
P00492 P00519 P00533 P00734 P00747 P00750 P00797 P00813 P00915 P00918 P01258 P01275 P01375 P01579 
P01584 P02144 P02545 P02585 P02593 P02708 P02741 P02751 P02763 P02768 P02788 P03372 P03886 P04035 
P04040 P04054 P04083 P04629 P04775 P04818 P05023 P05091 P05093 P05108 P05141 P05164 P05177 P05181 
P05362 P05369 P05412 P05543 P06133 P06213 P06239 P06241 P06276 P06280 P06401 P06858 P07101 P07202 
P07204 P07327 P07339 P07437 P07451 P07550 P07607 P07741 P07947 P07949 P08104 P08172 P08173 P08185 
P08235 P08236 P08246 P08254 P08311 P08482 P08483 P08588 P08684 P08697 P08729 P08842 P08908 P08909 
P08912 P08913 P08922 P09172 P09211 P09619 P09769 P09871 P09917 P0C1S8 P0C264 P10109 P10253 P10275 
P10276 P10696 P10721 P10826 P10827 P10980 P11021 P11142 P11177 P11229 P11362 P11387 P11388 P11413 
P11474 P11509 P11511 P11712 P11884 P11926 P12004 P12104 P12235 P12236 P12268 P12657 P12931 P13196 
P13500 P13569 P13612 P13631 P13674 P13716 P13726 P13945 P14091 P14207 P14324 P14416 P14550 P14616 
P14679 P14780 P14842 P14867 P14902 P15056 P15291 P15388 P15389 P15390 P15428 P15538 P16050 P16066 
P16234 P16388 P16435 P16591 P16662 P16860 P17252 P17302 P17405 P17516 P17948 P18054 P18089 P18505 
P18507 P18545 P18825 P19020 P19099 P19224 P19320 P19327 P19525 P19652 P19784 P19793 P20309 P20594 
P20648 P20813 P20839 P21266 P21397 P21439 P21451 P21452 P21462 P21549 P21554 P21589 P21709 P21728 
P21731 P21817 P21860 P21912 P21917 P21918 P21964 P22002 P22102 P22303 P22309 P22310 P22413 P22460 
P22462 P22557 P22607 P22748 P22888 P22894 P23141 P23219 P23378 P23415 P23416 P23434 P23443 P23458 
P23469 P23921 P23944 P23975 P23977 P24046 P24298 P24530 P24666 P24723 P25021 P25024 P25025 P25099 
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P25100 P25101 P25102 P25103 P25122 P25929 P25962 P25963 P26255 P26447 P26599 P26684 P27037 P27338 
P27487 P27695 P27732 P27815 P27986 P28221 P28222 P28223 P28335 P28476 P28482 P28566 P28647 P28702 
P28845 P29274 P29275 P29276 P29322 P29323 P29350 P29401 P30049 P30291 P30411 P30518 P30542 P30543 
P30556 P30560 P30613 P30711 P30729 P30872 P30874 P30939 P30966 P31213 P31350 P31388 P31391 P31644 
P31645 P31652 P31930 P31939 P31947 P32238 P32239 P32245 P32297 P32298 P32304 P32305 P32320 P32745 
P33032 P33151 P33402 P33527 P33535 P33765 P33981 P34896 P34903 P34913 P34949 P34969 P34995 P35218 
P35219 P35228 P35318 P35346 P35348 P35354 P35367 P35368 P35372 P35462 P35498 P35499 P35610 P35790 
P35916 P36021 P36507 P36537 P36544 P36888 P36894 P36896 P36897 P37023 P37088 P37231 P37288 P39748 
P39900 P40763 P41143 P41145 P41250 P41440 P41595 P41743 P41968 P42261 P42262 P42336 P42345 P42574 
P42681 P42684 P42685 P42858 P42898 P43088 P43116 P43119 P43140 P43166 P43220 P43403 P43681 P45954 
P45984 P45985 P46098 P46734 P47712 P47869 P47870 P47898 P47901 P47989 P48039 P48167 P48169 P48443 
P48542 P48544 P48545 P48637 P49019 P49137 P49146 P49327 P49336 P49419 P49585 P49759 P49841 P49895 
P50052 P50225 P50281 P50406 P50440 P50613 P51160 P51164 P51168 P51170 P51570 P51606 P51639 P51649 
P51681 P51692 P51787 P51788 P51813 P51857 P51956 P51957 P52209 P52895 P53350 P53582 P53597 P53667 
P54219 P54284 P54646 P54753 P54760 P54762 P54802 P55011 P55017 P55072 P55926 P56373 P56524 P57058 
P57789 P58406 P61088 P61168 P61169 P63142 P63316 P68366 P68371 P68400 P70604 P70605 P70673 P78334 
P78348 P78356 P78368 P78508 P78527 P80365 P80404 P83916 P97288 P97717 P97794 P98073 Q00526 Q00788
Q00975 Q01098 Q01453 Q01538 Q01650 Q01668 Q01717 Q01815 Q01959 Q02108 Q02127 Q02153 Q02156 Q02485 
Q02641 Q02763 Q02769 Q02779 Q02790 Q02880 Q03164 Q04759 Q04760 Q04828 Q05329 Q05513 Q05586 Q05932 
Q05940 Q06187 Q06203 Q06278 Q06418 Q06432 Q06643 Q07343 Q07699 Q07869 Q08209 Q08289 Q08499 Q08881 
Q09428 Q09470 Q0IJ49 Q12791 Q12809 Q12866 Q12879 Q12882 Q13043 Q13126 Q13131 Q13183 Q13224 Q13233 
Q13255 Q13258 Q13332 Q13370 Q13393 Q13464 Q13470 Q13526 Q13547 Q13563 Q13621 Q13627 Q13639 Q13698 
Q13705 Q13873 Q13882 Q13936 Q13946 Q13956 Q13976 Q14032 Q14191 Q14289 Q14376 Q14432 Q14500 Q14524 
Q14534 Q14643 Q14654 Q14749 Q14894 Q14973 Q14994 Q15303 Q15375 Q15413 Q15418 Q15569 Q15722 Q15746 
Q15759 Q15822 Q15825 Q15831 Q15835 Q15842 Q15858 Q16236 Q16288 Q16322 Q16348 Q16445 Q16512 Q16513 
Q16558 Q16566 Q16568 Q16659 Q16696 Q16739 Q16790 Q16832 Q16850 Q16853 Q17RV3 Q17ST2 Q2M2I8 Q32MC3 
Q32MK0 Q32P28 Q38Q88 Q3V008 Q3V050 Q4LE27 Q4U2R8 Q4VAM5 Q4VBY6 Q52WX2 Q53EW6 Q53GD3 Q56UN5 Q5DSZ6 
Q5DSZ7 Q5DT02 Q5JXL9 Q5KU17 Q5QD15 Q5SQQ7 Q5SUJ9 Q5T6X5 Q5TAT6 Q5VT25 Q5XXA6 Q60614 Q61743 Q62897 
Q62968 Q64737 Q68DU8 Q6DT37 Q6IB77 Q6P3R8 Q6PKF2 Q6RI86 Q6XUX3 Q6ZN16 Q6ZQN7 Q6ZWB6 Q71U36 Q7RTT9 
Q7Z2W7 Q86TI2 Q86TP1 Q86UX6 Q86V86 Q86VL8 Q86W47 Q86YV6 Q8IUX4 Q8IVL5 Q8IVL6 Q8IW41 Q8IYT8 Q8IZF0 
Q8IZS8 Q8N1C3 Q8N1Q1 Q8N4C8 Q8N568 Q8N5S9 Q8N695 Q8N752 Q8N8N7 Q8NDX3 Q8NE62 Q8NE63 Q8NER1 Q8NEV4 
Q8NFD2 Q8TCT1 Q8TCU5 Q8TD08 Q8TD43 Q8TDC3 Q8TDR2 Q8TDS4 Q8TE04 Q8WTQ7 Q8WUI4 Q91ZY1 Q91ZY2 Q923Y7 
Q92630 Q92731 Q92736 Q92769 Q92830 Q92887 Q92918 Q92952 Q92959 Q96BD0 Q96CX2 Q96FI4 Q96FL8 Q96GD4 
Q96L34 Q96LB2 Q96NT5 Q96NX5 Q96Q40 Q96QE3 Q96RJ0 Q96RP8 Q96SB4 Q99246 Q99250 Q99418 Q99527 Q99549 
Q99571 Q99643 Q99683 Q99700 Q99714 Q99808 Q99816 Q99928 Q9BPW9 Q9BR01 Q9BRL5 Q9BRS2 Q9BVS4 Q9BX84 
Q9BXA5 Q9BXC0 Q9BY41 Q9BY49 Q9BY64 Q9BYC2 Q9BYV1 Q9BZL6 Q9C007 Q9D6N1 Q9EQ60 Q9ERZ4 Q9GZV3 Q9H015 
Q9H1D0 Q9H1R3 Q9H221 Q9H222 Q9H244 Q9H2G2 Q9H2K8 Q9H2S1 Q9H2X6 Q9H2X9 Q9H3N8 Q9H3Y6 Q9H4B4 Q9H598 
Q9HAB3 Q9HAZ1 Q9HB55 Q9HBH1 Q9HC16 Q9HC97 Q9HCF6 Q9HCG7 Q9HCR9 Q9JIS7 Q9NP56 Q9NPA1 Q9NPA2 Q9NPD5 
Q9NQA5 Q9NR96 Q9NR97 Q9NRP7 Q9NS40 Q9NS75 Q9NS85 Q9NSA0 Q9NSY1 Q9NTF0 Q9NTN3 Q9NVH6 Q9NY47 Q9NY57 
Q9NYB5 Q9NYG8 Q9NYK1 Q9NYX4 Q9NZK7 Q9NZQ8 Q9P0X4 Q9P0Z9 Q9P289 Q9P2K8 Q9QYN8 Q9UBC3 Q9UBF8 Q9UBS5 
Q9UEE5 Q9UEW8 Q9UHC3 Q9UHC9 Q9UHD2 Q9UHL4 Q9UI33 Q9UIF8 Q9UIG8 Q9UK23 Q9UK32 Q9UKE5 Q9UL54 Q9UL62 
Q9ULX7 Q9UM07 Q9UN88 Q9UNA4 Q9UPE1 Q9UPY5 Q9UQB9 Q9UQD0 Q9UQL6 Q9WUD2 Q9Y233 Q9Y251 Q9Y271 Q9Y2H1 
Q9Y2H9 Q9Y2I1 Q9Y468 Q9Y5K3 Q9Y5N1 Q9Y5Y4 Q9Y5Y9 Q9Y616 Q9Y666 Q9Y694 Q9Y6L6 Q9Y6M4 Q9Z0U4 Q9Z0V1 
Q9Z2J6 V9GXZ4 A0A024QYT5 A0A024QYW7 A0A024QYX0 A0A024QZ12 A0A024QZ15 A0A024QZ20 A0A024QZ26 
A0A024QZ30 A0A024QZ70 A0A024QZA8 A0A024QZM9 A0A024QZS4 A0A024QZU0 A0A024QZU1 A0A024QZV1 A0A024QZW0 
A0A024QZY5 A0A024QZY7 A0A024R040 A0A024R049 A0A024R0C0 A0A024R0C6 A0A024R0H1 A0A024R0H9 A0A024R0I0 
A0A024R0J1 A0A024R0L5 A0A024R0Q9 A0A024R125 A0A024R136 A0A024R151 A0A024R157 A0A024R183 A0A024R1H6 
A0A024R1I3 A0A024R1V0 A0A024R222 A0A024R230 A0A024R244 A0A024R276 A0A024R2B3 A0A024R2H8 A0A024R2M7 
A0A024R2N2 A0A024R2Q0 A0A024R2W7 A0A024R2Y6 A0A024R324 A0A024R325 A0A024R328 A0A024R374 A0A024R397 
A0A024R3C5 A0A024R3C7 A0A024R3D5 A0A024R3G7 A0A024R3H7 A0A024R3K6 A0A024R3S2 A0A024R3S3 A0A024R3T2 
A0A024R3W4 A0A024R3Z2 A0A024R426 A0A024R440 A0A024R452 A0A024R4B2 A0A024R4E2 A0A024R4H0 A0A024R4X4 
A0A024R4X8 A0A024R4Z5 A0A024R567 A0A024R5B6 A0A024R5C5 A0A024R5E6 A0A024R5H1 A0A024R5I4 A0A024R5K6 
A0A024R5P0 A0A024R5S8 A0A024R5W3 A0A024R5X5 A0A024R5Z3 A0A024R5Z6 A0A024R5Z9 A0A024R603 A0A024R638 
A0A024R6L5 A0A024R6N2 A0A024R6Q6 A0A024R6R2 A0A024R6R4 A0A024R6T9 A0A024R704 A0A024R718 A0A024R720 
A0A024R728 A0A024R730 A0A024R7C0 A0A024R7E4 A0A024R7J0 A0A024R7M7 A0A024R7T2 A0A024R880 A0A024R8A6 
A0A024R8E2 A0A024R8J3 A0A024R8K3 A0A024R8S3 A0A024R8U1 A0A024R8U8 A0A024R906 A0A024R909 A0A024R913 
A0A024R928 A0A024R964 A0A024R980 A0A024R9A7 A0A024R9C1 A0A024R9H3 A0A024R9I2 A0A024R9I5 A0A024R9Q4 
A0A024R9Q5 A0A024R9X6 A0A024R9X9 A0A024R9Y0 A0A024R9Z8 A0A024RA31 A0A024RA66 A0A024RA96 A0A024RAE8 
A0A024RAG0 A0A024RAH0 A0A024RAH7 A0A024RAP2 A0A024RAP4 A0A024RAP7 A0A024RAT5 A0A024RAU7 A0A024RAV0 
A0A024RAV2 A0A024RAV7 A0A024RAY5 A0A024RB10 A0A024RB43 A0A024RB59 A0A024RB99 A0A024RBB2 A0A024RBB6 
A0A024RBG4 A0A024RBG6 A0A024RBH0 A0A024RBL3 A0A024RBN1 A0A024RBP6 A0A024RBU5 A0A024RBV5 A0A024RBW9 
A0A024RC53 A0A024RC61 A0A024RC92 A0A024RCE9 A0A024RCJ0 A0A024RCN9 A0A024RCW6 A0A024RD04 A0A024RD15 
A0A024RD18 A0A024RD21 A0A024RD25 A0A024RD33 A0A024RD58 A0A024RD59 A0A024RD62 A0A024RD88 A0A024RDA0 
A0A024RDA5 A0A024RDD4 A0A024RDH4 A0A024RDJ4 A0A024RDK3 A0A024RDL4 A0A024RDM3 A0A024RE05 A0A068F658 
A0A075B7B4 A0A087WSY1 A0A087WT22 A0A087WT64 A0A087WTS4 A0A087WU84 A0A087WV24 A0A087WVC4 A0A087WW63 
A0A087WW79 A0A087WWV0 A0A087WXV4 A0A087WYJ0 A0A087WYZ4 A0A087WZ06 A0A087WZ88 A0A087WZL8 A0A087X090 
A0A087X0I6 A0A087X0W8 A0A087X1B1 A0A088AWN0 A0A088QCU6 A0A090N7W1 A0A090N7W4 A0A090N7X8 A0A090N8Q6 
A0A090N8Y0 A0A090N8Z1 A0A0A0MQR8 A0A0A0MQX8 A0A0A0MR48 A0A0A0MR60 A0A0A0MR67 A0A0A0MRG0 A0A0A0MRG2 
A0A0A0MRL7 A0A0A0MRV2 A0A0A0MS52 A0A0A0MSE3 A0A0A0MSK3 A0A0A0MSK8 A0A0A0MSS8 A0A0A0MT22 A0A0A0MTA6 
A0A0A0MTJ0 A0A0A0N0L2 A0A0A6YYA8
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Appendix 3 Benchmark database of drug-protein
interactions for Goal 3
The list of 34456 drug-protein interactions that are included in the benchmark database from 
Chapter 5. We provide PubChem CIDs and names for drugs (highlighted in gray color) and 
UniProt accession numbers for protein targets for each drug. 
CID 119: gamma-aminobutyric acid
A0A024QZY7 A0A024R4E2 A0A024R909 A0A024R9X6 A0A024RCN9 A0A090N8Z1 A0A0A0MTJ0 A0A0A6YYA8 A8K177 B4DN83 B4E398 B7ZKN7 F1D8N7 O75899 
O88871 P02545 P13612 P21728 P23415 P24046 P31644 P34903 P50440 Q03164 Q16445 Q68DU8 Q6ZWB6 Q92830 Q96CX2 Q96QE3 Q9UBS5 Q9UIF8 Q9Z0U4
CID 137: delta-aminolevulinic acid
A0A024QZY7 B2CQT6 P02545 P13716 P24046 Q16348 Q9UIF8
CID 338: salicylic acid
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R6R4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RBW9 A0A024RD15 
A0A087WU84 A0A090N7W1 A0A090N7X8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K3J4 
A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2R807 B2RXH2 B3KUB4 B4DN15 B4DUH8 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 
L7RSL3 L7RXH5 O60656 P00352 P00533 P00915 P00918 P02768 P05177 P05181 P06133 P06239 P06241 P07451 P07550 P08173 P08236 P08246 P08254 
P08311 P08588 P08684 P08913 P09917 P11229 P11509 P11712 P14780 P14902 P15428 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 
P22748 P22894 P23219 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P30872 P30874 P31391 P32238 P32245 P32745 P33032 
P35218 P35346 P35354 P35367 P36537 P37288 P41143 P41595 P41968 P43166 P49146 P50052 P50406 P51681 Q01959 Q04828 Q08209 Q16790 Q38Q88 
Q4U2R8 Q92830 Q9NSA0 Q9UHC3
CID 444: bupropion
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAU7 A0A024RCN9 A0A024RD15 
A0A087WU84 A0A090N7W1 A0A0A0MQX8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K5W4 
A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B3KP78 B4DN15 B7Z1L9 B7Z242 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 
L7RSL3 L7RXH5 O94782 P00352 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 
P11712 P14780 P17252 P17405 P18825 P20813 P21397 P21452 P21554 P21728 P21917 P22303 P23975 P25021 P25024 P25025 P25101 P25103 P25929 
P28223 P28482 P30411 P32238 P32245 P32297 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P83916 Q01959 
Q08209 Q38Q88 Q92830 Q92887 Q9UIF8
CID 453: mannitol
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4E2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 
B7Z1L9 B7Z242 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 P00533 P00918 P02545 P05177 P05181 P06239 
P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 
P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P39748 P41143 P41595 
P41968 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q16236 Q38Q88 Q92830 Q9Y468
CID 564: epsilon-aminocaproic acid
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RAV2 A0A024RCN9 A0A024RD15 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8N7 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00352 P00533 P00747 P00750 P00918 
P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 P18825 
P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 
P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q13526 Q38Q88 Q92830 Q96QE3
CID 598: mesna
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 
P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 
P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 
P51681 Q01959 Q08209 Q38Q88
CID 612: lactate
A0A024R0H1 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5C5 A0A024R5I4 A0A024R5Z9 A0A024R6T9 A0A024R8J3 A0A024R8U1 A0A024R9I2 
A0A024R9I5 A0A024RAP2 A0A024RBB2 A0A024RD15 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 
A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B3KU60 B4DF30 B4DN15 B4DPF4 B7Z1L9 B7ZM24 B8K2Q5 C1ID52 E5KQF5 F1D8N3 
F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15374 O15375 O95907 P00533 P00915 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 
P08311 P08588 P08684 P08913 P11177 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P22748 P25021 
P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P30613 P32238 P32245 P33032 P35218 P35354 P35367 P36021 P37288 P41143 P41595 
P41968 P49146 P50052 P50406 P51681 P80404 Q01959 Q08209 Q16790 Q38Q88 Q92959 Q9BYV1 Q9H2X9 Q9Y666
CID 679: dimethyl sulphoxide
A0A024QYT5 A0A024QZS4 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MSS8 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0YJ76 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 E9KL36 F1D8N3 F1D8Q5 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O60885 P00533 P00918 P05177 
P05181 P06239 P06241 P07550 P08173 P08185 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 
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P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 
P41143 P41595 P41968 P47712 P49146 P50052 P50406 P51681 Q01959 Q02790 Q08209 Q38Q88
CID 681: dopamine
A0A024QZY7 A0A024R276 A0A024R3C5 A0A024R6L5 A0A024R6T9 A0A024R9Y0 A0A024RAP4 A0A024RAV2 A0A024RBW9 A0A024RCN9 A0A087WT22 A1A4V4 
A8K3J4 A8K5W4 B2R7Y7 B2RXH2 B3KUB4 B4DUH8 B4E398 B7Z242 B7ZKN7 B7ZW53 C1ID52 D0VY79 F8W6L1 L8B082 O15244 O15245 O43704 O75164 O94925 
P00352 P00915 P00918 P02545 P07451 P07550 P08588 P09172 P10253 P16050 P16662 P21397 P21728 P21917 P21918 P21964 P22309 P22310 P22748 
P27695 P28482 P30729 P35218 P35462 P39748 P42345 P43166 P43220 P50225 P61169 P83916 Q01453 Q01959 Q16790 Q16853 Q5DSZ7 Q5DT02 Q99549 
Q99700 Q99714 Q9UIF8 Q9UNA4
CID 750: polyglycine
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4Z5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RB99 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A6YYA8 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K228 A8K249 A8K7N8 A8KAF4 A8KAG8 A9ZM15 
B0ZBE0 B2CQT6 B2R7Y7 B4DN15 B4E398 B7Z1L9 B7Z3W8 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 H9NIM1 K9J958 L7RSL3 L7RXH5 O15399 
O60391 O75311 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P07741 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 
P13196 P14780 P17252 P18825 P21397 P21452 P21549 P21554 P21728 P21917 P22303 P22309 P22557 P23378 P23415 P23416 P23434 P25021 P25024 
P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P34896 P35354 P35367 P37288 P41143 P41250 P41595 P41968 P48167 
P48637 P49146 P50052 P50406 P50440 P51681 Q01098 Q01959 Q05586 Q08209 Q12879 Q13126 Q13224 Q14032 Q14749 Q38Q88 Q4VAM5 Q5T6X5 Q6IB77 
Q9BY49 Q9BYV1 Q9H598 Q9P0Z9
CID 774: histamine
A0A024QZY7 A0A024R909 A0A024RBW9 A0A024RCN9 A0A0A0MR48 A0A0A0MTJ0 A8K3J4 B2KJ49 B3KUB4 B4DUH8 B4DWC1 B4E398 B7ZKN7 O15244 O15245 
O75751 O94782 P00915 P00918 P02545 P07451 P22748 P25021 P25102 P27695 P28223 P34969 P35218 P35367 P43166 P58406 Q16790 Q91ZY1 Q91ZY2 
Q9H3N8 Q9QYN8 Q9UIF8 Q9UNA4 Q9Y5N1
CID 785: hydroquinone
A0A024QZY7 A0A024R909 A0A024R9Y0 A0A024R9Z8 A0A024RAV2 A0A024RBV5 A0A024RBW9 A0A024RCN9 A0A024RCW6 A0A024RDA5 A0A024RDJ4 A8K3J4 
A8KAF4 B2RXH2 B3KUB4 B4DUH8 B6ZGS9 B7ZKN7 D0VY79 D9YZU5 E5KQF5 F1D8N5 F1D8N7 F1D8P6 F1D8Q5 F8W6L1 O15118 O94925 P00352 P00915 P00918 
P02545 P07451 P08684 P15428 P16050 P22748 P35218 P39748 P42345 P43166 P83916 Q01453 Q13526 Q16790 Q5DSZ7 Q5DT02 Q96QE3 Q99549 Q99700 
Q99714
CID 838: epinephrine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RAP4 A0A024RAV2 
A0A024RBG4 A0A024RBW9 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 
A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K3J4 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B2RXH2 B3KUB4 B4DN15 B4DUH8 B7Z1L9 B7ZKN7 
B8K2Q5 C1ID52 D0VY79 E5KQF5 E9PG18 F1D8N3 F1D8P4 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O15296 O75164 O94782 P00352 
P00533 P00915 P00918 P05177 P05181 P06239 P06241 P07451 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P13945 
P14780 P17252 P18054 P18089 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P22748 P25021 P25024 P25025 P25101 P25103 P25929 P25962 
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A0A024RAU7 A0A024RD15 A0A024RDJ4 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 
A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2R807 B3KP78 B4DN15 B4E3E9 B7Z1L9 B7Z3P7 B7ZKN7 B7ZW53 B8K2Q5 C1ID52 
D2KUA6 D6RFW5 E5KQF5 F1D8N3 F1D8N7 F1D8P6 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O15379 O60656 O76082 P00533 P00918 P05177 
P05181 P06133 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P13726 P14780 P16662 P17252 P18825 
P19224 P21397 P21452 P21554 P21728 P21917 P22303 P22310 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 
P33032 P35354 P35367 P36537 P37288 P41143 P41595 P41968 P45954 P49146 P50052 P50406 P51649 P51681 P56524 P80404 Q01959 Q08209 Q13547 
Q16236 Q38Q88 Q5DSZ6 Q5DT02 Q8WUI4 Q92769 Q92830 Q92887 Q96QE3 Q9BY41 Q9UQL6
CID 3125: alpha-methyl-p-tyrosine
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RAV2 A0A024RCN9 A0A024RD15 
A0A024RDJ4 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8N7 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 
P00918 P05177 P05181 P06239 P06241 P07101 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 
P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 
P35354 P35367 P37288 P39748 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q13526 Q38Q88 Q99549 Q9UNA4
CID 3151: domperidone
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5Z3 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 
A0A024RDJ4 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1F5 B7Z1L9 B8K2Q5 C1ID52 D0VY79 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15244 
O15296 O75604 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P06280 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 
P11712 P14416 P14780 P17252 P17405 P18825 P19020 P20813 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 
P25929 P27695 P28223 P28482 P30411 P32238 P32245 P33032 P35318 P35354 P35367 P35462 P37288 P41143 P41595 P41968 P42345 P49146 P50052 
P50406 P51681 P61169 P83916 Q01453 Q01959 Q08209 Q38Q88 Q86VL8 Q96FL8 Q96QE3 Q99549 Q99700 Q9UNA4
CID 3152: donepezil
A0A024QZY7 A0A024R3D5 A0A024RCN9 A0A090N7W1 A2A3U5 B2RXH2 B7Z242 C1ID52 D3DNN4 P05177 P08684 P11712 P17405 P21397 P22303 P28223 
Q13627 Q92630
CID 3156: doxapram
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9H3 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 
C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O14649 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 
P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 
P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 
Q01959 Q08209 Q38Q88
CID 3157: doxazosin
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAU7 A0A024RCN9 A0A024RD15 A0A068F658 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K5W4 A8K7N8 A8KAF4 
A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B3KP78 B4DKC0 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6UYS5 H6VQ59 K9J958 L7RSL3 L7RXH5 
O15245 O75874 O94782 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 
P14780 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25100 P25101 P25103 P25929 P28223 P28482 
P30411 P32238 P32245 P33032 P35348 P35354 P35367 P35368 P37288 P39748 P41143 P41595 P41968 P42345 P49146 P50052 P50406 P51681 P83916 
Q01959 Q03164 Q08209 Q38Q88 Q96QE3 Q99700 Q9NS40 Q9UIF8
CID 3158: doxepin
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAV2 A0A024RCN9 A0A024RD15 A0A024RDJ4 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K5W4 
A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2KJ49 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958
L7RSL3 L7RXH5 O15296 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 
P11509 P11712 P14780 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P22310 P25021 P25024 P25025 P25101 P25103 P25929 
P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P35368 P37288 P41143 P41595 P41968 P43220 P49146 P50052 P50406 P51681 Q01453 
Q01959 Q08209 Q38Q88 Q8NER1 Q99700
CID 3168: droperidol
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 
B7Z1L9 B7Z1W5 B8K2Q5 C1ID52 D0VY79 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O00519 P00533 P00918 P02545 P05177 P05181 
P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 
P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 
P41968 P43220 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q38Q88 Q96QE3 Q99700
CID 3182: dyphylline
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A1E5M1 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B7Z1W5 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O43849 P00533 P00918 P02545 P05177 P05181 P06239 P06241 
P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 
P25021 P25024 P25025 P25101 P25103 P25929 P27815 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 
P49146 P50052 P50406 P51681 Q01959 Q07343 Q08209 Q08499 Q13946 Q38Q88
CID 3198: econazole
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15296 O94759 O94782 P00533 P00918 
P02545 P05093 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 
P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 
P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q16850 Q38Q88 Q99700 Q9NQA5
CID 3226: enflurane
A0A024R9X6 A0A087WZL8 A8K177 A8K496 B2RCW8 B4DTP4 B4E295 O15554 P02768 P03886 P05181 P18505 P18507 P23415 P30049 P31644 P34903 
P42261 P47870 P48167 P48169 P78334 Q09470 Q16445 Q8N1C3 Q99928 Q9UN88
CID 3241: epinastine
A0A024R3C5 A0A024R909 A0A024RCN9 A0A090N7W1 A4D1D2 B0ZBD3 O15244 P08913 P21728 P25021 P28223 P34969 P35367 Q86VL8 Q96FL8 Q96QE3
CID 3261: estazolam
A0A024R9X6 A8K177 A8K496 A8MPY1 B2RCW8 B4DTP4 O76068 P08684 P18505 P18507 P24046 P28476 P31644 P34903 P47870 P48169 P78334 Q16445 
Q8N1C3 Q99928 Q9UN88
CID 3278: ethacrynic acid
152
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3C7 A0A024R3S2 A0A024R5Z3 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 
A0A024RAV2 A0A024RCN9 A0A024RCW6 A0A024RD15 A0A024RD58 A0A024RD62 A0A024RDA5 A0A024RDJ4 A0A087WT22 A0A087WU84 A0A090N7W1 A0A090N8Z1 
A0A0A0MQX8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8K987 A8KAF4 A8KAG8 
B0ZBE0 B2R7Y7 B4DN15 B4DPF4 B6ZGS9 B7Z1F9 B7Z1L9 B8K2Q5 C1ID52 D0VY79 D2KUA6 E5KQF5 F1D8N3 F1D8N5 F1D8N7 F1D8P6 F1D8P8 F1D8Q5 F5H1T4 
G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O60656 O60760 O75874 O95467 P00352 P00533 P00918 P02545 P02768 P05023 P05177 P05181 P06239 P06241 
P07550 P08173 P08246 P08311 P08588 P08684 P08913 P09211 P11021 P11229 P11509 P11712 P14780 P17252 P18825 P19224 P21397 P21452 P21554 
P21728 P21917 P22303 P22309 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 
P41143 P41595 P41968 P42858 P49146 P50052 P50406 P51681 Q01959 Q08209 Q13526 Q13621 Q14191 Q14376 Q38Q88 Q92830 Q96QE3 Q99700 Q9HC16 
Q9UNA4
CID 3291: ethosuximide
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A090N8Z1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 
B4DN15 B7Z1L9 B7Z242 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O43497 P00533 P00918 P05177 P05181 P06239 
P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 
P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P37288 P41143 P41595 P41968 P49146 
P50052 P50406 P51681 Q01959 Q08209 Q38Q88 Q9P0X4
CID 3292: ethotoin
A0A024QZY7 E9PG18 O75874 P02545 Q14524 Q92830
CID 3305: etidronate
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MR60 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B6ZGS9 
B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O75164 O75874 P00533 P00918 P02545 P05177 P05181 P06239 
P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P17405 P18825 P21397 P21452 P21554 P21728 
P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 
P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q13332 Q38Q88 Q92830 Q9UNA4
CID 3308: etodolac
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A024RDJ4 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MSS8 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F1D8Q5 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O60656 
O94782 P00352 P00533 P00918 P02768 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 
P14780 P16050 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 
P32238 P32245 P33032 P35354 P35367 P37288 P39748 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P83916 Q01453 Q01959 Q08209 Q38Q88 
Q4U2R8 Q92830
CID 3324: famciclovir
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A087WWV0 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00352 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 
P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P15428 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 
P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 
P50406 P51681 Q01959 Q06278 Q08209 Q38Q88 Q99714
CID 3325: famotidine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 
B2R807 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15244 O15245 O75164 O75751 
P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 
P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 
P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01453 Q01959 Q08209 Q38Q88 Q86VL8 Q96FL8 Q9UNA4
CID 3331: felbamate
A0A024QZY7 A0A024R5Z9 A0A024RCN9 A0A090N7W1 A0A090N8Z1 C1ID52 P05177 P08684 P11712 Q12879 Q13224 Q16236 Q8TCU5
CID 3333: felodipine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R5Z3 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAP4 A0A024RAU7 
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A0A024R909 A0A0A0MTJ0 D0VY79 D3DNN4 F1D8P8 O15245 P07550 P22303
CID 4091: metformin
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3K6 A0A024R3S2 A0A024R4E2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAU7 
A0A024RBN1 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B3KP78 B4DN15 B7Z1F5 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O00763 
O15244 O15245 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 
P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P31939 
P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P42345 P42858 P49146 P50052 P50406 P51681 P54646 Q01959 Q08209 Q38Q88 
Q86VL8 Q92830 Q96FL8
CID 4095: methadone
A0A087WU84 A4D1D2 B8K2Q5 C1ID52 C4IXS7 P08684 P20813 P35372 P41143 Q8TCU5
CID 4107: methocarbamol
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4E2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00915 P00918 P02545 P05177 P05181 P06239 P06241 P07550 
P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 
P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 
P50406 P51681 P83916 Q01959 Q08209 Q38Q88
CID 4114: 8-methoxypsoralen
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3D5 A0A024R3S2 A0A024R4E2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAU7 A0A024RD15 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBE0 B2R7Y7 B3KP78 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8N5 F1D8P6 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 
O95467 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 
P18825 P20813 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 
P33032 P35354 P35367 P37288 P41143 P41595 P41968 P43220 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q38Q88
CID 4139: methylene blue solution
A0A024QZY7 A0A024R3C7 A0A024R4E2 A0A024R5Z3 A0A024R5Z9 A0A024R6L5 A0A024R9Y0 A0A024RAP4 A0A024RAV2 A0A024RCN9 A0A024RCW6 A0A024RD62 
A0A024RDA5 A0A087WT22 A0A087WYZ4 A0A090N8Z1 A0A0A0MQX8 A0A0A0MTJ0 A8KAF4 B2RXH2 B6ZGS9 B7Z1W5 B7Z2G8 B7Z2S5 B7ZKN7 D0VY79 D2KUA6 
E5KQF5 F1D8N7 F1D8P6 H6UYS5 O14727 O75164 O75874 O94782 O95467 P00352 P00390 P01375 P08684 P15428 P16050 P22303 P22888 P27695 P28482 
P39748 P42858 P43220 Q03164 Q13526 Q96QE3 Q99700 Q99714 Q9UIF8 Q9UNA4
CID 4158: methylphenidate
A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RCW6 A0A0A0MTJ0 A2RUS0 A4D1Q0 A4D2N2 A8K5W4 B0ZBD3 B0ZBE0 B2R7Y7 B4DK78 
B4E398 C1ID52 P00352 P02545 P08913 P18825 P23141 P23975 P32297 P39748 P83916 Q01959 Q15822 Q16236 Q92830
CID 4168: metoclopramide
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RBV5 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K5W4 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 
B4DN83 B4E398 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O95264 P00352 P00533 P00918 P02545 
P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14416 P14780 P17252 P18825 P21397 
P21452 P21554 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 
P41143 P41595 P41968 P46098 P49146 P50052 P50406 P51681 P61168 P83916 P97288 Q01959 Q08209 Q13639 Q38Q88 Q99549
CID 4170: metolazone
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RBW9 A0A024RCN9 A0A024RD15 A0A024RDJ4 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K3J4 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 
B2R7Y7 B2RXH2 B3KUB4 B4DN15 B4DPF4 B4DUH8 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 J3QSS1 K9J958 L7RSL3 L7RXH5 
P00352 P00533 P00915 P00918 P02545 P05177 P05181 P06239 P06241 P07451 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 
P11712 P14780 P15428 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P22748 P25021 P25024 P25025 P25101 P25103 P25929 
P28223 P28482 P30411 P32238 P32245 P33032 P35218 P35354 P35367 P37288 P41143 P41595 P41968 P43166 P49146 P50052 P50406 P51681 P55017 
Q01453 Q01959 Q08209 Q16790 Q38Q88 Q99714
CID 4171: metoprolol
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAU7 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 
B3KP78 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15244 O15245 P00533 P00918 P05177 P05181 
P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 
P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P35368 P37288 P41143 
P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88 Q92887
CID 4173: metronidazole
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4E2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MQX8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B7Z242 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8N7 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00352 P00533 P00918 
P02545 P05177 P05181 P06239 P06241 P07202 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 
P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 
P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P52895 Q01959 Q08209 Q16850 Q38Q88
CID 4174: metyrapone
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5S8 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 P02545 P05093 P05177 P05181 P06239 P06241 P07550 
P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P15538 P17252 P18825 P19099 P21397 P21452 P21554 P21728 P21917 
P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 
P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q38Q88
CID 4178: mexiletine
A0A024QZM9 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024R9Z8 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A024RDJ4 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 E9PG18 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 P02545 
P05177 P05181 P06133 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 
P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 




A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5S8 A0A024R5Z3 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RCN9 
A0A024RD15 A0A087WU84 A0A087WYJ0 A0A087WZL8 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTA6 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 
A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DKC0 B4DN15 B4E295 B5BNW5 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 E7ETZ0 F1D8N3 
F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 K9JA46 L7RSL3 L7RXH5 O15296 O15303 O15554 O75164 O75874 O94759 O94782 P00533 P00918 P02545 P05093 
P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 
P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35228 P35354 P35367 
P37288 P41143 P41595 P41968 P43220 P49146 P50052 P50406 P51681 Q01959 Q08209 Q16558 Q16850 Q38Q88 Q86W47 Q92952 Q99700 Q9BRL5 Q9H2S1 
Q9NPA1 Q9NQA5 Q9NS40 Q9UNA4
CID 4192: midazolam
A0A024QZY7 A0A024R5I4 A0A024R9X6 A0A024RAU7 A0A024RCN9 A4D1D2 A8K177 A8K496 A8MPY1 B2RCW8 B3KP78 B4DTP4 B7Z1F5 B7Z3P6 C1ID52 O15245 
O75164 O75874 O76068 P05181 P08684 P11712 P18505 P18507 P20813 P24046 P28476 P31644 P34903 P47870 P48169 P78334 P97717 Q01717 Q16236 
Q16445 Q8N1C3 Q96QE3 Q99928 Q9BY64 Q9UN88
CID 4195: midodrine
A0A024QZY7 A0A024R5Z3 A0A0A0MTJ0 B0ZBD3 C1ID52 P02545 P05177 P08684 P11712 P35368 Q92830
CID 4197: milrinone
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RCW6 A0A024RD15 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A7E2E5 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 
B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 D2KUA6 E5KQF5 F1D8N3 F1D8Q5 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O00408 
O76074 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 
P15428 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P27815 P28223 P28482 P30411 
P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P43220 P49146 P50052 P50406 P51681 Q01959 Q08209 Q13370 Q13526 Q14432 
Q38Q88
CID 4205: mirtazapine
A0A024QZY7 A0A024R3C5 A0A024R4E2 A0A024R6T9 A0A087WU84 A0A0A0MTJ0 A1A4V4 A8K5W4 B2R7Y7 B4E398 C1ID52 K9J958 O94925 P05177 P08684 
P08913 P11712 P18089 P18825 P21728 P21917 P28223 P28335 P34969 P35367 P43220 P83916 Q96QE3
CID 4211: mitotane
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3C7 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RCN9 
A0A024RCW6 A0A024RD15 A0A024RDJ4 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 
A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0FWH2 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B6ZGS9 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 D0VY79 D2KUA6 
E5KQF5 F1D8N3 F1D8N5 F1D8N7 F1D8P6 F1D8P8 F1D8Q5 F1D8S4 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O75164 P00533 P00918 P02545 P05108 
P05177 P05181 P06239 P06241 P07550 P08173 P08185 P08246 P08311 P08588 P08684 P08913 P10109 P11229 P11509 P11712 P14780 P15538 P17252 
P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 
P35354 P35367 P37288 P41143 P41595 P41968 P43220 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q13526 Q16236 Q38Q88 Q99549 Q9UIF8 
Q9Y468
CID 4212: mitoxantrone
A0A024QZY7 A0A024R136 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4X8 A0A024R5I4 A0A024R5Z3 A0A024R5Z9 A0A024R6L5 A0A024R6T9 
A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RAP4 A0A024RAU7 A0A024RAV2 A0A024RBV5 A0A024RCN9 A0A024RD15 A0A024RD25 A0A024RD62 
A0A024RDD4 A0A024RDJ4 A0A087WT22 A0A087WU84 A0A087WYZ4 A0A090N7W1 A0A090N8Z1 A0A0A0MQX8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 
A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8K7T1 A8KAF4 A8KAG8 B0LPE5 B0ZBE0 B2R7Y7 B2RXH2 B3KP78 B4DN15 B7Z1L9 B7Z1W5 
B7Z2G8 B7ZKN7 B8K2Q5 C1ID52 D0VY79 E5KQF5 F1D8N3 F1D8P8 F5H1T4 F8W6L1 G5E9C5 H6UYS5 H6VQ59 K9J958 L7RSL3 L7RXH5 O14746 O15118 O15244 
O15245 O15296 O60656 O75164 O75604 O75751 O75874 O94782 O94925 O95467 O96017 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 
P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11021 P11229 P11388 P11509 P11712 P14780 P16050 P17252 P18825 P19224 P19784 P21397 
P21452 P21554 P21728 P21917 P22303 P22309 P25021 P25024 P25025 P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 P32245 P33032 
P33527 P35354 P35367 P37288 P39748 P41143 P41595 P41968 P42345 P42858 P43220 P49146 P50052 P50406 P51681 P83916 Q01453 Q01959 Q02880 
Q03164 Q06187 Q08209 Q13526 Q14191 Q38Q88 Q86VL8 Q92830 Q92887 Q96FL8 Q96QE3 Q99549 Q99700 Q9UIF8 Q9UNA4 Q9Y468
CID 4236: modafinil
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O00519 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 
P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P21964 P22303 
P23977 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P35368 P37288 P41143 P41595 
P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88
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Q06187 Q06418 Q08209 Q08881 Q0IJ49 Q12866 Q13043 Q13131 Q13233 Q13464 Q13470 Q13547 Q13563 Q13627 Q13705 Q13873 Q13882 Q13976 Q14289 
Q15303 Q15375 Q15418 Q15569 Q15746 Q15759 Q15831 Q15835 Q16288 Q16512 Q16513 Q16566 Q16659 Q16790 Q17RV3 Q2M2I8 Q32MK0 Q38Q88 Q4LE27 
Q4VBY6 Q52WX2 Q53EW6 Q56UN5 Q5JXL9 Q5SQQ7 Q5VT25 Q6DT37 Q6P3R8 Q6PKF2 Q6XUX3 Q6ZN16 Q86UX6 Q86V86 Q86VL8 Q86YV6 Q8IW41 Q8IYT8 Q8N4C8 
Q8N568 Q8N5S9 Q8N752 Q8NE63 Q8NEV4 Q8NFD2 Q8TD08 Q8TDC3 Q8TDR2 Q8WTQ7 Q92630 Q92918 Q96FL8 Q96GD4 Q96L34 Q96NX5 Q96Q40 Q96SB4 Q99683 
Q9BRS2 Q9BVS4 Q9BX84 Q9BZL6 Q9H1R3 Q9H2G2 Q9H2K8 Q9H2X6 Q9H3Y6 Q9H4B4 Q9HAZ1 Q9NRP7 Q9NSY1 Q9NY57 Q9P289 Q9P2K8 Q9UBF8 Q9UEE5 Q9UEW8 
Q9UHD2 Q9UK32 Q9UKE5 Q9UL54 Q9UPE1 Q9UQB9 Q9Y2H1 Q9Y2H9 Q9Y616 Q9Y6M4 V9GXZ4
CID 5314: succinylcholine
A0A024QZ30 A0A024QZY7 A0A024R040 A0A024R2N2 A0A024R2Q0 A0A024R325 A0A024R3C5 A0A024R3S2 A0A024R4H0 A0A024R6T9 A0A024R9I2 A0A024R9Y0 
A0A024RAP2 A0A024RB43 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MSK8 A0A0A0MT22 A0A0A6YYA8 A0N0Q1 
A1A4V4 A2A3U5 A2RUS0 A4D0X1 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DF27 B4DK78 B4DN15 B4E1E9 B7Z1L9 B7ZKN7 B8K2Q5 
C1ID52 C4IXS7 D3DNN4 E5KQF5 E5KS60 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O14521 O15460 O60568 O75874 O75936 P00533 P00918 
P02708 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P20309 
P21397 P21452 P21554 P21728 P21912 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 
P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P53597 Q01959 Q08209 Q13183 Q32P28 Q38Q88 Q8IVL5 Q8IVL6 Q99643 
Q9BXA5 Q9BYC2 Q9NVH6
CID 5318: sulconazole
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B6ZGS9 
B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F1D8P9 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15296 O75604 O94782 P00533 P00918 P02545 
P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 P18825 P21397 
P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 P32245 P33032 P35354 
P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88 Q92830
CID 5320: sulfacetamide
A0A024QZY7 A0A024R4E2 A0A024R6L5 A0A024RDA5 A0A0A0MTJ0 B0YJ76 F1D8N5 O75874 P34949 P83916 Q92830 Q96FL8
CID 5344: sulfisoxazole
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A024RDA5 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 
B4DN15 B6ZGS9 B7Z1L9 B7Z242 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8N5 F1D8N7 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 P05177 
P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 
P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 
P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88
CID 5358: sumatriptan
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 
A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K5W4 A8K7N8 A8KAF4 A8KAG8 B0FWH2 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P9 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15244 O15245 P00533 P00918 P05177 P05181 P06239 P06241 
P07550 P08173 P08246 P08311 P08588 P08684 P08908 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 
P22303 P22309 P25021 P25024 P25025 P25101 P25103 P25929 P28221 P28222 P28482 P28566 P30411 P30939 P30966 P31388 P32238 P32245 P32305 
P33032 P34969 P35354 P35367 P37288 P41143 P41968 P47898 P49146 P50052 P51681 P83916 Q01959 Q08209 Q38Q88 Q96FL8
CID 5359: suprofen
A0A024R6T9 A0A087WU84 A0A087WWV0 B2R7Y7 B2RXH2 B8K2Q5 K9J958 P00352 P02545 P02768 P11712 P15428 P22309 P23219 P35354 P83916 Q92830
CID 5379: gatifloxacin
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MQX8 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 
B2RXH2 B4DN15 B7Z1L9 B7Z1W5 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00352 P00533 P00918 P02768 
P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11388 P11509 P11712 P14780 P15428 P16050 P17252 
P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 P32245 
P33032 P35354 P35367 P37288 P39748 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q02880 Q08209 Q38Q88 Q99714
CID 5381: tazarotene
A0A024QZY7 A0A024RCN9 A8K3H3 A8K840 B7Z7J5 F1D8S6 O94782 P10276 P10826 P13631 Q03164
CID 5391: temazepam
A0A024R9X6 A8K177 A8K496 A8MPY1 B2RCW8 B4DTP4 O60656 O76068 P02545 P06133 P16662 P18505 P18507 P19224 P22309 P24046 P28476 P31644 
P34903 P36537 P47870 P48169 P78334 Q16445 Q8N1C3 Q99928 Q9UN88
CID 5401: terazosin
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A068F658 A0A087WT22 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B2RXH2 B4DKC0 B4DN15 B4DN83 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 
O15245 O75164 O75874 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P06280 P07550 P08173 P08246 P08311 P08588 P08684 P08913 
P10253 P11229 P11509 P11712 P14780 P15428 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25100 
P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 P32245 P33032 P35348 P35354 P35367 P35368 P37288 P41143 P41595 P41968 P42858 
P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88 Q92887 Q96QE3 Q99714 Q9NS40 Q9UIF8
CID 5403: terbutaline
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MRL7 
A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 D0VY79 D3DNN4 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O94782 P00533 P00918 P02545 P05177 P05181 
P06239 P06241 P08173 P08246 P08311 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 
P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 
P50052 P50406 P51681 Q01959 Q03164 Q08209 Q38Q88
CID 5411: tetracaine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RBV5 A0A024RCN9 A0A024RD15 
A0A068F658 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B7Z242 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 E9PG18 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 
L7RXH5 O15296 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11021 P11229 P11509 
P11712 P14780 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 
P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01453 Q01959 Q08209 Q15858 Q38Q88 
Q92830 Q99250 Q99700 Q9UIF8 Q9Y5Y9
CID 5419: tetrahydrozoline
A0A024QZY7 A0A024R909 A0A024RAP4 B7ZKN7 C1ID52 O75874 P00352 P21728 P43220 P83916 Q96RJ0
CID 5426: thalidomide
A0A024QZY7 A0A024R2H8 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 
A0A024RDJ4 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 D2CGD1 E5KQF5 F1D8N3 F1D8N7 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 
O00519 P00352 P00533 P00918 P01375 P05177 P05181 P06239 P06241 P06401 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 
P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 
P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88
CID 5430: thiabendazole
A0A024R1V0 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Z8 A0A024RAP2 A0A024RBV5 A0A024RD15 
A0A087WT22 A0A087WTS4 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A0N0X8 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 
A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B8K2Q5 C1ID52 D0VY79 E5KQF5 F1D8N3 F1D8N7 F1D8P6 F5H1T4 F8VQZ7 
G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15118 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 
164
P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 
P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P53582 Q01959 Q08209 Q38Q88 
Q96FL8 Q96QE3 Q99700
CID 5452: thioridazine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R5Z3 A0A024R6L5 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 
A0A024RAP2 A0A024RAU7 A0A024RBV5 A0A024RCN9 A0A024RD15 A0A024RD25 A0A087WT22 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 
A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A0PJF5 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A4D2N2 A8K1F6 A8K249 A8K4S9 A8K5W4 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 
B0ZBE0 B2KJ49 B2R7Y7 B2RXH2 B3KP78 B4DN15 B4E398 B7Z1L9 B7Z2G8 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 F8W6L1 G5E9C5 H6VQ59 K9J958 L7RSL3 
L7RXH5 O00325 O15118 O75164 O75874 O94782 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P08173 P08246 P08311 P08684 P08908 
P08913 P11229 P11509 P11712 P14780 P16050 P17252 P17405 P18825 P21397 P21452 P21554 P21728 P21917 P21918 P22303 P25021 P25024 P25025 
P25101 P25103 P25929 P28221 P28222 P28223 P28335 P28482 P28566 P30411 P30939 P31388 P32238 P32245 P32297 P32305 P33032 P34969 P35354 
P35367 P35368 P37288 P39748 P41143 P41595 P41968 P42345 P42858 P43220 P48542 P49146 P50052 P50406 P51681 P83916 Q01453 Q01959 Q03164 
Q08209 Q15822 Q38Q88 Q92887 Q96QE3 Q99549 Q99700 Q99714 Q9UIF8 Q9UNA4
CID 5453: thiotepa
A0A024QZY7 A0A024R5I4 A0A024R6L5 A0A024R909 A0A024RAU7 A0A024RCN9 B3KP78 D9YZU5 F1D8P8 P02545 P08684 P09211 P15428 P20813 P83916 
Q9UNA4
CID 5472: ticlopidine
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3C7 A0A024R3S2 A0A024R5I4 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAP4 A0A024RAU7 A0A024RAV2 
A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 
A4D1Q0 A8K1F6 A8K249 A8K7N8 A8K7T1 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B3KP78 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 
H6VQ59 K9J958 L7RSL3 L7RXH5 O75164 O75604 O75874 O95467 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 
P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P20813 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 
P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P43220 P49146 P50052 
P50406 P51681 P83916 Q01959 Q08209 Q38Q88 Q96QE3 Q99700 Q9H244 Q9UIF8 Q9UNA4
CID 5479: tinidazole
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R4E2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MQX8 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07550 
P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 
P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 
P50406 P51681 P83916 Q01959 Q08209 Q38Q88 Q92887
CID 5487: tizanidine
A0A024QZY7 A0A024R909 A0A024RCN9 A2RUS0 O00519 P02545 P05177 P08913 P18825 P83916 Q96QE3 Q9UIF8 Q9UNA4 Q9Y2I1
CID 5503: tolazamide
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3K6 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RCN9 A0A024RD15 
A0A024RDJ4 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 
A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O75164 O94782 
O94925 P00352 P00533 P00918 P02768 P05177 P05181 P06239 P06241 P06280 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P10253 P11229 
P11509 P11712 P14780 P17252 P18054 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P27695 
P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 P78508 Q01959 Q08209 
Q38Q88 Q92830 Q9UIF8
CID 5523: tramadol
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RAP4 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 
A0A0A0MSK3 A0A0A0MT22 A0A0A6YYA8 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 
B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 
P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 
P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P43220 P49146 P50052 
P50406 P51681 Q01959 Q08209 Q38Q88 Q8TCU5 Q92887
CID 5533: trazodone
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAH7 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A0PJF5 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A4D2N2 A8K1F6 A8K249 A8K5W4 A8K7N8 
A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2KJ49 B2R7Y7 B2RXH2 B4DK78 B4DN15 B4E398 B7Z1L9 B8K2Q5 C1ID52 D0VY79 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 
K9J958 L7RSL3 L7RXH5 O00325 O00519 O94782 P00352 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P08246 P08311 P08684 P08909 P08913 
P11509 P11712 P14780 P14842 P15428 P17252 P17405 P18825 P21397 P21452 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 
P28221 P28223 P28335 P28482 P30411 P32238 P32245 P32297 P33032 P34969 P35354 P35367 P35368 P37288 P41595 P41968 P49146 P50052 P51681 
P83916 Q08209 Q15822 Q38Q88 Q92830 Q99714
CID 5546: triamterene
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5Z3 A0A024R5Z9 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 
A0A024RCW6 A0A024RD15 A0A024RDA5 A0A024RDJ4 A0A068F658 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MQX8 A0A0A0MRG0 A0A0A0MRL7 A0A0A0MSK3 
A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A5X2V1 A6NNF7 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 
B2R812 B2RXH2 B4DN15 B6ZGS9 B7Z1L9 B8K2Q5 C1ID52 D0VY79 D2KUA6 E5KQF5 F1D8N3 F1D8N5 F1D8N7 F1D8P8 F1D8Q5 F5H1T4 G5E9C5 H6VQ59 K9J958 
L7RSL3 L7RXH5 O60674 O75874 P00352 P00533 P00918 P01375 P02545 P05177 P05181 P06239 P06241 P06280 P07550 P08173 P08246 P08311 P08588 
P08684 P08913 P10253 P11229 P11509 P11712 P14780 P15428 P17252 P18054 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 
P25025 P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37088 P37288 P41143 P41595 P41968 P42345 
P49146 P50052 P50406 P51168 P51170 P51681 P83916 Q01453 Q01959 Q08209 Q13526 Q38Q88 Q92830 Q96QE3 Q99700 Q99714
CID 5556: triazolam
A0A024R5I4 A0A024R9X6 A0A024RAU7 A8K177 A8K496 A8K7N8 A8MPY1 B2RCW8 B3KP78 B4DTP4 O76068 P08684 P14867 P18505 P18507 P24046 P28476 
P31644 P34903 P47869 P47870 P48169 P78334 Q16445 Q8N1C3 Q99928 Q9UN88
CID 5566: trifluoperazine
A0A024QYX0 A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5Z3 A0A024R6L5 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 
A0A024RAP2 A0A024RAP4 A0A024RBV5 A0A024RCN9 A0A024RD15 A0A024RDJ4 A0A068F658 A0A087WT22 A0A087WU84 A0A087WYZ4 A0A090N7W1 A0A090N8Z1 
A0A0A0MQX8 A0A0A0MRG0 A0A0A0MRV2 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A6NGA6 A8K1F6 A8K249 
A8K5W4 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B7Z1W5 B7Z2G8 B8K2Q5 C1ID52 E5KQF5 E7ETZ0 F1D8N3 F1D8P8 F5H1T4 
F8W6L1 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15118 O15296 O75164 O75604 O75874 O94782 O95467 P00352 P00533 P00918 P02545 P02593 P05177 
P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11021 P11229 P11509 P11712 P14416 P14780 P16050 P17252 P18825 
P20648 P21397 P21452 P21554 P21728 P21917 P22303 P22310 P25021 P25024 P25025 P25101 P25103 P25929 P26447 P28223 P28335 P28482 P30411 
P30939 P32238 P32245 P33032 P34969 P35354 P35367 P37288 P41143 P41595 P41968 P42345 P42858 P43220 P47989 P49146 P50052 P50406 P51681 
P61088 P63316 P78527 P83916 Q01453 Q01959 Q08209 Q16236 Q38Q88 Q92830 Q96QE3 Q99549 Q99700 Q99714 Q9BRL5 Q9HC16 Q9NYX4 Q9UIF8 Q9UNA4
CID 5572: trihexyphenidyl
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RD15 A0A024RDJ4 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O15296 O75874 
O94782 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 
P17405 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P27695 P28223 P28482 P30411 P32238 
P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01453 Q01959 Q08209 Q38Q88 Q99700
CID 5578: trimethoprim
A0A024QZY7 A0A024R5I4 A0A024RAU7 A0A024RCN9 A0A024RDA5 A0A024RDJ4 A0A090N7W1 A0A0A0MTJ0 A4D1D2 B0YJ76 B3KP78 B7Z1F5 B7Z242 B7ZKN7 
C1ID52 O15245 P00352 P04818 P05177 P08684 P11712 P21397 P21728 P83916 Q92887 Q96QE3 Q99714 Q9HBH1
CID 5591: troglitazone
A0A024QYT5 A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 
A0A024RAU7 A0A024RAV2 A0A024RCN9 A0A024RCW6 A0A024RD15 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 
A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B6ZGS9 B7Z1F5 B7Z1L9 B7Z242 B7Z5E9 B8K2Q5 C1ID52
D2KUA6 E5KQF5 F1D8N3 F1D8N5 F1D8N7 F1D8P8 F1D8Q5 F1D8S4 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15245 O15296 O60341 O94782 O95342 
P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11474 P11509 P11712 P14780 P17252 
P18825 P19224 P21397 P21452 P21554 P21728 P21917 P22303 P22309 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 
P32245 P33032 P35354 P35367 P37231 P37288 P41143 P41595 P41968 P49146 P50052 P50225 P50406 P51681 Q01959 Q08209 Q38Q88 Q5DSZ6 Q5DT02 
Q92830 Q99808 Q9HCF6
CID 5593: tropicamide
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A024RDJ4 
A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0A0A0MTJ0 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 
A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B4DN83 B7Z1L9 B7ZKN7 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 
P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P20309 
P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 
P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q38Q88 Q99714
CID 5625: delavirdine
C1ID52 O00519 O15438 P08684 P11712 P33527 Q92887
CID 5656: venlafaxine
165
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 
A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K5W4 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 P00533 P00918 P02545 P05177 P05181 P06239 
P06241 P07550 P08246 P08311 P08588 P08684 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P23975 P25021 
P25024 P25025 P25101 P25103 P25929 P28482 P30411 P31645 P32238 P32245 P33032 P35354 P37288 P41143 P41968 P49146 P50052 P50406 P51681 
Q08209 Q38Q88
CID 5665: vigabatrin
A0A024RCN9 A0A024RDJ4 A0A0A0MTJ0 B7ZKN7 C1ID52 O94782 P21728 P80404 P83916 Q5SUJ9 Q92830 Q9H598
CID 5717: zafirlukast
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RAP4 A0A024RAV2 
A0A024RCN9 A0A024RD15 A0A087WU84 A0A090N7W1 A0A090N8Z1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 
A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B4E292 B7Z1F5 B7Z1L9 B7Z1W5 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F1D8P8 F5H1T4 G5E9C5 H6VQ59 
K9J958 L7RSL3 L7RXH5 O15244 O94782 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 
P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 P28223 P28482 
P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 Q01959 Q08209 Q15722 Q38Q88 Q5KU17 
Q86VL8 Q92830 Q96FL8 Q9NS75 Q9UIF8 Q9Y271
CID 5719: zaleplon
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 
A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K177 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B8K2Q5 
C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O76068 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 
P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 
P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P49146 P50052 P50406 P51681 
Q01959 Q06278 Q08209 Q38Q88 Q92830
CID 5732: zolpidem
A0A024R9X6 A8K177 B2RXH2 C1ID52 O76068 P02545 P05177 P08684 P11712 P14867 P15428 P31644 P34903 P47869 P48169 Q16445 Q99714
CID 5734: zonisamide
A0A024QZY7 A0A024R3H7 A0A024RBW9 A0A090N7W1 A8K3J4 B0YJ93 B3KQH9 B3KUB4 B4DUH8 B7Z1F5 B7Z242 B7ZKN7 E9PG18 O00519 O43497 O43570 
O60939 O76068 P00915 P00918 P07451 P08684 P21397 P22748 P35218 P35219 P35498 P35499 P43166 Q06278 Q07699 Q15858 Q16790 Q8N1Q1 Q99250
Q9C007 Q9NS85 Q9P0X4 Q9UI33
CID 5735: zopiclone
A0A024R9X6 A0A024R9Y0 A0A024RAV2 A0A024RCN9 A0A0A0MQX8 A0A0A0MTJ0 A8K177 B7Z1F5 C1ID52 O00519 O76068 O94782 P05181 P08684 P31644 
P34903
CID 5746: mitomycin C
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5Z3 A0A024R6L5 A0A024R6T9 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RAP4 
A0A024RD15 A0A087WT22 A0A087WU84 A0A087WYZ4 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1D2 A4D1Q0 
A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B2RXH2 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 
L7RXH5 O75874 O94782 O95467 P00352 P00533 P00918 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 
P11509 P11712 P14780 P14902 P16435 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 P25024 P25025 P25101 P25103 P25929 
P27695 P28223 P28482 P30411 P32238 P32245 P33032 P35354 P35367 P37288 P41143 P41595 P41968 P42858 P49146 P50052 P50406 P51681 Q01959 
Q08209 Q38Q88 Q99700 Q9UNA4
CID 5775: phentolamine
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024R9Y0 A0A024RAP2 A0A024RCN9 A0A024RD15 A0A087WU84 
A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBD3 B0ZBE0 
B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 E5KQF5 F1D8N3 F5H1T4 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O75164 O94925 P00533 P00918 P01258 P01275 
P02545 P05177 P05181 P06239 P06241 P07550 P08173 P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P17252 P18089 P18825 
P21397 P21452 P21554 P21917 P22303 P25021 P25024 P25025 P25100 P25101 P25103 P25929 P27815 P28223 P28482 P30411 P32238 P32245 P33032 
P35348 P35354 P35367 P35368 P37288 P41143 P41595 P41968 P43140 P43220 P49146 P50052 P50406 P51681 P83916 Q01959 Q08209 Q38Q88 Q96QE3 
Q99700 Q9UIF8 Q9UNA4 Q9Y2I1
CID 5978: vincristine
A0A024QZY7 A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R5I4 A0A024R5Z3 A0A024R6T9 A0A024R909 A0A024R9I2 A0A024RAP2 A0A024RAU7 
A0A024RCN9 A0A024RD15 A0A024RD21 A0A087WT22 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 
A4D1D2 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B3KP78 B4DMJ5 B4DN15 B4DXF8 B7Z1L9 B7Z3P6 B8K2Q5 C1ID52 D0VY79 E5KQF5 
F1D8N3 F5H1T4 F8W6L1 G5E9C5 H6VQ59 K9J958 L7RSL3 L7RXH5 O15296 P00533 P00918 P02545 P05177 P05181 P06239 P06241 P07437 P07550 P08173
P08246 P08311 P08588 P08684 P08913 P11229 P11509 P11712 P14780 P16050 P17252 P18825 P21397 P21452 P21554 P21728 P21917 P22303 P25021 
P25024 P25025 P25101 P25103 P25929 P28223 P28482 P30411 P32238 P32245 P33032 P33527 P35354 P35367 P37288 P41143 P41595 P41968 P42345 
P42858 P49146 P50052 P50406 P51681 P68366 P83916 Q01959 Q08209 Q16236 Q38Q88 Q92887 Q96QE3 Q99700
CID 6018: tetrabenazine
A0A024R3C5 A0A024R9Y0 A0A0A0MTJ0 B2RXH2 B7Z1W5 F1D8P8 O15296 O75164 O94925 P00352 P15428 P28482 P39748 P42345 P43220 P54219 Q05940 
Q96QE3 Q99714 Q9UNA4
CID 6049: EDTA
A0A024R6L5 A0A024RCN9 E5KQF5 O15296 Q16236
CID 6256: trifluorothymidine
A0A024QZY7 O75874 P02545 P04818 P18054 P43220 P83916 Q96QE3 Q99700 Q9UNA4
CID 6476: methsuximide
A0A024R9X6 A8K177 O43497 P31644 P32239 P34903 Q16445 Q9P0X4
CID 6503: Tris-HCl
A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R8U8 A0A024R9I2 A0A024R9I5 A0A024RAP2 A0A024RAP4 A0A024RBG6 A0A024RD15 
A0A024RD33 A0A087WU84 A0A088AWN0 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 
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A0A024R2N2 A0A024R2Q0 A0A024R3C5 A0A024R3S2 A0A024R6T9 A0A024R9I2 A0A024RAP2 A0A024RD15 A0A087WU84 A0A090N7W1 A0A0A0MRG0 A0A0A0MSK3 
A0A0A0MT22 A0N0Q1 A1A4V4 A2A3U5 A2RUS0 A4D1Q0 A8K1F6 A8K249 A8K7N8 A8KAF4 A8KAG8 B0ZBE0 B2R7Y7 B4DN15 B7Z1L9 B8K2Q5 C1ID52 D0VY79 
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A0A024QZY7 E9PG18 O75874 P08684 P83916 Q14524 Q92830 Q96QE3
CID 8271: mephobarbital
A0A024R9X6 A0A024RCN9 A0A0A6YYA8 A8K177 B4DK78 P02545 P14867 P20813 P31644 P34903 P42262 P48169 Q16445
CID 8612: chloroprocaine
B4E398 C4IXS7 P05023 Q01959 Q8TCU5 Q9Y5Y9
CID 10100: propoxyphene
A0A087WU84 A0A090N7W1 A4D2N2 B8K2Q5 C1ID52 P41143 P83916
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A0A024R8U1 A0A024RBB2 P18505 Q9BXC0 Q9HAB3
CID 12555: benzydamine
B2RXH2 B7Z1W5 C1ID52 O15296 O75874 P43220 P83916
CID 16362: pimozide
A0A024QZY7 A0A024R3C5 A0A024R3S2 A0A024R4E2 A0A024R6L5 A0A024R9Y0 A0A024RAP4 A0A024RBV5 A0A024RCN9 A0A024RCW6 A0A024RDJ4 A0A087WT22 
A0A087WV24 A0A090N7W1 A0A090N8Z1 A0A0A0MTJ0 A1A4V4 A2RUS0 A4D1D2 A8K5W4 A8KAF4 B0ZBD3 B2R7Y7 B2RXH2 B6ZGS9 B7Z1F5 B7ZKN7 B8K2Q5 
C1ID52 D0VY79 D2KUA6 E7ETZ0 F1D8N5 F1D8N7 F1D8P8 F1D8Q5 F8W6L1 K9J958 O15244 O15296 O43497 O54898 O75164 O75604 O75874 O94782 P00352 
P02545 P05177 P08684 P08908 P08913 P11021 P11229 P11712 P14416 P16050 P17405 P18825 P19020 P20813 P21917 P27695 P28221 P28223 P28482 
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B7Z242 P00915 P00918 P08684 P16066 P22748 P33402 Q02108 Q02153
CID 30623: dexrazoxane
A0A024RCN9 F1D8P8 P02545 P11388 P39748 Q02880 Q9UNA4
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